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ABSTRACT
Peptide bonds containing proline residues are
often resistant to the action of peptidases because of
the unique pyrrolidine-ring structure of proline.
Therefore, in order to hydrolyse proline peptide bonds
there are a number of proline-specific peptidases. At
the final stage of hydrolysis, dipeptides with
N-terminal proline are hydrolysed by prolinase and
those with C-terminal proline by prolidase. These two
enzymes have been little studied in human tissues and
the assay methods used up until now are relatively
insensitive.
Initially, prolinase was studied. A new
sensitive fluorimetric assay was developed for
estimating prolinase activity and a study was made of
its properties. Using ion-exchange chromatography, gel
filtration and isoelectrofocusing, two distinct forms
of prolinase were found to be present in cultured skin
fibroblasts. Human kidney, however, had only a single
form which also seemed to have non-specific dipeptidase
activity. To study this further, the enzyme was
purified from human kidney using a wide variety of
separative techniques and a number of properties
studied. The results confirmed that prolinase
substrates are hydrolysed by a non-specific dipeptidase
in human kidney.
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Two new methods for assaying prolidase were also
developed after which, detailed studies of the enzyme's
properties could be made. Prolidase deficiency is an
autosomal recessive disease associated with chronic
ulcerative dermatitis, mental retardation and
imidodipeptiduria. Using cultured skin fibroblasts
from two unrelated cases of prolidase deficiency, the
residual activity was determined with a variety of
substrates. The results showed a marked change in
substrate specificity rather than a complete deficiency
of prolidase in the cases. Later, using ion-exchange
chromatography, it was found that there are also two
forms of prolidase. These were designated peaks I and
II. The two forms differed in substrate specificity,
heat stability and inhibition with p-hydroxymercuri-
benzoate. In the two cases of prolidase deficiency,
fibroblast peak I was markedly reduced although still
detectable, whereas peak II was active against all
substrates except for a 90% reduction against
glycyl-proline. These results imply that the two forms
of prolidase are structurally related.
Finally, the first peak of prolidase was purified
from human kidney and injected into rabbits to raise
specific antisera to the enzyme. Using immunoblotting
after polyacrylamide gel electrophoresis, it was then
possible to show that the first peak of prolidase is
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1.1. PROLINE AND PROLINE-SPECIFIC PEPTIDASES
The pyrrolidine-ring structure of proline makes
it unique among the amino acids, it also lacks the
amino group common to all the other amino acids. The
nitrogen atom is part of the rigid pyrrolidine ring not
allowing any rotation of the N-Cx bond. Because of
this, whenever proline (or hydroxyproline) occurs in a
peptide chain, it interrupts the a-helix and creates a
kink or bend. In this way proline residues have a
large effect upon the structure and conformation of
peptides and proteins in solution. Proline and
hydroxyproline, which comprise about one quarter of all
the amino residues in collagen, are regularly spaced
forcing the chain to assume a peculiar kinked type of
helix because of the rigidity of the pyrrolidine ring.
In collagen this gives rise to the triple helix.
Because of this unusual structure, proline-
containing peptides are often resistant to the action
of peptidases (Walter et al., 1980). Thus to complete
the hydrolysis of proteins and peptides to their
constituent amino acids, there are a number of
proline-specific peptidases. At the final stage of
hydrolysis dipeptides of the form Proline-X (where X =
C-terminal amino acid with one amino group) are
hydrolysed by the specific dipeptidase prolinase [E.C.
1
3.4.13.8] (see fig. la). Alternatively, dipeptides of
the form X-Proline (X = N-terminal amino acid with one
amino group) are hydrolysed by the specific dipeptidase
prolidase [E.C. 3.4.13.9] (see fig. lb). Other
dipeptides not containing proline are hydrolysed by one
or more non-specific enzymes.
Prolidase deficiency (McKusick 26413) is an
autosomal recessive disease with characteristic
clinical features and is discussed in section 1.4. No
such deficiency of prolinase has been observed.
1 1 Prolinase I 1
VC—NH-CH9C—OH >- N C-OH + NH2CH2C-OHH II 2|| H II ^
0 0 o 0
Prolyl-Glycine Proline Glycine
Prolidase
, I .^N-^C-OH >- NH2CH2C-OH + ^N-^C-OH





Fig. 1 The actions of a) Prolinase and b) Prolidase.
1.1.1. The physiological roles of prolinase and
prolidase
The precise physiological roles o£
proline-specific enzymes are unknown. It is assumed
that they aid in the general catabolism of the peptides
and proteins to their constituent amino acids for
eventual reut ilisation by the cell. Some of these
enzymes have widely different distributions in tissues
suggesting that they may be intimately related to the
specialised functions of particular tissues (Walter et
al., 1980 ; Imai et al., 1982). The high content of
proline in collagen probably signifies that these
enzymes must be important in collagen turnover with
prolinase and prolidase acting at the final step.
A large number of neuroactive peptides and
hormones contain proline (see Table 1), so these
enzymes are likely to be of importance in the
termination of hormone functions. Also, proline is a
putative neurotransmitter (Felix and Kunzle, 1976) so
it is quite possible that prolinase and prolidase play
a key role in its availability. Inhibition or
activation of prolinase and prolidase may also have an
important influence on the distribution and levels of
proline and proline dipeptides (Hui and Lajtha, 1980).
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Table 1. Peptide hormones containing proline
Adrenocorticotrophic hormone (ACTH)











Luteinising hormone releasing hormone (LH-RH)
fi-Lipotropin











The action of prolinase was first described by
Grassman et al. (1932) and has subsequently been
purified to varying degrees from porcine (Davis and
Smith, 1953; Mayer and Nordwig, 1973) and bovine
(Akrawi and Bailey, 1976; 1977) kidney. The enzyme has
no activity against either prolinamide, tripeptides or
dipeptides in which the imino group is acylated (Smith,
1955 ) and may therefore be considered to be a strict
dipeptidase. Various preparations have had low
activities against prolyl-leucinamide and towards
dipeptides without N-terminal proline (Sarid et al.,
1962; Nordwig and Mayer, 1973; Akrawi and Bailey, 1976)
but it is not clear whether these activities were due
to contaminating enzymes. However, it has been
proposed that the prolinase and non-specific
dipeptidase activities may be due to a single enzyme
(Hayman and Patterson, 1971).
1.3. PROLIDASE
Prolidase activity was first detected by Bergmann
and Fruton (1937) and is widely distributed in man and
animals (Smith, 1951; Hui and Lajtha, 1978). The
enzyme has been purified from porcine kidney (Davis and
Smith, 1957) and intestine (Sjostrom et al., 1973).
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More recently human erythrocyte prolidase has been
purified for the first time (Endo et al.f 1982).
Like prolinase, prolidase is a strict dipeptidase
requiring both a free a-amino and a-carboxyl group.
Tripeptides or N-acyl derivatives of dipeptides are not
cleaved. The enzyme is highly specific for proline at
the C-terminus although cleavage of dipeptides with
C-terminal hydroxyproline and sarcosine does occur.
Prolidase therefore probably recognises the imide bond
rather than the pyrrolidine ring. It shows little
specificity for amino acids at the N-terminus (Walter
et al., 1980), and has been shown to be specific for
the trans isomers of X-Pro dipeptides (Lin and Brandts,
1979; King et al., 1986). The enzyme is reported to be
composed of two identical non-covalently bound subunits
with a molecular weight of 55,000 giving a molecular
weight of 110,000 for the native enzyme (Endo et al.,
1982).
Manganese ions have been shown to activate
prolidase (Smith, 1948a; Walter et al., 1980), whereas
EDTA, fluoride, citrate (Adams and Smith, 1952) and
iodoacetamide and p-chloromercuribenzoate (Davis and
Smith, 1957) exhibit an inhibitory effect. If
manganese is added prior to iodoacetamide no inhibition
is observed, indicating that manganese binds to an SH
group.
Recently a hypothetical active-site model has
been proposed for prolidase (King et al., 1986)
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modifying an earlier model proposed by Hui and Lajtha
(1978). This new model is shown in Fig. 2. Its main
characteristics are: i) cationic and anionic binding
sites for the C- and N-termini respectively; ii) a
pocket to bind the pyrrolidine ring; iii) a binding
2 +
site for Mn oriented such that the peptide bond
carbonyl group can only be polarised if the substrate
is in the trans conformation; and iv) no specific
binding site for the N-terminal amino acid.
Fig. 2 Hypothetical active site of prolidase as
proposed by King et al. (1986); the hatched




Nearly 20 years ago, Goodman et al. (1968)
described a patient with massive urinary excretion of
glycyl-proline and skin and visceral symptoms
resembling lathyrism. Buist et al. (1972)
reinvestigated this patient and found that purified
porcine prolidase hydrolysed the imidodipeptides in the
urine and hypothesised a prolidase deficiency. In 1974
Powell et al. were the first to directly demonstrate a
deficiency of prolidase activity in both the
erythrocytes and leucocytes from a 7-year old boy with
imidodipeptiduria and similar clinical features to
Goodman's patient. Prolinase activity was normal.
Prolidase deficiency was then confirmed in the patients
of Jackson et al. (1975). Up until now about 20 cases
of prolidase deficiency have been reported (Myara et
al., 1984a).
1.4.2. Clinical findings
Recently Der Kaloustian et al. (1982) made an
exhaustive clinical review of prolidase deficiency.
The first symptoms of the disease can appear as early
as six days of life and are usually manifested in the
first years of life. Symptoms related to collagen
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disturbance are the most important: skin ulceration or
fragility with scar formation, purpuric lesions,
telangiectasia, poliosis, photosensitivity and
thickening of the skin with lymphoedema. There may
also be musculoskeletal abnormalities including joint
laxityr osteoporosis and structural anomalies. The
predominant dermatological feature is chronic
recalcitrant ulceration on the lower parts of the legs.
Among prominent non-dermatological findings associated
with prolidase deficiency are: mental retardation,
unusual facial appearance, splenomegaly, optical
findings and deafness. Recurrent infections including
otitis media, sinusitis and cellulitis are also common
and could be due to a disturbance of the complement
fraction Clq which contains a high level of iminoacids
(Porter and Reid, 1978; Scriver et al., 1983).
Although the lymphoedema might possibly be
explained by osmotic disturbances resulting from the
accumulation of non-degraded dipeptides, the manner in
which deficiency of prolidase is responsible for the
clinical manifestations of the disease is unclear,
particularly since there are reports of asymptomatic
cases (Umemura et al., 1978; Isemura et al., 1979).




Massive imidodipeptiduria is the major laboratory
finding and patients may excrete as much as 3g
proline/day (Scriver et al., 1983). Characterisation
of the urinary dipeptides reveals a number of
proline-containing dipeptides the major ones of which
are shown in Table 2. Glycyl-Proline comprises one
fifth of the total imidodipeptides excreted (Scriver et
al., 1983).
Since proline and hydroxyproline together account
for 22% of the amino acid residues in collagen, it
would be expected that collagen metabolism would be
most affected by an enzyme defect such as prolidase
deficiency. Originally, it was proposed that the
imidodipeptides were excreted as the result of a
massive increase in collagen turnover with increased
collagen metabolism (Powell et al., 1974). However,
more recent data indicate the imidodipeptides to be
derived to a considerable extent from sources other
than collagen, as proposed by Sheffield et al. (1977).
In collagen there are approximately equivalent
concentrations of proline and hydroxyproline residues.
In prolidase deficiency the imidodipeptides are mostly
of the form X-proline with only a small amount of
X-hydroxyproline excreted (Powell et al., 1977;














Table 2. The major dipeptides excreted in the urine of a
patient with prolidase deficiency
(after Powell et al., 1974)
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are in relatively high concentrations whereas glutamate
and aspartate have very low levels in collagen.
Royce and Danks (1982) showed a normal
proline in collagen secreted by skin fibroblasts from
hydroxylation of a prolidase deficient patient
supporting the hypothesis that proteins other than
collagen contribute to the constitution of the
imidodipeptiduria. This imidodipeptiduria is not
symptomatic of prolidase deficiency and has been
reported in rickets (Scriver et al., 1964; Scriver,
1964; Saville and Alderman, 1970), hyperparathyroidism
(Thomson et al., 1969; Cahill et al., 1970) and unusual
bone diseases (Marshall, 1962; Seakins, 1963; Alderman
et al., 1969; Isaacs et al., 1971). Thus prolidase
activity should be determined to confirm an enzymatic
nature to the imidodipeptiduria.
1.4,4. Collagen investigations
A number of investigations have been undertaken
to study the effect of prolidase deficiency on
collagen. Amino acid composition, the hydroxylation
rate of proline and lysine residues and glycosylation
of hydroxylysine were similar to that in normal
collagen (Myara et al., 1984a). Also, Isemura et al.
(1981) examined the skin collagen of a patient with
prolidase deficiency for the distribution of
borohydride-reducible cross-links and the ratio of type
III to type I collagen. The patient's skin contained
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more dihydroxylysinonorleucine and a larger proportion
of type III collagen. This modification was also noted
by Myara et al. (1983) studying prolidase-deficient
fibroblasts in which they found: i) collagen is present
in normal amounts; ii) a modified ratio of type I to
type III collagen; iii) collagen hydroxylation is
normal; iv) the proline pool is significantly decreased
because proline is trapped for imidodipeptide synthesis
and thus cannot be reused.
Jackson et al. (1975) proposed a blocking of the
normal re-cycling of proline, slowing the normal rate
of production of collagen or leading to the formation
of an abnormal collagen. The collagen-related clinical
manifestations of prolidase deficiency may therefore be
related to this proline deficit. However, patients do
not seem to benefit from proline-supplemented diets.
1.4.5. Genetics
The gene locus of prolidase has been assigned to
chromosome 19 in man (McAlpine et al., 1976; Brown et
al., 1978). Prolidase deficiency is a genetic disease
inherited as an autosomal recessive trait (Powell et
al. , 1974; Gejyo et al., 1980 ; Isemura et al., 1981).
Heterozygotes present without any clinical or
biochemical symptoms and their erythrocyte prolidase
activity was about 50% of that of controls (Ogata et
al., 1981). As with other genetic diseases there is a
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fair deal of heterogeneity and some asymptomatic cases
have been reported (Isemura et al., 1981; Arata et al.,
1979) .
Lewis and Harris (1969) studied prolidase in
erythrocytes from a number of different individuals
after starch gel electrophoresis. This showed the
existence of various prolidase phenotypes. The usual
phenotype is referred to as Pep Dl and the variants Pep
D2, Pep D2-2 and Pep D3-1.
1.4.6. Treatment
Because of the massive loss of proline through
imidodipeptiduria, Powell et al. (1974) suggested
treatment with a dietary supplement of proline. This
was attempted by Sheffield et al. (1977) and Isemura et
al. (1979) but without any clinical improvement.
Sheffield et al. (1977) then proposed therapy with
drugs that may act on collagen synthesis or inhibit
collagenase such as diphenylhydantoin or oxaceprol.
Manganese and ascorbic acid, cofactors for prolidase
activity and collagen synthesis, were also suggested
for treatment. Diphenylhydantoin and oxaceprol failed
to improve the clinical condition of one patient but
manganese and ascorbic acid led to a disappearance of
skin rashes and a dramatic reduction in glycy1-proline
excretion, but without any improvement in the leg
ulcerations (Charpentier et al., 1981). In an earlier
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study high doses of ascorbic acid in intravenous
infusions had been ineffective (Lapiere and Nusgens,
1969). Pedersen et al. (1983) treated their four-year
old patient with manganese, ascorbic acid and proline
daily and saw a definite clinical improvement of the
skin manifestations. Discrepancies between the results
of various authors may be due to the different ages of
the patients, the severity of the skin lesions or the
combination of drugs used.
Enzyme replacement therapy has been attempted in
two patients (Isemura et al., 1981; Endo et al., 1982).
No significant changes in the imidodipeptiduria were
observed and the clinical symptoms were unchanged
though Endo et al. (1982) found prolidase activity in
the patient's erythrocytes to be raised to about 35% of
control values after erythrocyte infusion.
Ogata et al. (1981) treated the leg ulcerations
with wet dressings containing antibiotics or proline
and also attempted split thickness skin grafting. This
had a temporary beneficial effect for about a month
followed by rejection in one patient whereas another
patient kept the grafts for two years before they were
rejected.
The anti-leprosy drug, Dapsone (diamino 4,4'
diphenyl sulphone), has been administered to several
patients and did cause accelerated epithelialisation of
the ulcers. Dapsone may therefore be considered for
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use in the treatment of prolidase deficiency, though
its mechanism of action is unknown.
The most recent proposal for the treatment of the
leg ulcerations seems to be the most promising. Arata
et al. (1986) applied a topical ointment containing
both glycine and proline to the leg ulcers of an adult
patient and observed a dramatic improvement. These
ulcers still remain healed after six months.
It seems to be most important that prolidase
deficiency is diagnosed in early childhood in order to
begin therapy at as early an age as possible. Then the
leg ulceration and maybe even the mental retardation
might be prevented by drug therapy.
1.5. AIMS OF THIS PROJECT
Although there are a number of published methods
for measuring prolinase and prolidase, they all suffer
drawbacks in the analysis of human cultured cells used
in the diagnosis of enzyme deficiencies. For example,
the method of Troll and Lindsley (1955) as modified by
Powell et al. (1974) is time-consuming, uses benzene
and insensitive, requiring high levels of protein in
the assay. The method of Arata et al. (1979) used an
amino acid analyser to separate the products for the
substrate, followed by ninhydrin detection and also
needed high levels of protein in the assay. Thus there
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was a need to develop simple sensitive assays for both
enzymes.
Initially a new fluorimetric assay was developed
for prolinase adapting the method of Roth (1971) and
using o-phthalaldehyde to detect the amino acid
liberated. Using this method it was then possible to
derive optimal assay conditions for prolinase and make
a study of its properties. Previous work on prolinase
has been performed on animal tissues and few studies
have been undertaken with the human enzyme (Smith,
1960; Delange and Smith, vl971; Walter et al., 1980).
A variety of chromatographic procedures were undertaken
to study the possibility of more than one form of
prolinase being present. Ion-exchange chromatography
and gel filtration showed two distinct components of
prolinase to be present in human cultured skin
fibroblasts but only one in human kidney. As it has
been proposed that a single enzyme can hydrolyse both
prolinase and non-specific dipeptidase substrates
(Binkley et al., 1968; Hayman and Patterson, 1971),
prolinase was isolated from human kidney to study
further the relationship between the two enzymes.
Two methods were developed for prolidase which
detect the C-terminal amino acid liberated from the
hydrolysed substrate. The methods were adapted from
the assays of Shoaf et al. (1974) and Matsuomoto et al.
(1982) and used to determine the conditions of assay
and to investigate the properties of prolidase.
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Prolidase-deficient fibroblasts from two unrelated
cases of prolidase deficiency were used to study the
properties of the residual prolidase activity. The
major form of prolidase was then purified from human
kidney using a variety of chromatographic procedures
and injected into rabbits to raise specific antibodies
to prolidase. These were then used to investigate the
presence of cross-reacting material in the prolidase-
deficient fibroblasts.
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2. DEVELOPMENT OF A FLUORIMETRIC ASSAY FOR PROLINASE
2.1 INTRODUCTION
Existing methods for the estimation of prolinase
activity (Josefsson and Lindberg, 1965; Powell et al.,
1974; Sheffield et al., 1977; Arata et al., 1979) are
relatively insensitive and are therefore unsuitable for
the rapid assay and characterisation of prolinase in
human cultured cells. Also, the described conditions
of assay have been derived from animal tissues, as
human prolinase has not been characterised (Smith,
1960; Delange and Smith, 1971; Walter et al., 1980).
The action of prolinase on a proline dipeptide produces
an equimolar amount of proline and amino acid so a
highly sensitive method detecting the primary
amino-group on the amino acid would be ideally suited
for the assay of prolinase. The fluorogenic reaction
between o-phthalaldehyde and amines in the presence of
a sulphhydryl reagent as described by Roth (1971), is
one of the most sensitive methods for the determination
of primary amines. A modification of the Roth reaction
was therefore developed for the estimation of prolinase
activity.
Conditions of assay were assessed for human
cultured skin fibroblasts and prolinase activity
determined in cultured amniotic fluid cells,
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2.2.1. Enzyme source and preparation of extract
Human skin fibroblasts and amniotic fluid cells
were cultured as described in the appendix (section
11.1.). Tissue samples were obtained at autopsy 24hr
after death and red and white blood cells were prepared
from venous blood from children by Dextran
sedimentation (Snyder and Brady, 1969). All samples
were stored at -70°C prior to assay.
Extracts were prepared by the addition of
ice-cold distilled water, sonication at 4-6pm (MSE
Ultrasonic Disintegrator Mkll) for 30 sec for cells and
60 sec for tissues followed by centrifugation at 1000 x
g for 10 min.
2.2.2. Fluorimetric enzyme assay
The basic assay system developed consisted of
50 pi extract (0.2 mg protein/ml), 50 pi 50 mM barbital
/ HCl buffer (pH range 6.8-9.6) and 100 pi 30 mM
Sigma Ltd)
prolyl-glycine (Pro-Gly, . Each assay tube was
/\
incubated for up to 120 min at 37°C after which 200 pi
7-2 g/iperchloric acid was added to stop the reaction. After
keeping at 5°C for 15 min, the assay tubes were spun at
2000 x g for 10 min to remove precipitated protein, and
50 pi portions taken for estimation of liberated
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glycine. Substrate and extract blanks and a glycine
standard were run simultaneously.
Glycine was estimated by a modification of the
method of Roth (1971) based on that used for tyrosine
(Guy and Butterworth, 1978). The reagent (100 ml)
consisted of 3 ml o-phthalaldehyde (12 g/1 methanol),
3 ml 2-mercaptoethanol (0.6% v/v in ethanol) and 94 ml
150 mM Na2CC>2 / NaHCO^ buffer pH 9.5 and was freshly
prepared. 850 pi of this reagent was added to 50 pi
incubation mixture or amino acid standard. The
reaction was timed from addition of reagent and the
development and subsequent decay of fluorescence was
followed in a Perkin-Elmer 1000 fluorimeter (excitation
365 nm, emission 455 nm) . Before use the fluorimeter
was standardised against the stable fluorochrome
(excitation 365nm, emission 455nm)
quinine A to give 250 fluorescence units at 1 mg/1.
Standard curves for each amino acid were then
constructed using a range of concentrations up to 0.25
mM. pH profiles (pH 6.8-9.6) were also constructed with
0 , 0 .025 and 1 mM MnC^ final concentration in the
assay. The effect of Manganese ions on prolinase
activity was also studied at pH 7.4 with a range of
MnC^ concentrations 0-2 mM and at pH 9.2 with a range
0-0.2 mM.
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2.2.3. Spectrophotometric enzyme assay
For comparison with the fluorimetric method, the
spectrophotometric method for prolinase as given by
Powell et al. (1974) was used. The assay consisted of
50 pi cell extract (5 mg/ml), 100 pi 200 mM borate
buffer pH 8.0 and 50 pi 24 mM Pro-Gly. The assay tubes
were incubated for 30 or 60 min at 37°C after which
was
1.3 ml ethanol added, allowed to stand for 10 min,
A
spun at 2000 x g for 10 min and a 1 ml sample read at
220 nm on a Perkin-Elmer dual beam spectrophotometer.
The assay was also stopped and analysed as for the
fluorimetric assay.
2.2.4. Time and protein linearities for prolinase
The linearity of the hydrolysis of Pro-Gly was
determined for skin fibroblasts with incubations up to
3 hr and for levels of protein up to 1.6 mg/ml.
Protein was measured (Lowry et al., 1951) using bovine
serum albumin as standard as described in the appendix
(section 11.3.) .
2.2.5. Prolinase activities in cells and tissues
Prolinase activity was also determined at pH 7.4
and 9.2 for a range of human skin fibroblast cultures
(n = 15), amniotic fluid cells (passage 2 + 3, n = 19),
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erythocytes (n = 3), white cells (n = 3) and a number
of tissues. The specific activities of Cathepsin B and
B-hexosaminidase were simultaneously determined for the
tissue extracts as described by Butterworth and Duncan
(1979, 1980) and Butterworth and Guy (1979).
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2.3. RESULTS
2.3.1. Reaction of amino acid standards with
o-phthalaldehyde-mercaptoethanol reagent
After addition of o-phthalaldehyde-mercapto-
ethanol reagent, the time taken to reach the maximum
fluorescence and the rate of decay of this fluorescence
depended upon the particular amino acid. Glycine and
alanine were the most reactive (Fig.3) of the amino
acids studied and reached a maximum fluorescence after
one minute, however this fluorescence then decayed and
25% of this reading was lost after 8 minutes. The
reaction for valine, leucine, phenylalanine and
glutamic acid was maximal after U minutes and stayed
stable for at least 5 minutes. Because of the decay of
fluorescence it was important to take a reading on the
fluorimeter 1 minute after addition of reagent for
glycine and alanine and at any time between l£ and 5
minutes for the other amino acids. In this way
standard curves for the amino acids were constructed
(Fig.4) and were found to be linear within the limits
of the capability of the fluorimeter. The method was
highly sensitive and 10 nmoles glycine, alanine,
valine, leucine, phenylalanine and glutamic acid gave
950, 830, 1050, 990, 1050, and 1060 fluorescence units
respectively. The blank due to the reagent was less
than 20 units and increased by only a few units after
25
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Fig. 3 Time course of the fluorescent reaction of
o-phthalaldehyde - mercaptoethanol reagent
with amino acid standards. 850 pi reagent
was reacted with 50 pi assay mixture cont¬
aining 15 nmol glycine or alanine and 7.5
nmol valine, phenylalanine or leucine.














Fig. 4 Standard curves for amino acid standards
(50 pi) reacting with 850 pi o-phthal-
aldehyde - mercaptoethanol reagent.
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several hours. By comparison the spectrophotometric
method of Powell et al. ( 1974 ) relies on the fall in
absorption at 220 nm as peptide bonds are hydrolysed
and resulted in a drop in optical density of 0.025 for
100 nm of substrate hydrolysed.
The pH of the reaction mixture has a large effect
on the rate of the fluorescence-producing reaction and
is optimal close to pH 9.5. It is therefore important
to ensure that the reagent is sufficiently buffered to
counteract the low pH of the final assay mixture
resulting from the addition of perchloric acid as
protein precipitant. The amount of assay mixture taken
to estimate the liberated amino acid can be increased
but the reagent buffer molarity must be increased
accordingly. Although 100 mM will suffice for 50 pi
assay volume, 150 mM was routinely used to permit
either 50 or 100 pi to be taken. 1000 mM buffer was
required for 400 pi of assay volume, the maximum
tested.
2.3.2. Determination of pH optimum for prolinase
in 25 mM barbital / HC1 buffer
The pH profile^for the hydrolysis of Pro-Gly by
prolinase in skin fibroblasts was highly dependent upon
the level of manganese ions present (Fig.5). Without
added manganese a broad optimum at pH 8.4 to 9.4 was
found, whilst the optimum with 1 mM MnC^ was 7.4 - 7.8
and with 0 .025 mM MnC^/ pH 9.2, this last condition
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giving the highest activity. The optimal concentration
of MnCl2 at pH 7.4 was 1 mM and at pH 9.2,. 0.0 25 mM
with inhibition above these respective concentrations
(Fig.6).
Fig. 5 pH profiles for human skin fibroblast prolinase
assayed with Pro-Gly in the presence of (A) 0;
(•) 0.025 mM; and (O) 1 mM MnCl2.
100% = maximum activity with 0.025 mM MnCl2
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Fig. 6 Effect of different levels of manganese on
human skin fibroblast prolinase activity
against Pro-Gly assayed at a) pH 7.4 and
b) pH 9.2.
a) 100% = 45 nmol/min/mg
b) 100% = 78 nmol/min/mg
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2.3.3. Time and protein linearities
The prolinase assay was linear with time for at
least 3 hr at pH 7.4 and 9.2 and with protein
concentrations up to a level hydrolysing as much as 20%
of substrate (Fig.7). A typical assay containing 10 ug
fibroblast protein hydrolysed less than 4% of the
substrate.
2.3.4. Prolinase activities
Using Pro-Gly, cultured skin fibroblasts (n = 15)
had a prolinase mean specific activity (ninol/min/mg
protein + SD) of 42.4 + 12.2 (range 26-72) at pH 7.4
and 80.1 + 24.2 (range 47-134) at pH 9.2, whilst
amniotic fluid cells (n = 19) were 56 .9 + 30 . 3 (range
21-124) and 108.5 + 58.5 (range 41-237) respectively
(Fig.8). The omission of four epithelioid amniotic
fluid cell cultures tested, which had high prolinase
values, resulted in mean values very similar to those
for fibroblasts. Three white blood cell samples
(polymorphonuclear cells) had specific activities of
34, 55 and 82 at pH 7.4 and 51, 77 and 122 at pH 9.2
respectively. Three red blood cell samples had rather
low specific activities of 7.3, 8.7 and 8.8 at pH 7.4
and 10.5, 11.8 and 12.9 at pH 9.2 respectively.
Prolinase was also estimated in a number of tissues
obtained at autopsy (Table 3). Apart from heart
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muscle, all the tissues had moderate activities, with




Fig. 7 a) Time and b) protein linearities for human
skin fibroblast prolinase assayed with Pro-Gly
at pH 7.4 with 1 mM MnC^.





Fig. 8 Prolinase activities at pH 7.4 with 1 mM MnC^
and pH 9.2 with 0.025 mM MnC^ for cultured




pH 7.4 pH 9.2
Cathepsin B IS-Hex
Kidney 451 974 8.2 49.5
Thyroid 338 554 94.2 41.9
Thymus 200 324 28 .6 82.6
Pancreas 160 317 5.3 29.1
Adrenal 153 273 7.9 52.4
Pituitary 150 270 2.9 26.2
Liver 115 237 6.9 68.4
Choroid Plexus 116 234 5.2 31.1
Cerebral Cortex 123 231 0.8 5.8
Small Bowel 107 211 3.8 69.1
Lung 101 183 2.2 14.4
Skeletal Muscle 87 155 1.1 6.5
Skin 80 125 2.6 7.2
Spleen 64 117 2.4 15.9
Cartilage 54 108 4.0 23.4
Placenta 55 89 1.8 9.7
Heart 19 29 2.4 13.8
Table 3. Specific activity (nmol/min/mg protein) of






provides a simple and sensitive assay for amino groups.
It has an advantage over other methods in that it does
not react with proline, hence substrates of the type
proline-amino acid which have no N-terminal amino
groups, will not produce a fluorescence. In alternative
assays, for example the ninhydrin method (Mayer and
Nordwig, 1973), there is a reaction with proline
requiring the separation of substrate and products.
Furthermore, the estimation of amino acids using
ninhydrin is about ten times less sensitive than with
o-phthalaldehyde. The method given for prolinase by
Powell et al. (1974), based on the detection of proline
using the ninhydrin method of Troll and Lindsley
(1955), is time-consuming, uses benzene and needs at
least twenty times as much enzyme protein in the assay
as in the present method. Also this technique doesn't
lend itself to large numbers of samples as generated by
kinetic and chromatographic studies. Comparison was
therefore made with the method of Josefsson and
Lindberg (1965) as modified by Powell et al. (1974),
which depends on the fall in absorbance at 220 nm as
the substrate peptide bond is hydrolysed. A 10%
hydrolysis resulted in a drop in optical density of
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about 0.03 representing 120 nm glycine. The present
method would give a reading of about 1400 for a blank
of less than 20. The small drop in absorbance, read
against the initial high value resulted in low
sensitivity and required a very accurate technique.
Also the spectrophotometric method was unsuitable in
the presence of haemoglobin, whereas it had no effect
in the present fluorimetric method. By using the
complete assay volume of 400 pi instead of 50 pi for
amino acid estimation, the amount of enzyme needed may
be as little as 1 pg per assay, making this method as
much as 200 times as sensitive as previous methods.
Prolyl-Glycine was used as the preferred
substrate, despite glycine's short-lived fluorescence,
because this was the substrate most frequently used in
other studies on prolinase (Mayer and Nordwig, 1973;
Powell et al., 1974) and allowed comparison of the
present with previous findings.
2.4.2. pH profile
The broad pH optimum, pH 8.4-9.4, in the absence of
manganese ions compares with pig kidney prolinase which
showed optimal activity at pH 8.75 (Mayer and Nordwig,
1973). The optimum pH of 9.2 in the presence of 0.025
mM MnCl2 was similar to that observed in human plasma
(Myara et al., 1985a).
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2.4.3. Prolinase activities
Prolinase activity in human skin fibroblasts was
similar to the mean value of 67 nmol/min/mg recently
reported by Myara et al.(1984b). However, the mean
value of 16 nmol/min/mg observed by Arata et al. (1979)
was probably much lower because of sub-optimal assay
conditions without added manganese. Although
erythrocyte prolinase activity was relatively low
compared with fibroblasts, it was markedly higher than
previously reported values of 0.20 (Powell et al.,
1974 ) and 0.14 (Isemura et al., 1981). White blood
cell prolinase was also higher than the activity of 24
nmol/min/mg reported by Powell et al. (1974). These
large discrepancies are probably the result of
sub-optimal assay conditions.
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3. STUDIES ON PROLINASE IN HUMAN TISSUES
3.1. INTRODUCTION
Having developed a rapid and sensitive method for
the estimation of prolinase activity, it was possible
to characterise the human enzyme and elucidate some of
its properties. Very little research into human
prolinase has been undertaken so a study was made to
determine i) intracellular localisation, ii) effect of
heat, iii) effect of pH, iv) activities in a variety of
human tissues, v) substrate specificity and vi)
kinetics. Also a variety of separative procedures were





The intracellular localisation of prolinase was
determined in fibroblasts by subcellular fractionation
as described by Guy and Butterworth (1978). A cell
extract (1 mg/ml) was prepared in 0.25 M sucrose by
homogenising in an all glass Potter-Elvehjem
homogeniser (10 up-down strokes). The homogenate was
centrifuged at 800 x g for 5 min to bring down
non-disrupted cells and then re-homogenised. The
resulting homogenate was then used for differential
centrifugation. The total enzyme activity was then
determined in a portion of this homogenate. The
remaining homogenate was then centrifuged at 3,500 x g
for 10 min to yield a pellet which was resuspended to
obtain the heavy fraction. The supernatant was then
centrifuged at 22,500 x g for 20 min for the light
fraction and then 100,000 x g for 30 min for the
microsomal fraction, the final supernatant being the
soluble fraction. Prolinase (section 2.2.2.), lactate
dehydrogenase (Bergmeyer, 1965), fumarase (Whittaker
and Barker, 1972), a-L-fucosidase and ^-hexosaminidase
(Butterworth and Guy, 1979) activities were determined
in all fractions, the latter two enzymes were also
assayed in the presence of 0.1% Triton-X-100 (Sigma
Ltd). Protein was also determined by the method of
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Lowry et al. (1951) as described in the appendix
(section 11.3.).
3.2.2. Effect of heat
For heat stability, extracts in 10 mM barbital /
HC1 buffer pH 7.4 were treated at 45-60°C for 5 min or
at 52°C for up to 60 min prior to assay. 100 mM NaCl
and 0.2 mg/ml BSA were added to see if they might
stabilise prolinase to heat.
3.2.3. pH stability
pH stability was determined by adjusting the pH
of an extract (0.5 ml) with 0.01 mM HC1 or NaOH,
leaving for 30 min and neutralising prior to assay.
3.2.4. Substrate Specificity
Substrate specificity was studied in fibroblasts
and amniotic fluid cells with a number of dipeptide
substrates. Amino acids coupled to proline (Sigma Ltd)
included glycine, alanine, leucine, phenylalanine,
valine and glutamic acid (Pro-Gly, Pro-Ala, Pro-Leu,
Pro-Phe, Pro-Val, Pro-Glu). These substrates were
assayed at pH 7.6 with 1 mM MnC^ and pH 9.2 with 0.025
mM MnC^. Hydroxyprolyl-glyc ine (Hypro-Gly) was
assayed at pH 8.8 with ImM MnC^- Also, the hydrolysis
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of two non-specific dipeptidase substrates, Glycyl-
Leucine (Gly-Leu) and Phenylalanyl-Alanine (Phe-Ala)
was determined using a micromethod based upon the assay
of Shoaf et al. (1974).
3.2.5. Substrate kinetics
Substrate Kms were obtained for prolinase using
Pro-Gly assayed at pH 7.6 with or without 1 mM MnC^ at
concentrations up to 10 mM substrate or at pH 9.2 with
or without 0.025 mM MnC^ at concentrations up to 20 mM
substrate.
3.2.6. Dialysis
The effect of dialysis on prolinase was also
studied by dialysing fibroblast extracts for 60 min
against distilled water, 10 mM barbital / HC1 buffer pH
7.4 or 100 mM NaCl.
3.2.7. Ion-exchange chromatography
Ion-exchange chromatography was performed using
DEAE-Cellulose 52 (Whatman Ltd). 25g resin was
dispersed in 150 ml 10 mM barbital / HC1 and then
titrated back to pH 7.4 with 0.5M HCl. The slurry was
allowed to settle then the supernatant decanted. The
remaining slurry was made up to 150 ml again with
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buffer, the pH checked, then poured into a 1 x 25 cm
column. The extract (2 ml) was dialysed for 60 min
against the elution buffer, centrifuged at 100,000 x g
for 30 min, then applied to the column. Elution was
performed with a 0-250 mM NaCl linear gradient in 10 mM
barbital / HC1 buffer pH 7.4 and 1.25 ml fractions
collected.
3.2.8. Gel filtration
Gel filtration was carried out with Sephadex G
150-120 (Sigma Ltd). The gel was swollen and
equilibrated according to the manufacturers directions
and poured into a column (2.5 x 55 cm). The extract (2
ml) was dialysed for 60 min against the elution buffer,
centrifuged at 100,000 x g and applied to the column.
Elution was performed with 10 mM barbital / HC1 pH 7.4
containing 100 mM NaCl with an ascending flow-rate of 4
ml/hr and 1.25 ml fractions collected.
3.2.9. Sucrose density isoelectrofocusinq
Isoelectrofocusing was performed in a sucrose
gradient using a modification of the method of Godson




For hydrophobic chromatography, butyl-agarose
(Miles Ltd) in a 0.8 x 10 cm column was equilibrated
with 20 mM maleate buffer pH 6.5. A 2 ml sample,
dialysed against this buffer, was applied to the column
and eluted with a 0-300 mM NaCl linear gradient in the
same buffer.
3.2.11. Affinity chromatography
Affinity chromatography was performed by applying
a 2ml sample, dialysed against elution buffer, to a 0.8
x 9 cm column of Concanavalin-A Sepharose (Pharmacia
Ltd) equilibrated with 10 mM barbital / HCl pH 7.4
containing 0.1 mM MnCl2, 100 mM NaCl and 0.1% (v/v)
Triton-X-100 and eluted with a 0-1 M a -methyl-D-
glucoside (Sigma Ltd) linear gradient in the same
buffer. Wheat-germ lectin-Sepharose (Sigma Ltd)
affinity chromatography was also performed in a 0.8 x 9
cm column equilibrated with 10 mM barbital / HCl pH 7.4
containing 100 mM NaCl and 0.1% (v/v) Triton-X-100.
Elution was carried out with a 0-1 M N-acetyl-D-




Prolinase was found to be almost entirely in the
final supernatant on subcellular fractionation (Table
4). Lactate dehydrogenase and fumarase showed their
typical localisation as did the lysosomal enzymes,
a-L-fucosidase and fi-hexosaminidase, which also showed
their latency effect with Triton-X-100.
3.3.2. Heat stability
The enzyme was thermolabile with a log-linear
fall-off in activity at 52°C (Fig.9a), but with a
marked transition point at about 55°C and a rapid loss
of activity at higher temperatures (Fig.9b). The





Total Heavy Light Microsomal Soluble
Prolinase 100 2 0 0 98
Lactate Dehydrogenase 100 10 0 10 80
Fumarase 100 54 0 0 46
a-L-Fucosidase
a) + Sucrose 100 36 4 1 52
b) + 0.1% Triton-X-100 400 304 30 3 54
6-Hexosaminidase
a) + Sucrose 100 37 10 10 52
b) + 0.1% Triton-X-100 748 510 57 15 49
Protein 100 24 15 13 48
Table 4. Subcellular distribution of prolinase in cultured
skin fibroblasts.
Total refers to the activity in the original extract.
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Time (min)
Fig. 9 Effect on fibroblast prolinase activity of
a) heating at 52°C for up to 60 min and
b) heating at various temperatures for 5 min .
Prolinase was assayed with Pro-Gly at pH 7.4
in the presence of 1 mM MnCl2.
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3.3.3. pH stability
Prolinase was stable between pH 6.5 and 9.5 but
the activity was markedly reduced by up to 70% at pH 6
or below (Fig.10).
Fig. 10 pH stability of fibroblast prolinase activity
assayed with Pro-Gly. The pH of an extract
(0.05 ml) was adjusted with 0.01 mM HC1 or
NaOH, left for 30 min and neutralised prior to
assay at pH 7.4 with 1 mM MnC^.
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3.3.4. Substrate specificity
The hydrolysis of a number of proline dipeptides,
hydroxyprolyl-glycine and two non-specific dipeptidase
substrates Gly-Leu and Phe-Ala by skin and amniotic
fluid cell cultures are given in Table 5. Pro-Leu,
Pro-Phe and Pro-Val gave almost twice the activities of
Pro-Gly and Pro-Ala at both pHs and for both cell
types. Hypro-Gly gave much lower activities than all
the proline dipeptides having 20% or less of the
activity of Pro-Gly. Pro-Glu was not hydrolysed by
cultured cell prolinase. Gly-Leu was hydrolysed at a
much faster rate than any of the prolinase substrates
This was not a result of the use of different assay buffers,
in both fibroblasts and amniotic fluid cells. . A high
activity was also found for Phe-Ala in fibroblasts
though amniotic fluid cells had a relatively low
activity against this substrate.
3.3.5. Substrate kinetics
Double-reciprocal plots were constructed for
Pro-Gly (Fig 11) according to Lineweaver and Burk
(1934). The hydrolysis of Pro-Gly was found to obey
normal Michaelis-Menten kinetics giving Kms of 6.8 mM
at pH 7.4 and 2.3 mM at pH 9.2.
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Substrate PH Fibroblasts Amniotic fluid
cells
Pro-Gly 7.6 27 53
9.2 42 89
Pro-Ala 7.6 44 77
9.2 66 115
Pro-Leu 7.6 63 117
9.2 106 189
Pro-Phe 7.6 57 127
9.2 115 211
Pro-Val 7.6 69 129
9.2 81 175
Hyp-Gly 00CO 6 12
Gly-Leu 00 • o 462 150
Phe-Ala o•00 218 68
Table 5. Dipeptidase activity (nmol/min/mg protein)
of cultured cells at indicated pH values*.
* Barbital / HCl buffer, pH 7.6 + ImM MnC^/ pH 9.2 +





Fig. 11 Fibroblast prolinase activity at pH 7.4 (A) and




Dialysis of the enzyme for 60 min against
distilled water reduced prolinase activity by 75-85%,
but by only 25% against 100 mM NaCl and less than 20%
against 10 mM barbital / HCl pH 7.4.
3.3.7. Chromatography
For assays of prolinase by the fluorescent method
after chromatographic procedures, it was not usually
necessary to centrifuge following addition of
perchloric acid, as the enzyme blank was very low. The
chromatographic profiles obtained for DEAE-Cellulose,
gel filtration, isoelectrofocusing and hydrophobic
chromatography are shown in Figs. 12, 14, 15 and 16.
3.3.7.1. DEAE-Cellulose
Ion-exchange chromatography with DEAE-Cellulose
(Fig.12) showed two forms of prolinase, a large peak
eluting with 120 mM NaCl and a small peak eluting with
145 mM NaCl. The smaller peak was more pronounced when
assayed at pH 7.4 than pH 9.2. The two peaks gave the
same pH profile in the presence of 0.025 MnC^ with a
pH optimum at about pH 9.4, but with ImM MnC^ the
first peak gave an optimum near pH 8.0, whilst that of
the second peak was nearer pH 7.4 (Fig.13).
Fig. 12 DEAE-Cellulose chromatography of human skin
fibroblast prolinase assayed at pH 7.4 (•) and
pH 9.2 (^) with Pro-Gly. 1 x 25 cm column
eluted with 0-250 mM NaCl in 10 mM barbital /
HCl buffer pH 7.4. A, B-hexosaminidase;
B, a-L-fucosidase.
100% = 15 nmol/min/ml at pH 9.2 and 9 nmol/min/ml at pH7.4
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Assay pH
pH profile of peak I (—) and peak II ( )
prolinase activity separated by DEAE-Cellulose
chromatography assayed with 1 mM (A) and 0.025
mM (•) MnClg.
100% = 6 nmol/min/ml
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3.3.7.2. Sephadex G150-120
Gel filtration (Fig.14) also separated prolinase
into a large and a small peak and again the latter was
more pronounced when assayed at pH 7.4.
3.3.7.3. Isoelectrofocusing
For sucrose density isoelectrofocusing it was
necessary to dilute the fractions tenfold to reduce the
blanks produced by the reaction between the ampholines
and o-phthalaldehyde. A large peak was obtained at pi
5.75 with a smaller peak at pi 4.8 (Fig 15). The
latter peak was associated with a protein band,
of the original extract
although it was not removed by centrifugation
^ and
showed a relatively higher activity at pH 7.4.
3.3.7.4. Butyl-agarose
Hydrophobic chromatography with butyl-agarose
yielded only a single peak of prolinase activity
(Fig.16) eluting at 90 mM NaCl. Cathepsin B was
unbound, 8-D-glucuronidase was released almost
immediately on application of the chloride gradient
whilst 6-hexosaminidase was tightly bound.
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3.3.7.5. Concanavilin-A-Sepharose and Wheat-germ lectin
Sepharose
Prolinase did not bind to Concanavalin-A-
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Fig. 14 Sephadex G150-120 gel filtration of fibroblast
prolinase assayed with Pro-Gly at pH 7.4 (•)
and pH 9.2 (^). 2.5 x 55 cm column eluted
with 10 mM barbital / HC1 buffer pH 7.4,
containing 100 mM NaCl. Vo, void volume;
A, 13-hexosaminidase; B, a-L-fucosidase.
100% = 11 nmol/min/ml at pH 9-2 and 6 nmol/min/ml at pH 7.4
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pH
Fig. 15 Sucrose density isoelectrofocusing of human
skin fibroblast prolinase assayed with Pro-Gly
at pH 7.4 (•) and pH 9.2 (■') . ( ) fl-hexos-
aminidase. Isoelectrofocusing was performed
as described in the appendix, section 11.4.
100% = 7 nmol/min/ml at pH 9.2 and 4 nmol/min/ml at dH 7.4
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Fig. 16 Butyl-agarose hydrophobic chromatography of
human skin fibroblast prolinase assayed with
Pro-Gly at pH 7.4 (•) and pH 9.2 ($).
0.8 x 10 cm column equilibrated with 20 mM
maleate buffer pH 6.5, and eluted with 0-300
mM NaCl in the same buffer.
(OOOO) a-L-fucosidase; ( ) fl-glucuronidase;
( ) acid phosphatase.




Prolinase in cultured skin fibroblasts was
completely soluble, similar to pig kidney prolinase in
which 87% of the activity remained in the supernatant
after centrifugation of a homogenate at 100,000 x g
(Mayer and Nordwig, 1973).
3.4.2. Substrate specificity
The variable ratios of activities at pH 7.6 to
9.2 for the different substrates (Table 5) indicate
that there may be a single enzyme with variable
responses for each substrate or possibly more than one
form of prolinase.
Pig kidney prolinase was found to hydrolyse
Hypro-Gly faster than Pro-Gly (Davis and Adams, 1955;
Sarid et al., 1962 ) and was claimed to be a more
specific substrate for the enzyme. However, Mayer and
Nordwig (1973) found the reverse to be true with
Hypro-Gly being hydrolysed at a third of the rate of
Pro-Gly also in pig kidney. This probably highlights
the importance of conditions of assay. In contrast,
for human cultured cells, Hypro-Gly was a very poor
substrate and of little use in the estimation of
prolinase. Pro-Glu was not hydrolysed by prolinase in
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cultured cells which agrees with the finding for the
pig kidney enzyme (Davis and Smith, 1953).
The relative cleavage rates of the different
substrates by cultured cell prolinase contrasted
markedly with those of pig kidney prolinase in which
Pro-Gly and Pro-Ala were hydrolysed at up to twenty
times the rate of Pro-Leu and Pro-Phe (Mayer and
Nordwig, 1973). It is noteworthy that the non-specific
dipeptidase activity was higher than prolinase
activity. The difference between the fibroblast and
amniotic fluid cell cultures for the two non-specific
substrates deserves further study.
3.4.3. Substrate kinetics
As analysed by Lineweaver-Burk plots the Km of
2.3 mM for Pro-Gly was of the same order as the value
of 6.1 reported recently for human plasma prolinase
assayed at pH 9.0 with 0.02 mM MnC^ (Myara et al.,
1985a) .
3.4.4. Chromatography
The two chromatographic techniques, DEAE
ion-exchange and gel filtration, used to characterise
the human skin fibroblast enzyme confirmed the
existence of two components of prolinase activity.
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4. PURIFICATION OF PROLINASE FROM HUMAN KIDNEY AND ITS
RELATIONSHIP WITH NON-SPECIFIC DIPEPTIDASE
4.1. INTRODUCTION
Prolinase has been purified from a number of
animal tissues (Sarid et al., 1962; Mayer and Nordwig,
1973; Akrawi and Bailey, 1976) and in all cases the
final preparations had activity against non-specific
dipeptidase substrates, which was attributed to a
contaminating enzyme. However, it has been proposed
that the two activities may be due to a single enzyme
(Hayman and Patterson, 1971). As kidney has been
widely used in studies on dipeptidases from animals
(Sarid et al., 1962; Mayer and Nordwig, 1973; Akrawi
and Bailey, 1976) and had the highest prolinase
activity of the human organs tested (Table 3.)
prolinase was purified using human kidney. Increasing
lability of dipeptidases with purification appears to
preclude purification to homogeneity (Hayman and
Patterson, 1971; Mayer and Nordwig, 1973). To
ascertain whether human kidney prolinase and
non-specific dipeptidase were the same enzyme,
properties of the enzyme were studied, including
substrate kinetics (Dixon and Webb, 1964, pp 84 -87),





Prolinase was assayed in 25 mM barbital / HC1
buffer pH 9.2 using Pro-Ala, Pro-Gly, Pro-Leu, Pro-Phe
and Pro-Val. The liberated amino acid was determined
fluorimetrically as described earlier (Section 2.2.2.).
Non-specific dipeptidase was assayed in 25 mM barbital
/ HC1 buffer, pH 8.0, containing 10 mM Gly-Leu,
alanyl-leucine (Ala-Leu), valyl-leucine (Val-Leu),
seryl-leucine (Ser-Leu), phenylalanyl-glycine (Phe-Gly)
or leucyl-glycyl-glycine (Leu-Gly-Gly) and the
liberated leucine or phenylalanine determined
spectrophotometrically by the L-amino acid oxidase /
peroxidase-coupled oxidation of o-dianisidine method of
Shoaf et al. (1974). Prolidase was assayed against
glycyl-proline (Gly-Pro) by estimation of liberated
proline (Mayer and Nordwig, 1973) and against
phenylalanyl-proline (Phe-Pro) by estimation of
liberated phenylalanine as above. Proline imino-
peptidase (EC 3.4.11.5) activity was determined by
estimation of liberated proline from prolyl-glycyl
-glycine (Pro-Gly-Gly) (Butterworth and Priestman,
1984a) .
Column fractions were diluted appropriately
before enzyme assay with BSA (0.25 mg/ml) in 10 mM
barbital buffer pH 7.4, containing 50 mM NaCl. Protein
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was determined by the method of Lowry et al. (1951) as
described in the appendix (section 11.3.). One unit
of enzyme activity was defined as the formation of 1
pmol of product/min at 37°C.
4.2.2. Extract preparation
Human kidney was obtained at autopsy 24 hr after
death and stored at -70°C. A 20% (w/v) extract was
prepared by homogenising in 10 mM barbital / HC1 buffer
pH 7.4 containing 50 mM NaCl (buffer A). The
homogenate was sonicated at 8-12 pm for 60 sec and
centrifuged at 100,000 x g for 60 min.
4.2.3. Chromatographic procedures
All chromatographic procedures were carried out
at 4°C unless otherwise stated.
4.2.3.1. DEAE-Cellulose
Kidney extract (50 ml) was applied to a 3.5 x 45
cm DEAE-cellulose column equilibrated with buffer A.
After washing with 200 ml buffer A, the column was
eluted with 500 ml of a 50-300 mM NaCl linear gradient
and 10 ml fractions collected.
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4.2.3.2. Ultroqel AcA44
The DEAE-cellulose peak (95 ml) was concentrated
ten-fold using a PM10 ultrafiltration membrane system
(Diaflo Ltd), applied to a 2.5 x 75 cm Ultrogel AcA 44
(LKB Ltd) column, eluted with buffer A with an
ascending flow-rate of 20 ml/hr and 10 ml fractions
collected.
4.2.3.3. Metal-ion-chelate chromatography
For metal chelate chromatography, iminodiacetic
acid was coupled to epoxy-activated Sepharose 6B (Sigma
Ltd) (Porath et al., 1975) and converted to a metal
chelate gel by the passage of 5 ml 50 mM NiCl2 or 50 mM
MnCl2 in water through 2.5 ml gel in a 1 cm x 3.5 cm
2 +
column. The Ni gel was equilibrated with buffer A
and 40 ml of Ultrogel prolinase peak was applied to the
column. After washing with 20 ml 10 mM barbital / HC1
pH 7.4 containing 10 mM NaCl (buffer B), the column was
eluted with 60 ml of a 0-100 mM imidazole linear
gradient (in buffer B) and 2 ml fractions collected.
4.2.3.4. Hydrophobic chromatography
The prolinase peak (16 ml) from the metal chelate
chromatography was applied to a 1.4 cm x 25 cm
butyl-agarose column equilibrated with buffer B. The
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column was washed with 75 ml buffer B, eluted with 100
ml of a 10-300 mM NaCl linear gradient and 4 ml
fractions collected.
4.2.3.5. Hydroxylapatite
30 ml prolinase peak from the hydrophobic
chromatography was applied to a 1.3 cm x 5 cm
hydroxylapatite (BDH Ltd) column equilibrated with
buffer A. The column was washed with 50 ml buffer A,
eluted with 100 ml of a 0-150 mM phosphate linear
(pH 7.4)
gradient in buffer A^and 5 ml fractions collected.
4.2.3.6. Chromatofocusing
After hydroxylapatite chromatography the
prolinase peak (15 ml) was concentrated ten-fold by
ultrafiltration, diluted (1+1) with 25 mM imadazole /
HC1 buffer pH 7.4 and applied to a 1.3 cm x 5 cm PBE 94
(Pharmacia Ltd) column equilibrated with this buffer.
Elution was carried out with 60 ml polybuffer 74
(Pharmacia Ltd) titrated with HC1 to pH 4.0 and 2 ml
fractions collected.
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4.2.4. Molecular weight determination
For molecular weight determination a 1% (w/v)
kidney extract (10 ml) in buffer A was applied to a 2.5
cm x 75 cm Ultrogel AcA 44 column, eluted with buffer A
with an ascending flow-rate and 10 ml fractions
collected. The elution volumes of prolinase,
B-hexosaminidase and a-mannosidase were determined. A
mixture (10 ml) containing 1 ml of the enzyme peak from
hydrophobic chromatography and five protein standards
was applied to the same column and 3 ml fractions
collected. The elution volumes of the protein
standards were determined following detection at 280
nm.
4.2.5 Polyacrylamide gel electrophoresis
Discontinuous polyacrylamide gel electrophoresis
(4.5% stacking, 7.5% separating gel, 0.75 mm thick) was
performed using a Bio-Rad Protean slab electrophoresis
cell (Davis, 1964). Concentrated samples (10 pi) of
the original kidney extract and the hydroxylapatite
peak were applied and electrophoresed at 14 mA for 4.5
hr. The gel lanes were cut into 0.25 cm strips and
bisected, one half for prolinase and the other half for
non-specific dipeptidase estimation. For prolinase
each gel strip was put into 100 pi 50 mM barbital / HCl
pH 9.2 containing 0.025 mM MnC^, assayed for 60 min
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following the addition of 100 pi 10 mM Pro-Phe and
liberated phenylalanine estimated (section 4.2.1.).
For non-specific dipeptidase each gel strip was put
into 100 pi barbital / HC1 pH 8.0, assayed for 60 min
after the addition of 100 pi Gly-Leu and liberated
leucine estimated as for phenylalanine above. Protein
bands were detected using the silver staining method of
Merril and Goldman (1984).
4.2.6. Enzyme characteristics
Studies were performed on the dipeptidase peak
eluted after hydrophobic chromatography and after
chromatofocusing following equilibration with buffer A
by ultrafiltration.
4.2.6.1. Heat stability
For heat studies, enzyme samples were incubated
at 53°C for up to 30 min prior to assay of prolinase
(Pro-Ala) and non-specific dipeptidase (Gly-Leu).
4.2.6.2. p-Hydroxymercuribenzoate
The inhibition of prolinase and non-specific
dipeptidase by p-hydroxymercuribenzoate (PHMB) (Sigma
Ltd) was also studied. Enzyme samples were treated
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with 1-50 pM PHMB for 5 min at 37°C prior to assay with
Pro-Ala and Gly-Leu.
4.2.6.3. Substrate specificity
A number of potential substrates were tested with
the enzyme preparation retained after chromatofocusing
to determine the substrate specificity.
4.2.6.4. Substrate kinetics
The type of inhibition and Ki values were
determined (Dixon, 1953) by studying the hydrolysis of
Pro-Ala (2 or 5 mM) at pH 9.2 in the presence of
Gly-Leu (0.5-10 and 1-25 mM respectively) and of
Gly-Leu (0.5 or 2 mM) at pH 8.0 in the presence of
Pro-Ala (0.1-2 and 1-10 mM respectively). As a test of
the activities being due to a single enzyme (Dixon and
Webb, 1964, pp 84-87; see appendix, section 11.5.),
Pro-Ala (5 mM) hydrolysis at pH 9.2 with or without
Gly-Leu (5 mM) , Gly-Leu (5 mM) hydrolysis at pH 9.2
with or without Pro-Ala (5 mM) and the Ki value for




The purification of prolinase and non-specific
dipeptidase is summarised in Table 4. To assay the two
enzyme activities in the original kidney extract, it
was necessary to dilute to a low protein level (< 0.01
mg/ml) at which the enzyme was unstable. Addition of
BSA (0.25 mg/ml) stabilised the enzyme to dilution.
During the purification procedure the protein level of
the active fractions up to and including the
hydroxylapatite column was sufficient to maintain
stability, but addition of BSA was required for
dilution of column fractions prior to assay. A
preparation retained after hydrophobic chromatography
was stable for 9 months at 4°C in the presence of BSA.
Coelution of both of the enzyme activities as a single
peak was observed for all the separative procedures,
either performed singly with a crude kidney extract or
during the sequential purification. The ratio of the
two activities was similar following each of the
separative procedures.
During the sequential purification procedure the
two enzyme activities coeluted with the highest
activity at 110 mM NaCl for DEAE-Cellulose column, 30
. . . 2 +
mM imidazole for the Ni chelate column, 100 mM NaCl
for the butyl-agarose column and 30 mM phosphate for
69
the hydroxylapatite column. A manganese chelate gel
did not retain either enzyme activity. The relative
elution volumes (Ve/Vo) of B-hexosaminidase and a-D-
mannosidase fell on the gel filtration molecular weight
calibration curve at 110,000 and 180,000 respectively.
The position of the enzyme, as detected by its
prolinase and non-specific dipeptidase activity,


























Fig. 17 Calibration of Ultrogel for M determination.
Key: (1) a-D-mannosidase; (2) alcohol dehydrogenase;
(3) fl-hexosaminidase; (4) haemoglobin; (5) ovalbumin;
(6) chymotrypsinogen; (7) cytochrome C; (8) prolinase
and non-specific dipeptidase.
70
Elution from the chromatofocusing column indicated a pi
of 5.3 for the enzyme. Silver staining of the
polyacrylamide gel following electrophoresis of the
pooled enzyme activity from the hydroxylapatite column
revealed the presence of two major and three minor
bands (Fig.18a). Band I was the marker bromophenol
blue and band II was a staining artifact. The gel
showed a coincident band of prolinase and non-specific
dipeptidase (Fig.18b). A crude kidney extract gave the
same position for the two enzyme activities.
100 5 0 O 50
Relative activity (%)
lOO
Fig. 18 Polyacrylamide gel electrophoresis of human
kidney dipeptidase. (a) Silver staining for protein in
the separating gel (10 cm). o, origin; +, anode end of
gel. (b) Dipeptidase relative activity in gel slices
(0.25 cm) against Gly-Leu and Pro-Phe assayed
throughout the length of the gel.
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4.3.2. Enzyme properties
As recovery of enzyme activity was poor from the
chromatofocusing column and involved exposure to acidic
pH, properties of the enzyme were studied following the
hydrophobic as well as the chromatofocusing procedures.
However the results were the same for both enzyme
preparations. Heat treatment of the enzyme at 53°C
resulted in a similar rate of loss of activity against
Gly-Leu and Pro-Ala with a 50% loss of activity after
about 12 min (Fig.19). The thiol reagent PHMB was
markedly inhibitory of enzyme activity against both
substrates with 50% inhibition at about 14 pM (Fig.20).
Time (min)
Fig. 19 Heat treatment of human kidney dipeptidase,
assayed against Pro-Ala (•) and Gly-Leu (O).
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4.3.3. Enzyme activities with different substrates
The activity of the final enzyme preparation
against a range of potential substrates (10 mM) is
given in Table 5. Of the non-specific dipeptidase
substrates the highest activity was against Gly-Leu,
whilst Phe-Gly was not hydrolysed. Three of the
prolinase substrates (Pro-Leu, Pro-Phe and Pro-Val)
gave activities that were higher than the activity
towards Pro-Ala, the substrate used to follow the
enzyme purification. The enzyme had no activity
towards Pro-Gly-Gly, the substrate for proline

















Pro-Ala 0 .43 13
Pro-Gly 0.29 9




Table 7. Hydrolysis of dipeptides and tripeptides
by the purified human kidney enzyme.
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4.3.4. Substrate kinetics and inhibition studies
Analysis of substrate interactions by Dixon plots
(Dixon, 1953) showed that Gly-Leu was a competitive
inhibitor of enzyme activity towards Pro-Ala with an
apparent Ki of 1.1 mM at pH 9.2 (Fig. 21) and Pro-Ala
was a competitive inhibitor of enzyme activity towards
Gly-Leu with an apparent Ki of 0.22 mM at pH 8.0
(Fig. 22) and 2. 2mM at pH 9.2. The Km for the enzyme
against Pro-Ala was 0.47 mM at pH 9.2 and the Km
against Gly-Leu was 0.79 mM at pH 8.0 and pH 9.2. The
expected hydrolysis of equimolar concentrations of two
substrates by a single enzyme in an extract can be
calculated using the experimentally determined values
of Vmax and the Kms for the two substrates (Dixon and
Webb, 1964, pp 84-87; see appendix, section 11.5.) The
present data gave a calculated total activity of 8.9
units/ml. As the observed total activity was 9.2
units/ml, it seems highly probable that the preparation





Fig. 21 Determination of Ki for Gly-Leu inhibition of
N
prolinase activity against Pro-Ala by the
method of Dixon (1953). a) 2 and b) 5 mM




Fig. 22 Determination of Ki for Pro-Ala inhibition of
A
non-specific dipeptidase activity against
Gly-Leu by the method of Dixon (1953).
a) 0.5 and b) 2 mM Gly-Leu, V = units/ml.
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4.4. DISCUSSION
4.4.1. Purification and properties
Non-specific dipeptidase purified from pig and
Guinea pig intestinal mucosa (Noren et al., 1973;
Piggott and Fottrell, 1975) and mouse ascites tumour
(Hayman and Patterson, 1971) hydrolysed prolinase
substrates. Conversely, prolinase purified from pig
kidney (Sarid et al., 1962; Mayer and Nordwig, 1973),
bovine kidney (Akrawi and Bailey, 1976) and mouse brain
(Reith and Neidle, 1979) hydrolysed non-specific
dipeptidase substrates. Also, the major peak of human
skin fibroblast prolinase coincided with a peak of
non-specific dipeptidase on DEAE-Cellulose
chromatography (Butterworth and Priestman, 1984).
Generally, the two activities had been considered to be
due to at least two enzymes and whether there is an
enzyme capable of hydrolysing both prolinase and
non-specific dipeptidase substrates is undecided,
particularly for human tissues.
Prolinase and non-specific dipeptidase from human
kidney were soluble in agreement with results for human
skin fibroblasts (section 3.2.1.) and pig kidney (Mayer
and Nordwig, 1973). The accuracy of the molecular
weight calibration curve was demonstrated by obtaining
the expected molecular weights for a-D-mannosidase and
^-hexosaminidase (Marinkovic and Marinkovic, 1976a,b).
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The determined molecular weight of 100,000 for the
human kidney dipeptidase was similar to the value
reported for bovine kidney prolinase (Akrawi and
Bailey, 1976), but was lower than the value of 300,000
estimated for pig kidney prolinase (Mayer and Nordwig,
1973). The inhibition of human kidney dipeptidase by
p-hydroxymercuribenzoate indicates the presence of a
thiol group at the active site, as previously suggested
for monkey intestinal (Das and Radhakrishnan, 1972) and
pig kidney enzyme (Sarid et al., 1962).
4.4.2. Chromatography
The elution position of the human kidney enzyme
on DEAE cellulose chromatography corresponded with
that of the major peak of human skin fibroblast
prolinase (see Fig. 12; Butterworth and Priestman,
1984) .
Metal chelate chromatography separates proteins
on the basis of their affinity for heavy metal ions
(Porath et al., 1975; Porath and Olin, 1983).
2+ 2 +
Histidine and cysteine form complexes with Zn , Co ,
+ . 2 +
Hg and Ni and proteins containing these ammo acids
on their surface can potentially bind to metal chelated
2+
Sepharose (Porath et al., 1975). Although Mn
activates prolinase (Fig.6) and a number of other
enzymes (Dixon and Webb, 1964, pp. 672-785) the weak
2 +
capacity of gel-immobilised Mn for protein binding
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2 +
(Porath et al., 1975 ) could explain why the Mn gel
did not adsorb prolinase. Affinity elution of human
2+ . .
kidney dipeptidase from a Ni gel by imidazole
strongly suggests the presence of histidine residues on
the surface of the enzyme (Porath and Olin, 1983). The
human kidney dipeptidase results demonstrate the
usefulness of the inclusion of a metal chelate
chromatography step in enzyme purification.
The binding of human skin fibroblast prolinase to
butyl-agarose (Fig.16) and of pig intestinal
non-specific dipeptidase to hydroxylapatite (Noren et
al., 1973) was the same as that of the human kidney.
Although bovine (Akrawi and Bailey, 1976) and pig
(Mayer and Nordwig, 1973) kidney gave a pi of 4.3 on
isoelectrofocusing, the pi value of 5.3 for the human
kidney preparation was within the range 5.05-5.3
obtained by chromatofocusing of cultured human skin
fibroblasts, liver and kidney (Butterworth and
Priestman, 1984). The marked loss of human kidney
enzyme activity on chromatofocusing was probably due to
exposure to acidic pH, which is known to inactivate the
enzyme (see Fig.10). The presence of multiple bands of
activity, probably owing to subunits and reaggregation,
on polyacrylamide gel electrophoresis of purified pig
kidney prolinase (Mayer and Nordwig, 1973) was not a
feature of the human kidney enzyme.
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4.4.3. Substrate specificity
Although Gly-Leu was the best of the substrates
tested for human kidney dipeptidase, the hydrolysis of
non-specific dipeptidase substrates varies widely
depending upon conditions of assay and source of enzyme
(Hayman and Patterson, 1971; Mayer and Nordwig, 1973;
Noren et al., 1973). The ability of the human kidney
enzyme to hydrolyse prolinase substrates was similar to
that of human skin fibroblast prolinase (Table 5). In
contrast with the human enzyme, pig kidney (Mayer and
Nordwig, 1973) and Guinea pig intestinal mucosal
(Piggott and Fottrell, 1975) prolinase had very little
activity toward Pro-Leu and Pro-Phe. The failure of
the human kidney enzyme to hydrolyse Pro-Gly-Gly, the
substrate for proline iminopeptidase, and Gly-Pro and
Phe-Pro, substrates for prolidase, agrees with the
previous findings for pig and bovine kidney prolinase
(Sarid et al., 1962; Mayer and Nordwig, 1973; Akrawi
and Bailey, 1976).
4.4.4. Conclusion
Throughout the purification procedures the human
kidney prolinase and non-specific dipeptidase
activities could not be separated. The enzyme peaks
were congruent and the ratio of their activities was
constant following each of the separative procedures.
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In addition, the responses of the two activities to
PHMB and to heat treatment were the same. These data,
together with the competitive inhibition of prolinase
and non-specific dipeptidase activity by Gly-Leu and
Pro-Ala respectively and the analysis of substrate
interaction (Dixon and Webb, 1964, pp 84-87), provide
firm evidence for the existence of an enzyme
hydrolysing both prolinase and non-specific dipeptidase
substrates in human kidney.
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5. ASSAYS FOR PROLIDASE
5.1. INTRODUCTION
Three methods were developed for the assay of
prolidase. Firstly, a modification of the ninhydrin
method of Nordwig and Mayer (1973) for proline-
detection was developed. The other two methods,
modified from the asssays of Shoaf et al. (1974) and
Matsuomoto et al. (1982), detect the C-terminal amino
acid liberated from the substrate. These latter two
methods are novel for the assay of prolidase and are
more sensitive than the first. Conditions of assay
were determined in cultured skin fibroblasts from
controls and from two unrelated cases of prolidase
deficiency using Glycyl-Proline (Gly-Pro) and
Phenylalanyl-Proline (Phe-Pro) as substrates. Like
prolinase, prolidase is also activated by manganese
ions (Walter et al., 1980), so a detailed study was
made of its manganese requirements.
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5.2. METHODS
5.2.1. Enzyme source and preparation of extracts
Human skin fibroblasts were cultured as described
in the appendix (Section 11.1.) and extracts prepared
as described in section 2.2.1. Skin fibroblast
cultures were obtained from a male Turkish patient
(Case 1, Pedersen et al., 1983) and a male Italian
patient (Case 2, Sheffield et al., 1972). The patients
had imidodipeptiduria and a marked deficiency of
prolidase activity against Gly-Pro in erythrocytes and
cultured skin fibroblasts. Protein was estimated by
the method of Lowry et al. (1951) using bovine serum
albumin as standard (see appendix, section 11.3.)
5.2.2. Assays for prolidase
5.2.2.1. Ninhydrin method
25 pi extract was incubated with 50 pi 50 mM
barbital / HC1 pH 8.0 containing 2 mM MnC^ and the
assay started by the addition of 25pl 80 mM Gly-Pro or
(Sigma Ltd)
Phe-Pro After incubation at 37°C for 30 min 200 pi
15% TCA was added and the liberated proline estimated
using a modification of the method of Mayer and Nordwig
(1973). After stopping the assay with TCA, 250 pi 3.6
mM glycine was added followed by 1.0 ml ninhydrin
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reagent (1% ninhydrin (w/v) in acetic acid / phosphoric
acid / distilled water, 12:3:5 by volume) and mixed
thoroughly on a vortex mixer before heating in a
boiling water bath for 30 mins. The tubes were then
left to cool down to room temperature, mixed again, and
the absorbance read at 515 nm on a Perkin-Elmer
dual-beam spectrophotometer. The rate of development
of colour was assessed by heating a proline standard at
100°C for up to 90 min. Gly-Pro was also heated for
this length of time to determine the extent of
hydrolysis due to heat.
5.2.2.2. L-amino acid oxidase method
Phenylalanine liberated from the hydrolysis of
phenylalanyl-proline (Phe-Pro) was estimated
spectophotometrically using a micro-method based upon
the non-specific dipeptidase assay of Shoaf et al.
(1974). The assay mixture was the same as for the
ninhydrin method above (5.2.2.1.). After 30 min
incubation, the reaction was stopped by heating at
100°C for one minute. 250 pi reagent (25 mM barbital /
HC1 pH 8.0 containing 0.27 g/1 L-amino acid oxidase
type VI (Sigma Ltd); 20 mg/1 horseradish peroxidase
type II (Sigma Ltd); and 2 g/1 o-dianisidine. 2HC1
(Sigma Ltd)) was added and after 10 min incubation at
37°C, 250 pi 50% (v/v) sulphuric acid added. The
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colour was read at 530 nm and compared with a
phenylalanine standard curve.
5.2.2.3. Homovanillic acid method
The method of Matsuomoto et al. (1982) for
monoamine oxidase was applied to the fluorimetric
estimation of phenylalanine. The assay mixture was the
same as for the ninhydrin method above (5.2.2.1.).
After heating the assay tubes at 100°C for one minute
to stop the reaction, 400 pi reagent (25 mM barbital /
HC1 pH 8.0 containing 0.1 g/1 L-amino acid oxidase type
VI; 10mg/l horseradish peroxidase type II; 50 mM EDTA;
and 0.5 pM homovanillic acid (Sigma Ltd)) was added.
After incubation at 37°C for 10 min, 500 ul 0.5 M NaOH
was added and the fluorescence read on a Perkin-Elmer
1000 fluorimeter (excitation 323 nm; emission 426 nm)
and related to a phenylalanine standard curve.
Addition of EDTA was needed to prevent precipitation of
manganese on addition of NaOH.
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5.2.3. pH optimum, time and protein linearities
The optimum pH for prolidase activity was
determined for a control fibroblast culture and for
prolidase-deficient fibroblasts by assay with a range
of buffers (25 mM barbital / HCl) pH 7.0-9.0. Time and
protein linearities for the hydrolysis of Phe-Pro were
determined by incubating at 37 °C for up to 60 min and
with protein levels up to 1.6 mg/ml.
5.2.4. Effect of manganese
Extracts from control fibroblasts and from the
two cases were preincubated with 1.33 mM MnC^ (1 mM
final concentration in the assay) using Phe-Pro as
substrate. A control was also preincubated with this
level of manganese and assayed with a range of other
prolidase substrates (Gly-Pro, Ala-Pro, Met-Pro,
Leu-Pro, Val-Pro and Ser-Pro). To determine the
optimal level of manganese for the assay, control
fibroblasts were assayed with 0-5 mM MnC^ with or
without preincubation for 5 min using Gly-Pro and
Phe-Pro as substrates. The effect of preincubation for
5 min with manganese levels up to 0.5 mM was measured





The ninhydrin reaction for proline detection was
linear for at least 100 nmoles in the assay giving an
optical density of about 1.2 after heating in a boiling
water bath for 30 min (fig. 23a). The development of
colour over a period of 90 min is shown in Fig. 23b,
which also shows the rapid hydrolysis of Gly-Pro on
of the assay
heating in acid conditions (about 200 nmoles after 90
min). All the other substrates were more stable and
gave lower substrate blanks than Gly-Pro.
The L-amino acid oxidase colorimetric method gave
an optical density (OD) of 0.285 for 10 nmoles
phenylalanine (Fig. 24a) and was linear up to at least
an OD of 1.0 equivalent to 35 nmoles phenylalanine.
The L-amino acid oxidase fluorimetric method gave a
reading of 900 fluorescent units for 10 nmoles
phenylalanine (Fig. 24b) with the fluorimeter
standardised to 200 units with 1 mg/1 quinine.
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Time (min)
Fig. 23 a) Standard curve for proline reacting with
ninhydrin reagent.
b) Development of colour with time for a proline
standard (50 nmol) (#) and for Gly-Pro hydrolysis
(A) .
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Fig. 24 a) Standard curve for phenylalanine in
L-amino acid oxidase reagent.
b) Standard curve for phenylalanine in
horaovanillic acid reagent.
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5.3.2. pH optimum, time and protein linearities
An optimum of pH 8.0 was obtained for both normal
and abnormal fibroblast prolidase (Fig. 25). Prolidase
activity was linear with time for at least 60 min and
with protein levels up to 40 pg in the assay (Fig. 26).
A range of 5-15 pg protein per assay was used for the






Fig. 25 pH profiles for prolidase from control (•),
case 1 (♦) and case 2 (■) fibroblasts
using Phe-Pro as substrate (section 5.2.2.2.).
(100 % = 97 nmol/min/mg protein)
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pg protein in assay
Fig. 26 a) Time and b) protein linearities for prolidase
using Phe-Pro as substrate (section 5.2.2.2.).
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5.3.3. Manganese
Whereas control prolidase activity was unaltered
by preincubation in buffer before addition of
manganese, preincubation with 1.33 raM MnCl2 for up to
60 min showed that optimal activation for Phe-Pro was
achieved after about 5 min. This was followed by a
gradual return to the original activity (Fig. 27). A
similar pattern was observed for all the other
substrates studied (Fig. 28) except Gly-Pro. The
profile for Gly-Pro was markedly different, increasing
rapidly in the first 15 min and then rising at a slower
rate up to 60 min when its activity was ten-fold higher
than without preincubation (Fig. 28). The abnormal
prolidase was stable in buffer but was progressively
inhibited in the presence of manganese (Fig. 27, case 1
shown). Optimal activity for control prolidase against
Phe-Pro was observed with 1 mM MnCl2 final
concentration in the assay (Fig. 29a) with a small fall
off in activity with higher concentrations. This was
true whether the enzyme was preincubated or not. The
hydrolysis of Gly-Pro required a higher level of 2.5 mM
MnCl2 for optimal activity (Fig. 29b).
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Fig. 27 Effect of preincubation of control (•)
and case 1 (O) fibroblast extracts for
up to 60 min with 1.33 mM MnClg ( )
or without MnCl2 ( ) on prolidase









Fig. 28 Effect of preincubation of prolidase with 1.33 mM
MnClg for up to 60 min for a range of substrates.
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Fig. 29 Effect of manganese on prolidase activity
with (•) and without (A) 5 rain preincubation
for a) Phe-Pro and b) Gly-Pro.
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The abnormal prolidase was activated by the
addition of manganese but the optimal level for case 1
activity against Phe-Pro was 0.05 mM whereas case 2 had
about 90% maximal activity at this level (Fig. 30).
Abnormal prolidase activity was always reduced by
preincubation irrespective of the level of manganese.
However, both cases still required 60 min preincubation
with 0.05 mM MnC^ for the optimal hydrolysis of
Gly-Pro (Fig. 31).
Fig. 30 Effect of MnCl^ on control (•), case 1 (x) and case 2 (a)
prolidase activity. Extracts were preincubated with MnCl2
for 5 min at 37°C at the levels shown before the addition
of Phe-Pro resulting in a 25% reduction of the manganese




Fig. 31 a) Effect of preincubation for 5 min with
different levels of MnClg for case 1 assayed
with Gly-Pro.
b) Preincubation of case 1 (•) and case 2 (a)





As both L-amino acid oxidase methods gave larger
readings for a given enzyme level than the proline
method, they were more suitable for the rapid analysis
of large numbers of samples such as may be generated by
kinetic and chromatographic studies. However, the
ninhydrin assay is the only method which can be used
with Gly-Pro as substrate. Glycine in the ninhydrin
reaction increased the proline standard reading and was
used in the method as recommended by Mayer and Nordwig
(1973). This eliminated any tendency for glycine
liberated from Gly-Pro to increase the reading.
Because of the rapid hydrolysis of Gly-Pro with heating
under acid conditions assays were heated in the boiling
water bath for 20 instead of 30 min. This resulted in
lower substrate blanks as noted by Myara et al. (1982).
Gly-Pro was used in the studies to enable comparison
with previous studies. Phe-Pro, which is more easily
assayed with the L-amino acid oxidase methods, is a
novel substrate for studying prolidase.
The pH optimum of 8.0 for hydrolysing Phe-Pro was
similar to that of 7.8 reported for human erythrocyte
prolidase using Gly-Pro as substrate (Endo et al.,
1982). In contrast, bovine prolidase had optimal
activity at pH 7.0 (Yoshimoto et al., 1983).
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5.4.2. Manganese
In previous studies Gly-Pro has been used with a
wide range of different levels of manganese in the
assay and have shown an almost complete absence of the
enzyme in the disease. The conditions of assay have
varied from no manganese (Arata et al., 1979), 10 mM
(Sheffield et al. , 1977 ), or 16 mM (Endo and Matsuda,
1981) with no preincubation to 1 mM preincubated for 2
hr (Powell et al., 1974; Ogata et al. , 1981), 0.9 mM
preincubated for 24 hr (Myara et al., 1982 ) or 10 mM
for 1 hr at 37°C (Endo and Matsuda, 1981). Based on
the present findings, these variable manganese
conditions would partly explain the very variable
prolidase levels reported in the literature (Powell et
al., 1974; Sheffield et al., 1977; Arata et al., 1979;
Endo and Matsuda, 1981; Ogata et al., 1981; Myara et
al., 1982; Pedersen et al., 1983; Lombeck et al.,
1986). In addition, the manganese levels which are
optimal for control prolidase are not necessarily those
required by the abnormal enzyme.
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6. STUDIES ON PROLIDASE
6.1. INTRODUCTION
Prolidase deficiency can be diagnosed by assaying
prolidase in cultured skin fibroblasts (Sheffield et
al., 1977; Arata et al., 1979; Myara et al. , 1983) as
well as in red and white blood cells (Powell et al.,
1974; Endo and Matsuda, 1981; Ogata et al., 1981). As
noted in section 5.4.2. all these studies utilised
Gly-Pro as substrate and indicated an almost complete
deficiency of prolidase activity. However, there has
been no research into the the properties of the
residual prolidase activity in the disease or any
measurements made using other imidodipeptide
substrates. Having determined the optimal conditions
of assay for control prolidase, a number of
characteristics of the normal and abnormal enzyme were
therefore studied, enabling diagnosis of the disease to




The substrate specificity of prolidase was
determined as previously described (5.2.2.1.) in
control (n=10) and prolidase deficient fibroblasts
using Gly-Pro, Phe-Pro, Ala-Pro, Val-Pro, Leu-Pro,
Ser-Pro, Met-Pro (Sigma Ltd) and Glu-Pro (BaChem Ltd).
After preincubation of an extract with 1.33 mM MnC^ at
37°C for 5 min, substrate was added (final
concentration 20 mM) and incubated for a further 30
min. Liberated proline was then estimated by the
ninhydrin method (5.2.2.1.). Gly-Pro, Phe-Pro, Leu-Pro
and Ala-Pro were also assayed after 5 min preincubation
without manganese, adding manganese with the substrate,
and without any additional manganese in the assay.
6.2.2. pH stability
The pH stability of human skin fibroblast
prolidase was determined using Phe-Pro as substrate.
The pH of an extract (0.5 ml) was adjusted with 0.01 M
HCl or NaOH to pHs from 4.0-10.0, left at room




The effect of heat on prolidase activity in
control and prolidase deficient fibroblasts was
investigated by heating extracts in 50 mM barbital /
HC1 pH 8.0 in a water bath at 30-60°C for 5 min or at
48°C for up to 60 min. This was carried out in the
presence (1.33 mM) or absence of manganese. For
samples treated without manganese an equivalent amount
of MnC^ was added with the substrate.
6.2.4. Substrate kinetics
Substrate kinetics of control and abnormal
prolidase were studied after preincubation with 1.33 mM
MnCl2 for 5 min for all the substrates over the
concentration range 1-20 mM. Km and Vmax were
calculated by constructing Eadie-Hofstee plots using a
Hewlett-Packard HP97 (Zivin and Waud, 1982).
Product formation studies were also performed for
the hydrolysis of Phe-Pro using the method of Chrastil
and Wilson (1982)(see appendix, sectionll.6.). Product
(phenylalanine) formation was followed for up to 24 hr
with a limiting substrate level (0.5 mM) for control
and prolidase deficient fibroblasts with the same
extract protein level.
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6.2.5. Effect of PHMB
The effect of p-hydroxymercuribenzoate (PHMB) on
prolidase activity against Phe-Pro was assessed by
adding 0.01-0.5 mM PHMB before or after treatment with
1.33 mM MnC^. Based upon these results, 0.05 mM PHMB
was added to normal and abnormal prolidase following




Ion-exchange chromatography was performed using
DEAE-Cellulose prepared as described in section 3.2.7.
in a 1 x 25 cm column. The extract (2 ml) was dialysed
for 60 min against the elution buffer, centrifuged at
100 ,000 x g for 30 min, then applied to the column.
300 ml of
Elution was carried out with a 0-250 mM NaCl linear
K
gradient in 10 mM barbital / HC1 buffer pH 7.4 and 1.25
ml fractions collected.
6.2.6.2. Gel filtration
Gel filtration was performed with Sephadex G
150-120 (Sigma Ltd) in a 2.5 x 55 cm column. 2ml
extract was dialysed against elution buffer for 60 min,
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centrifuged at 100,000 x g for 30 min and applied to
the column. Elution was carried out with 10 mM
barbital / HCl buffer pH 7.4 containing 100 mM NaCl
with an ascending flow-rate of 4 ml/hr and 1.25 ml
fractions collected.
6.2.6.3. Isoelectrofocusing
Sucrose density isoelectrofocusing was performed
in 'J' tubes (see appendix, section 11.4.) by applying
0.75 ml samples of control and case 1 fibroblast
extracts with 'narrow-range' ampholine pH 4-6.
Fractions (0.22 ml) were collected and assayed for
prolidase using Phe-Pro with 5 min preincubation or
Gly-Pro with 60 min preincubation with 1.33 mM MnC^.
Control was assayed for 30 min and case 1 for 60 min.
Prolidase was also assayed with Leu-Pro and Ala-Pro




Skin fibroblast prolidase activated by
preincubation with manganese showed a tight range of
values for each of the eight substrates studied (Fig.
32). The highest specific activity was against Ser-Pro
whilst the lowest was against Glu-Pro, the only
substrate which wasn't activated by manganese.
Activity against Gly-Pro, when fully activated by 60
min preincubation with 2.5 mM MnC^r was increased
about 2.5 fold to a mean specific activity of 220
nmol/min/mg protein. Abnormal prolidase activity
against Gly-Pro was reduced to 3-6% of control activity
depending upon the manganese conditions used. The
reduction in activity against the other substrates was
not nearly as marked, ranging from 27 to 80% of control
(see Fig. 32).
Prolidase activities against four different
substrates in fibroblasts from controls and the two
cases with and without manganese are shown in Table 8.
Clearly there is a marked deficiency in the cases
against each of the four substrates when assayed
without manganese. After preincubation with manganese,
the deficiency was still marked for Gly-Pro (94%), but
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Substrate
Fig. 32 Prolidase activity of control (•), case 1 (*)
and case 2 (a) skin fibroblasts ( ; mean
activity) following preincubation with 1.33
mM MnClg for 5 min at 37°C against 20 mM
substrate (X-Pro; X=amino acid shown).
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6.3.2. pH and Heat stability
Prolidase was stable over the range pH 4.5-9.5
with a fall off to less than 50% of the neutral pH
activity at pH 4.0 (Fig. 33).
Fig. 33 pH stability of skin fibroblast prolidase.
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Both normal and abnormal prolidase activities
against Phe-Pro were thermolabile above 45°C with only
about 10% residual activity at 55°C after 5 min (Fig.
34a). Following the loss of activity at 48°C (Fig.
34b) showed that 70-90% of control enzyme activity
(example shown was typical of 6 controls studied) was
lost after 60 min without manganese. However, if
manganese was present the enzyme was protected and only
lost about 25% of activity. The two cases (case 2
shown) showed a similar pattern of loss of enzyme
activity as in the controls in the absence of
manganese, but in the presence of manganese the
abnormal enzyme was initially rather more labile.
Hence the addition of manganese increased the heat
stability of the normal, but decreased that of the
abnormal enzyme.
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Fig. 34 Heat stability of control ( ) and case 2 ( )
prolidase activity against Phe-Pro without (x)
or with (•) 1.33 mM MnCl0. (a) Effect of 5 min
at 30-60°C. (b) Effect of preincubation at
48°C for up to 60 min.
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6.3.3. Substrate kinetics
The response of normal and abnormal prolidase
(case 2), following preincubation with 1.33 mM MnC^
for 5 min, to a number of substrates was analysed by
Eadie-Hofstee plots. The results for the corrected Km
and Vmax are given in Table 9. The estimates for data
variation (SD(E) rad; Zivin and Waud, 1982) was less
than 0.07 for all the substrates, indicating the
results to be acceptable. The normal enzyme exhibited
biphasic kinetics for Phe-Pro (Fig. 35a), whilst the
abnormal enzyme showed only a single line (Fig. 35b).
Plots for all the other substrates were monophasic for
controls and cases. The abnormal enzyme had a lowered
affinity for all the substrates, the smallest change
being for Glu-Pro and the largest for Ser-Pro, Phe-Pro
and Leu-Pro. The maximum activity of the abnormal
enzyme, calculated from the Eadie-Hofstee plots was
increased for Met-Pro, unchanged for Phe-Pro and
Leu-Pro, somewhat reduced for Ser-Pro and Val-Pro and










Ser-Pro 3.8 36.2 279 142
Ala-Pro 2.3 8.1 221 62
Met-Pro 4.5 14 .4 147 210
Phe-Pro ISJ • 00 • 00 24.9 136 147
Gly-Pro 2.8 13 .7 150 20
Leu-Pro 1.3 10 .4 80 72
Val-Pro 0.9 3.3 68 40
Glu-Pro 4.4 6.1 33 6
Table 9. Substrate kinetics of control and case 2
prolidase. 1-20 mM substrate analysed by
Eadie-Hofstee plots (Zivin and Waud, 1982).
25 pi extract was preincubated with 50 pi 50 mM barbital / HC1 pH 8.0
containing 2 mM MnCl^ for 5 min and the assay started by the addition
of substrate and incubation at 37°C for 30 min.
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1/s
Fig. 35 Lineweaver and Burk plots for a) control and
b) case 1 skin fibroblast activity against
Phe-Pro.
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Analysis of product formation (Fig. 36), using
Phe-Pro as substrate by the method of Chrastil and
Wilson (1982)(see appendix, section 11.6.), indicated
the abnormal enzyme had an unchanged sterical constant
value (n) of over 0.9 and a maximum product formation
value (pffl) of 0.35 mM. The rate constant related to
the diffusion coefficient (k) was reduced to 0.0023 as
compared with 0.0086 1/g/sec for control enzyme.
1 15
Fig. 36 Determination of a) sterical structure constant
n, and b) rate constant k, for prolidase in
control (•) and case 1 (A) fibroblast extracts
assayed with Phe-Pro. The constants are obtained
as the slopes of the linear part of each plot
(see appendix, section 11.6.).
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6.3.4. Inhibition with PHMB
Both control and case prolidase activity against
Phe-Pro was strongly inhibited by treatment with PHMB
prior to incubation with manganese. However,
preincubation with 1.33 mM MnC^ prior to addition of
PHMB, protected the normal enzyme but not the abnormal
enzyme from inhibition (Fig. 37). Addition of PHMB and
manganese simultaneously gave an intermediate result
for control prolidase with 0.05 mM PHMB plus 1.33 mM
MnCl2 inhibiting by 30% compared to less than 5% when
PHMB was added after the manganese. The abnormal
prolidase (cases 1 and 2) was inhibited by greater than
95% under both these conditions. Table 10 shows the
effect of 0.05 mM PHMB on prolidase activity against a
number of substrates after preincubation with manganese
for three controls and for both cases. The addition of
manganese prior to PHMB protected normal prolidase
activity for all the substrates except for a small
reduction with Gly-Pro and a moderate reduction for
Met-Pro. However, the abnormal enzyme was markedly
inhibited for all the substrates, except for a moderate




Fig. 37 Effect of PHMB on control ( ) and abnormal
( ) prolidase activity against Phe-Pro.
m, PHMB added before manganese;
o, PHMB added with manganese;
•, PHMB added after manganese;








Ser-Pro 100 97 100 14 14
Ala-Pro 92 98 100 0 4
Met-Pro 45 53 56 4 3
Phe-Pro 113 108 100 6 3
Gly-Pro 76 81 80 58 58
Leu-Pro 117 93 75 2 4
Val-Pro 131 126 120 4 3
Table 10. Relative activity (%) of prolidase against
different substrates following PHMB treatment.
Prolidase activated by preincubation with 1.33
mM MnC^ for 5 min at 37°C and PHMB added with
substrate to give a concentration of 0.05 mM.
119
6.3.5. Chromatography
DEAE-Cellulose ion-exchange chromatography gave a
single peak of prolidase eluting at 135 mM NaCl, just
after the second peak of prolinase at 130 mM NaCl (Fig.
38). Sephadex gel filtration also gave a single peak
of prolidase eluting just before the first prolinase
peak (Fig. 39). As all the prolidase activity was
found to be below pH 6.0 on a preliminary run,
isoelectrofocusing was carried out with a narrow-range
pH 4-6 ampholite gradient. Control fibroblast
prolidase showed a peak for Gly-Pro and Phe-Pro at pi
4.5 (Fig. 40). Prolidase-deficient fibroblasts (case
1) showed a peak at pi 4.6 for both these substrates.
The prolidase activity against Leu-Pro and Ala-Pro
coincided with these peaks. The minor peak at about pi
5.0 was associated with a large precipitated protein
band and was probably artifactual.
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Fig. 38 DEAE—Cellulose ion—exchange chromatography of
human skin fibroblast prolidase (Phe-Pro, ■ );
prolinase (Pro-Gly, • ) and proline imino-
peptidase (Pro-Gly-Gly, A ). 1 x 25 cm column
eluted with 0-250 mM NaCl in 10 mM barbital /
HCl buffer pH 7.4.
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Fig. 39 Sephadex G150-120 gel filtration of human skin
fibroblast prolidase (Phe-Pro, ); prolinase
(Pro-Gly, ); and 13-hexosaminidase (- -) .
2.5 x55 cm column eluted with 10 mM barbital /
HCl buffer pH 7.4 containing 100 mM NaCl.
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4.0 4.4 4.8 5.2
pH
Fig. 40 Sucrose density isoelectrofocusing of control
(•) and case 1 (A) fibroblast prolidase
assayed with Gly-Pro ( ) or Phe-Pro ( ) .
Isoelectrofocusing was performed as described




The reported mean specific activity (nmol/min/mg
protein) of control skin fibroblast prolidase against
Gly-Pro ranged from 7.2 (Arata et al., 1979), 20
(Sheffield et al., 1977), 50 (Myara et al., 1982) to
154 (Pedersen et al., 1983 ), all less than for the
present level of 220 under optimal conditions. This
wide range of activities is a reflection of the
variable manganese conditions used. Abnormal prolidase
activity against Gly-Pro has consistently been reported
to be absent or very low (Powell et al., 1974;
Sheffield et al., 1977; Arata et al., 1979; Endo and
Matsuda, 1981; Ogata et al., 1981; Myara et al., 1982;
Pedersen et al. , 1983) and in the present study both
cases also had reduced activities, 3-6% of control
depending upon assay conditions. The marked deficiency
of activity against Gly-Pro in the two cases was not a
feature of the other substrates tested and indicates a
change in substrate specificity rather than a complete
absence of the enzyme. The deficiency against
substrates with a polar amino acid (glycine, serine and
glutamic acid) was greater than against those with a
non-polar amino acid (alanine, valine, phenylalanine,
leucine and methionine)(Fig. 32). Thus it seems that
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the disease is a result of a change in the structure of
the enzyme at or close to the active site.
6.4.2. Heat stability
The results for the heat stability of prolidase
may indicate that the normal enzyme consists of two
forms, one labile and one stable in the presence of
manganese (Fig. 34b). In prolidase deficiency it
appears that this stable form is largely absent.
6.4.3. Substrate kinetics
Owing to the altered Km values, the deficiency in
abnormal prolidase activity would be more marked the
lower the substrate level used. The substrate
(Gly-Pro) levels used in previous work has varied from
1 (Sheffield et al., 1977), 3 .7 (Powell et al. , 1974),
7 (Arata et al., 1979), 10 (Endo et al., 1981) to 47 mM
(Myara et al., 1982) which would differentially affect
the level of control and abnormal prolidase activity.
As with manganese conditions (see section 5.4.2.), the
level of substrate optimised for the assay of control
prolidase would not be optimal for the abnormal enzyme.
The biphasic kinetics of control prolidase
against Phe-Pro (Fig. 35a) provide further evidence for
the existence of two enzymes, though it is interesting
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that, of the substrates tested, this is only observed
for Phe-Pro.
The data for product formation studies indicated
no major alteration in enzyme structure or absorption
affinity for the substrate, but faulty activation or
presence of inactive enzyme (Chrastil and Wilson,
1982) .
6.4.4. Inhibition with PHMB
The effect of PHMB on prolidase was tested as
PHMB has been shown to bind to pig intestinal prolidase
(Sjostrom and Noren, 1974) and bovine intestinal
prolidase (Yoshimoto et al., 1983). Also, sulphhydryl
reagents such as iodoacetamide have been reported to
inhibit pig kidney prolidase (Davis and Smith, 1953)
and this inhibition was noted to be prevented by
manganese. In keeping with these findings, human
prolidase was inhibited by PHMB and protected by
manganese ions. Since PHMB and iodoacetamide react
with SH groups, the prevention of PHMB inhibition of
control prolidase activity by manganese ions indicates
that manganese activates prolidase by binding to SH
groups. Prolidase activity in the two cases, however,
was much more susceptible to inhibition by PHMB after
preincubation with manganese (see Table 10). The
failure of manganese to protect the activity of the two
cases indicates the absence of this form of prolidase
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or that the genetic alteration in the enzyme may
involve one or more SH groups.
6.4.5. Chromatography
The chromatographic profiles for DEAE-Cellulose,
Sephadex and isoelectrofocusing all indicate that
cultured skin fibroblasts have only a single enzyme,
prolidase, for the hydrolysis of imidodipeptides. The
pi of 4.5 observed in the present study is almost the
same as that of 4.4 seen in guinea pig brain (Browne
and O'Cuinn, 1983) and pig intestine (Sjostrom and
Noren, 1974). The pi of 4.6 for abnormal prolidase was
not significantly different from the pi of the control
enzyme.
6.4.6, Conclusions
From these results, a number of properties can be
observed to distinguish control and abnormal prolidase.
In addition to the differing responses to preincubation
with manganese (section 5.3.3.), three other properties
may be considered to be diagnostic: 1) substrates:
abnormal enzyme has reduced specific activities and
increased Km values compared to control; 2) heat
stability: control is more stable, but abnormal more
labile to heat treatment in the presence of manganese
and 3) PHMB: inhibition of control prevented by
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manganese, abnormal more susceptible to inhibition in
presence of manganese. These results may be explained
by either a change in the properties of a single form
of prolidase or the presence of two isoenzymes, at
least one of which is affected in the disease.
Although only a single form was observed with the
separative techniques used here and in human
erythrocytes (Endo et al., 1982), an unstable second
form may be losing its activity at some stage in the
preparative procedure. Also the results here indicate
that a second form would not be able to hydrolyse
Gly-Pro efficiently and would require the use of other
substrates for detection. Which of these hypotheses is
correct will be resolved by the use of further
chromatographic procedures and assay of prolidase with
a number of substrates.
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7. A SECOND COMPONENT OF PROLIDASE ACTIVITY
7.1. INTRODUCTION
Although only one form of prolidase was found in
the previous studies (section 6.3.5.), the changed
properties of prolidase in the disease state (section
6.3.) could be most easily explained by the presence of
more than one form of prolidase in controls. Hence a
further chromatographic study was undertaken to see if
a second form had not been found for methodological
reasons. Indeed a second form of prolidase was found
and a DEAE-Cellulose batch method was developed to
enable the rapid separation of the two forms of
prolidase. The distribution of the two forms was
studied in a range of human cells and tissues.
Properties of the two prolidases in controls and the
two cases of prolidase-deficiency were studied in order






Cell and tissue extracts were prepared by the
addition of ice-cold 10 mM barbital / HCl buffer pH 7.4
containing 50 mM NaCl, sonication at 4-6 pm for 30 sec
for cells or homogenisation in a Potter-Elvehjem
homogeniser followed by sonication for 60 sec for
tissues. Extracts were then centrifuged at 100,000 x g
for 60 min.
The separation of cell and tissue prolidase into
two components was achieved by applying 1 ml
fibroblast, amniotic fluid or white cell extract (^5
mg/ml), 1 ml red blood cell extract or serum (50 mg/ml)
or 1 ml (10% w/v) tissue extract in 10 mM barbital /
HCl buffer pH 7.4 containing 50 mM NaCl to a 0.8 x 5 cm
DEAE-Cellulose column, eluting with 70 ml of a 50-300
mM NaCl linear gradient and collecting 1.5 ml
fractions.
7.2.1.2. DEAE batch method
A DEAE-Cellulose batch method was then developed
for the rapid separation and estimation of the two
prolidase activities. A mixture of 0.25 ml 50% (v/v)
130
DEAE-Cellulose slurry in 10 mM barbital / HC1 pH 7.4,
0.125 ml NaCl and 0.125 ml 2% (w/v) extract in the same
buffer was mixed for 15 min at 10°C, centrifuged at
1,000 x g for 10 min and the amount of unbound
prolidase estimated against Phe-Pro. The concentration
of NaCl added was varied from 400 to 1200 mM to find
the optimal levels for recovery of peak I without peak
II and for total recovery. The addition of 480 mM NaCl
released peak I prolidase and 1000 mM NaCl released
both peaks and their sequential use allowed the
separation of both peaks. The reproducibility of the
method was checked by estimating the percentage of each
of the peaks in a cerebral frontal cortex extract ten
times. The percentage of the two peaks was also
estimated for a number of cells and tissues using the
batch method. The volumes used in the method can be
proportionately increased to allow the preparation and
characterisation of the separated peaks.
7.2.2. Substrate specificity
Prolidase activity of the peaks, separated by
column chromatography or the batch method, was measured
with a variety of substrates (Gly-Pro, Phe-Pro,
Ala-Pro, Val-Pro, Met-Pro and Leu-Pro; Sigma Ltd) by
estimating liberated proline (section 5.2.1.1.) or
phenylalanine (section 5.2.1.2.). Activities were
related to protein using bovine serum albumin as
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standard (Lowry et al., 1951; see appendix, section
11.3.).
7.2.3. Properties
The manganese requirement, heat stability at
48°C, inhibition by p-hydroxymercuribenzoate and
substrate kinetics (Km) of the two peaks of prolidase
from controls and the two cases were studied as




Initial work using a 1 x 25 cm DEAE-Cellulose
column showed two peaks of prolidase activity in
cultured skin fibroblasts, eluting at 135 and 210 mM
NaCl respectively. Dialysis of an extract against
(10 mM Barbital / HC1 pH 7.4 containing 50 mM NaCl)
buffer^inactivated peak II, but the inclusion of 0.1 mM
dithiothreitol during dialysis prevented this loss.
Chromatography of fibroblast prolidase activity of the
prolidase-deficient cases against Phe-Pro showed a
marked deficiency of peak I as compared to control
activity, although a very small residual activity could
be detected (Fig. 41). Peak II was not reduced in the
two cases. In control fibroblasts peak I was very
active against Gly-Pro compared with Phe-Pro, whereas
peak II was relatively less active against Gly-Pro
(Fig. 42). The activity against Phe-Pro was split
about 60% peak I and 40% peak II estimated by
calculation of areas under the elution curve. Activity
against Gly-Pro was split about 85% peak I, 15% peak
II.
The activity against six other substrates was
also investigated, though not for peak I in the cases
owing to insufficient activity for reliable
measurements using the proline detection method. The




















Fig. 42 Skin fibroblast prolidase separated by DEAE-
Cellulose chromatography. Prolidase was assayed
with Gly-Pro (A—▲) and Phe-Pro (• •) „
135
II against Met-Pro and a markedly reduced activity
against Gly-Pro as compared to control peak II (table
11) .
In order to compare the proportions of the two
peaks in a number of different cells and tissues, small
0.8 x 5 cm DEAE-Cellulose columns were used to reduce
the sample size required. Recovery of prolidase
activity was above 70% and all the control cells and
tissues examined had both peaks of prolidase. Red
blood cells, kidney, liver and spleen had about
two-thirds peak I, cerebral frontal cortex slightly
more peak II and pancreas about two-thirds peak II
(Fig. 43). Serum had a very low prolidase specific
activity (1.0 nmol/min/mg protein) and showed a single



































































































































































7.3.2. DEAE-Cellulose batch chromatography
Whilst column chromatography is ideal for fine
analytical work, the technique does not readily permit
analysis of small quantities of many samples in a short
time. The DEAE-Cellulose batch method was therefore
developed to allow rapid analysis of large numbers of
samples. To follow the binding of the two peaks,
advantage was taken of their differing responses to
manganese in that peak I needs preincubation for full
activity, whilst peak II does not (see section 7.3.3.2.
below). Without preincubation there was a plateau of
prolidase activity at 120-140 mM NaCl representing peak
I rising to a new plateau at about 250 mM NaCl, the
difference representing peak II (Fig. 44). On
preincubation with manganese, prolidase activity
increased to a new level at 120-130 mm NaCl
representing peak I activation which was also reflected
in the increased level at 250 mM NaCl. A final
concentration of about 120-130 mM NaCl would,
therefore, separate peak I from peak II and 250 mM NaCl
liberate both peaks. By the sequential use of 120 and
250 mM NaCl the two peaks can be obtained separately.
As the recovery of prolidase activity was greater than
95%, the estimation of the two peaks would be more
reliable with the batch than the column method.
Following separation by the DEAE-Cellulose batch method






Fig. 44 Activity of fibroblast prolidase assayed against
Phe-Pro unbound to DEAE-Cellulose in the batch
method at different final concentrations of NaCl
(A) no preincubation, MnClg added with substrate
(•) preincubation with 1 mM MnCl2 for 5 min.
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expected prolidase activity (Fig. 45), indicating no
interference with each other in the assay.
The reproducibility of the batch method, as
checked by estimating the two peaks ten times for one
cerebral frontal cortex extract, was excellent with the
coefficient of variation for peak I being 2% and for
peaks I and II 3%, the same as the 2-3% for the
prolidase assay. The specific activities against
Phe-Pro and the percentage of peak I determined by the
batch method for a number of cells and tissues are
given in Table 12. A 2% (w/v) extract was needed for
tissues except kidney and pancreas (1% w/v), and about
1 mg protein for red and white blood cells, fibroblasts
and amniotic fluid cells. An assay time of 20 min was
required for all the enzyme sources except for red
blood cells (30 min). The reduced requirement for
material enabled white blood cells to be analysed and
showed moderate enzyme activity with about equal
amounts of the two peaks, making them a useful source
of prolidase for analysis of the two peaks in the
disease state. The specific activity and percentage of
the two peaks for fibroblasts and amniotic fluid cells
were similar, indicating that a prolidase abnormality
detected in skin fibroblasts should also be present in
amniotic fluid cells. The two cases had 16% and 11%
peak I activity which was higher than indicated by the





Fibroblast prolidase activity against Phe-Pro
after preincubation for up to 60 min with 1 mM
MnCl2 for peak I (O), peak II (•) and peak I
+11 estimated experimentally (■) and
theoretically (A) on an equal activity basis
after 5 min preincubation.
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Sample Specific Activity %age Peak I
Fibroblasts
Controls (n=10) 100 + 8+ 53+4
Case 1 42 16
Case 2 57 11
Amniotic fluid cells
(n=10) 108 +15 55+3
Red blood cells 5.7, 6.1, 6.7 68, 73
White blood cells 54, 58, 64, 66 42, 42, 44, 50
Kidney 190 , 213, 236, 291 60, 68, 73
Liver 56, 63 77, 77
Spleen 57, 71 68, 74
Pancreas 235, 287 24, 34
Cerebral frontal cortex
(n=10) 108 +16 40+4
Heart 64, 77 53, 61
Skeletal muscle 55 50
Table 12. Cell and tissue prolidase activity against
•k
Phe-Pro and percentage peak I estimated by
the DEAE-Cellulose batch method.
* nmol/min/mg protein
t Mean + SD
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enzyme in the column method may have resulted in an
underestimate of abnormal peak I.
The DEAE-Cellulose batch method allowed the rapid
preparation of the two peaks with excellent recovery
permitting analysis of both peaks in the disease, as
shown for case 1 in Table 13. Control peak I
hydrolysed Ala-Pro and particularly Gly-Pro at a faster
rate than peak II. In case 1, peak I residual activity
against all five substrates was low compared to that of
the control. Peak II residual and relative activities
in case 1 were similar to those of the control, except








































































































































































A number of properties of peaks I and II
prolidase activity of control and prolidase-deficient
fibroblasts were studied. When compared, the results
were the same for the peaks separated by both the
DEAE-Cellulose column and batch methods.
7.3.3.1. pH profile
The pH optimum of control and abnormal prolidase
activity against Phe-Pro was pH 8.0 following
preincubation with 1 mM MnC^ (Fig. 46). Analysis of
control peak I showed that without preincubation with
manganese, the activity decreased with increasing pH,
but that activation after preincubation with manganese
increased with pH and an optimum of pH 8.0 was
obtained. Although peak II also had a pH optimum of
8.0, higher activity was seen without preincubation.
The pH profile of an extract would therefore depend






















Fig. 46 pH profile of control fibroblast peak I (-
and peak II ( ) without (O) or with (•)
preincubation for 30 min with 1 mM MnClg.
Phe-Pro was used as substrate.
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7.3.3.2. Manganese
Control peak I activity towards Phe-Pro was
optimal following 10-20 min preincubation at 37°C with
1 mM manganese but was reduced by preincubation without
manganese (Fig. 47A, B). In contrast, control peak II
was inactivated by preincubation with manganese (Fig.
47 A) and optimal activity was obtained by the addition
of 0.5-1.0 mM MnCl2 with the substrate (Fig. 47B). The
two abnormal peaks had the same responses, except that
peak II was even more unstable in the presence of
manganese.
Control peaks I and II both needed preincubation
with 5 mM MnCl2 for 60 min for full activity against
Gly-Pro (Fig. 47C). The very small amount of peak I in
the cases also needed this level for optimal activity,
whilst Peak II needed only 0.1 mM MnCl2 (Fig. 47C)
As a consequence of these different effects of
manganese on the two peaks of prolidase, the specific
activity and proportions of the peaks of a particular
cell-type or tissue will depend upon the conditions.
In practise, estimates obtained after 5 min

































































At 48°C, loss of control peak I activity against
Phe-Pro was completely prevented by the presence of 1
mM MnC^, whereas control peak II activity was only
partially protected. However, abnormal peak II was
very labile in case 1 whether or not manganese was
present, whilst in case 2 the activity was more stable
in the absence of manganese and more labile in its
presence than control peak II (Fig. 48). As indicated










































7.3.3.4. Effect of PHMB
Control peak I preincubated for 30 min with 1 mM
MnC^ for Phe-Pro and 60 min for Gly-Pro lost about 20%
of activity against both substrates when treated with
0.05 mM PHMB (Fig. 49). Control peak II against
Phe-Pro, which doesn't require preincubation with
manganese, was inhibited 90% with 0.05 mM PHMB, whilst
the activity against Gly-Pro, which does require
preincubation, was only inhibited 50% following
preincubation with 1 mM MnC^ for 60 min. However,
peak II activity in both cases against Phe-Pro and
Gly-Pro was completely abolished by 0.05 mM PHMB





Fig. 49 Effect of different levels of PHMB on skin
fibroblast prolidase peak I (•--•) and peak II
(A—▲) assayed with Phe-Pro after 5 min
preincubation with 1 mM MnClg.
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7.3.3.5. Substrate kinetics
The substrate kinetics of normal and abnormal
prolidase for Gly-Pro and Phe-Pro were analysed by
Eadie-Hofstee plots and the Km values given in Table
14. The estimates of data variation (SD(E)Rad; Zivin
and Waud, 1982) for both substrates was less than 0.07,
indicating acceptable results. There was insufficient
abnormal peak I activity for the reliable estimation of
Km values. The results indicate that peak II prolidase
in the cases had decreased affinities for both Gly-Pro
and Phe-Pro.
Preincubation MnCl2
Substrate Source (min) (mM) Km
Gly-Pro Control extract 5 5 2.5
Control extract 60 5 9.0
Control peak I 60 5 17.0
Control peak II 60 5 7.0
Case 2 peak II 60 5 33.0
Phe-Pro Control peak I 30 1 0.5
Control peak II 0 1 8.0
Case 1 peak II 0 1 16.0
Case 2 peak II 0 1 36.0





The finding of a second form of prolidase
explains the presence of moderate prolidase activity in
prolidase-deficient fibroblasts (6.3.1.). The pH
optimum of both peaks against Phe-Pro was about 8.0 in
agreement with the value for a fibroblast extract
(5.3.1.) and similar to pH 7.8 for erythrocytes against
Gly-Pro (Myara et al., 1984a). The isolated
erythrocyte enzyme (Endo et al., 1982) is equivalent to
the present peak I and showed comparable relative
activities for Gly-Pro, Ala-Pro and Leu-Pro. Previous
investigations of prolidase (Endo et al., 1982; Myara
et al., 1984a; section 6.3.5.) would not have picked up
peak II for a number of reasons: erythrocytes have
little peak II and dialysis inactivates peak II, as
does the use of high manganese levels and prolonged
preincubation. That dithiothreitol prevents the loss
of peak II activity on dialysis, indicates a need to
preserve SH groups on the enzyme during dialysis.
The results with the batch method were in
reasonable agreement with the column chromatography
data, with erythrocytes, kidney, liver and spleen
having more peak I and pancreas more peak II. The high
level of peak II in the pancreas indicates a
155
particularly important role for this enzyme in the
pancreas.
7.4.2. Substrate specificity
The previous finding that the enzyme in
prolidase-deficient fibroblast extracts showed changes
in the rate of hydrolysis of a number of substrates
(section 6.3.1.) can be explained by the changed rate
at which both peaks hydrolyse the various substrates.
Indeed, the much reduced ability of abnormal peak II to
hydrolyse Gly-Pro as compared with the other substrates
explains why only activity against Gly-Pro showed a
marked deficiency in the disease fibroblasts (6.3.1.).
Reports showing residual activity against Gly-Pro in
the disease (Gray et al., 1983 ; Pedersen et al., 1983;
Naughten et al., 1984) can be attributed to the use of
assay conditions capable of detecting peak II activity.
That control and abnormal fibroblast prolidase have
different Km values for a number of substrates (Table
9) can be partially explained by the loss of peak I
activity, as the two peaks have different Km values,
and by changes in the abnormal peak II values.
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7.4.3. Manganese
A wide variety of manganese conditions have been
used for the assay of prolidase against Gly-Pro
(section 5.4.2.). Although optimal activity against
Gly-Pro for both control peaks can be obtained under
the same conditions, abnormal prolidase needed a much
lower level of manganese (section 5.3.3.). This can be
explained by the loss of peak I together with a
reduction in the manganese required by peak II. As no
one combination of manganese and preincubation time can
give optimal activity against Phe-Pro for both peaks
simultaneously, the conditions and response for an
extract represent a compromise between the requirements
for the two peaks. Hence the failure of prolidase-
deficient fibroblast activity against Phe-Pro to be
increased by preincubation with manganese can be
explained by the loss of manganese-activated peak I in
the disease.
7.4.4. Heat stability
Stabilisation of control fibroblast prolidase
activity to heat by manganese (section 6.3.2.) is due
to complete protection of peak I and partial protection
of peak II. Although in abnormal fibroblasts an
absence of peak I would result in a lower level of
protection by manganese, abnormal peak II is more
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labile in the presence of manganese giving an even
greater reduction in prolidase activity on heat
treatment.
7.4.5. Inhibition by PHMB
Protection of human fibroblast prolidase peak I
activity by manganese against PHMB inhibition suggests
that manganese ions bind to prolidase via sulphhydryl
groups, as found for swine kidney prolidase (Davis and
Smith, 1953). The inability of manganese to protect
peak II activity and the need to add manganese with the
substrate indicates that at least part of the manganese
effect on peak II activity involves interaction with
the substrate. The loss of peak I explains the failure
of manganese to protect prolidase-deficient fibroblast
activity against PHMB (section 6.3.4.).
7.4.6. Implications
The finding of a second form of prolidase
explains the presence of a moderate prolidase activity
for a number of substrates in prolidase-deficient cells
(section 6.3.1.). The differences in the properties of
the two prolidases and their changes in the disease
mean that particular attention has to be paid to their
estimation. This can be achieved most easily by the
use of the DEAE-Cellulose batch method followed by
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appropriate assay conditions. Alteration of both
prolidases in prolidase deficiency indicates a
structural relationship. As human prolidase (peak I)
is known to consist of two subunits (Endo et al.,
1982), the most likely explanation is a common subunit
which is changed in the disease such as to alter
substrate hydrolysis.
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8. PURIFICATION OF HUMAN KIDNEY PROLIDASE AND RAISING
OF SPECIFIC ANTISERA IN RABBITS
8.1. INTRODUCTION
Although prolidase has been purified from several
animal tissues (Davis and Smith, 1957; Baksi and
Radhakrishnan, 1974; Hui and Lajtha, 1980; Browne and
O'Cuinn, 1983; Yoshimoto et al. , 1983) and bacteria
(Ryden, 1971; Kaminogawa et al., 1984), the human
enzyme has only been purified from erythrocytes (Adams
and Smith, 1952; Endo et al., 1981). As erythrocytes
have very low prolidase activity (Table 12, section
7.3.2.), prolidase was purified from human kidney which
had the highest activity of the range of tissues in
Table 12. Purified prolidase was injected into rabbits
to raise specific antisera, which were used to study





Human kidneys were obtained at autopsy 24 hr
after death and stored at -40°C. A 20% (w/v) extract
was prepared by homogenising 1 Kg kidney in 4.51 10 mM
barbital / HCl buffer pH 7.4 containing 1 mM MnCl2 in a
Waring blender. The homogenate was then centrifuged at
23 ,000 x g for 2 hr and the supernatant stored at
-40°C. The pellet was resuspended in 1.0 1 buffer,
disrupted further in a Silversen homogeniser and stored
at -40°C overnight. This preparation and the original
supernatant were then thawed and centrifuged at 23,000
x g for 2 hr.
8.2.2. Chromatographic procedures
All chromatography was performed at 4°C unless
otherwise stated. Column fractions were diluted
appropriately with bovine serum albumin (0.25 mg/ml) in
10 mM barbital / HCl buffer pH 7.4 containing 50 mM
NaCl prior to assay of prolidase activity against
Phe-Pro.
8.2.2.1. DEAE-Cellulose
4.51 kidney extract was applied to a 10 x 25 cm
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DEAE-Cellulose column equilibrated with 10 mM barbital
/ HC1 buffer pH 7.4. After washing with 51 of the same
buffer containing 50 mM NaCl (buffer A), the enzyme was
eluted with 4.51 buffer containing 0.25M NaCl and 250
ml fractions collected.
1.6 2 Kg (NH^^SO^ was added to the pooled enzyme
peak (3.751) to bring it to 60% saturation and left for
24 hr at 4°C to precipitate. The precipitate was
removed by centrifugation at 18,000 x g for 2 hr and
then dialysed against 4 x 51 buffer A. The dialysate
( 580 ml) was then applied to a 4.5 x 75 cm DEAE-
Cellulose column equilibrated with buffer A. After
washing with 2.51 of the same buffer, the column was
eluted with 31 of a 50-500 mM NaCl linear gradient and
10 ml fractions collected.
8.2.2.2. Concanavalin-A Sepharose
3 ml buffer A containing 100 mM MnC^, MgC^ and
CaCl^ was added to 300 ml of the pooled DEAE-Cellulose
enzyme peak and applied to a 2 x 35 cm Concanavalin-A
Sepharose column equilibrated with buffer A containing
the above salts at a concentration of 1 mM. The enzyme





For metal-chelate chromatography a Ni gel was
prepared as previously described (section 4.2.3.3.).
300 ml of the eluate from the Concanavilin-A column was
applied to a 1.4 x 50 cm column equilibrated with
buffer A. After washing with 200ml of the same buffer,
the column was eluted with a 0-150 mM Imidazole linear
gradient in buffer A and 4.75 ml fractions collected.
8.2.2.4. Hydroxylapatite chromatography
The prolidase peak (60 ml) from the nickel-
chelate gel was applied to a 2.4 x 35 cm hydroxyl¬
apatite column equilibrated with buffer A. The column
was washed with 100 ml buffer A, eluted with 200 ml of
a 0-50 mM sodium phosphate linear gradient followed by
50 ml 50 mM sodium phosphate and 5 ml fractions
collected.
8.2.2.5. Gel filtration
The hydroxylapatite peak (75 ml) was concentrated
five-fold using a PM 10 ultrafiltration membrane
system, applied to a 2.5 x 90 cm Ultrogel AcA 44 column
and eluted with buffer A at an ascending flow-rate of
26 ml/hr and 5 ml fractions collected.
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8.2.2.6. Hydrophobic chromatography
The prolidase peak (47 ml) after gel filtration
was applied to a 1 x 25 cm u-aminohexyl-agarose (Miles
Ltd) column equilibrated with 10 mM barbital / HCl pH
7.4 containing 10 mM NaCl. After washing with 100 ml
buffer the column was eluted with 70 ml of a 10-300 mM
NaCl linear gradient and 1.6 ml fractions collected.
8.2.2.7. Preparative polyacrylamide gel electrophoresis
The prolidase peak (19.5 ml) after hydrophobic
chromatography was concentrated ten-fold in the PM10
ultrafiltration membrane system. 0.5 ml electro¬
phoresis sample buffer (2% bromophenol blue in 10%
(w/v) sucrose) was added to 1.5 ml of the concentrated
enzyme peak and applied to the surface in a preparative
polyacrylamide gel electrophoresis apparatus (Shandon
Ltd) set up as described by Smith (1976). The
acrylamide to bis-acrylamide ratio was 30:0.8% (w/w)
and the gel concentration was 7.5%. Electrophoresis
was carried out at 30 mA for 60 min followed by 80 mA
for 6 hr, collecting 1.9 ml fractions. The fractions
containing the enzyme were pooled (9.5 ml) and used for
studying its properties and for raising antibodies in
rabbits.
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8.2.3. Properties of purified prolidase
8.2.3,1. Electrophoresis
The purified enzyme was studied by analytical
disc gel electrophoresis in gel rods (Davis, 1964) to
assess the purity of the final preparation. Rods were
stained with Coomassie blue and also cut into slices
for estimating enzyme activity. The molecular weight
of prolidase subunits was determined under denaturing
conditions by SDS PAGE, performed by the method of
Weber and Osborn (1969) in a Bio-Rad Protean slab
electrophoresis cell. The stacking and separating gels
were 5.5% and 12% acrylamide respectively and the
buffer system as described by Laemmli (1970). Purified
prolidase, Dalton Mark VII-L molecular weight standards
(Sigma Ltd) and samples from various stages of the
purification were mixed with sample buffer, heated at
95°C for 5 min, and electrophoresed at 10 mA for 60 min
followed by 15 mA for 3 hr. The gel was then trans¬
ferred to fixing solution (40% (v/v) methanol, 5% (v/v)
acetic acid) before staining with 0.25% (w/v) Coomassie
blue in this solution. After destaining, the gel was
laid flat on a sheet of filter paper (Whatman 3 mm) and




The specific activity of the purified preparation
against Gly-Pro, Phe-Pro, Ala-Pro, Val-Pro and Met-Pro
(20 mM final in the assay) was determined with 60 min
preincubation (5 mM MnC^) for Gly-Pro and 20 min
preincubation (1 mM MnC^) for the other substrates.
Liberated proline was estimated by the ninhydrin method
described in section 5.2.1.1.
8.2.3.3. Manganese
The manganese requirements for purified prolidase
were studied for the hydrolysis of Gly-Pro and Phe-Pro.
The enzyme was preincubated for 0, 10, 30 and 60 min
with 0, 0.1, 1.0, 2.5 and 5.0 mM MnC^. The manganese
concentration during the preincubation was maintained
in the assay by adding an appropriate level of MnC^
with the substrate. A 1/500 dilution of the purified
enzyme was used for Gly-Pro and a 1/100 dilution for
Phe-Pro.
8.2.3.4. Substrate Kinetics
Substrate kinetics of purified prolidase with
Gly-Pro after 60 min preincubation with 5 mM MnC^ ana
for Phe-Pro after 30 min preincubation with 1 mM MnC^
were studied over the range 1-20 mM substrate. Kms
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were calculated from Lineweaver and Burk plots (1934).
8.2.4. Immunological studies
8.2.4.1. Immunisation of rabbits
Antisera to the purified prolidase were raised in
two male New Zealand white rabbits, 1 year old, fed on
a normal diet. The animals were bled prior to
immunisation to obtain samples of pre-immune serum.
Purified prolidase was mixed with an equal amount of
Freund's complete adjuvant (Behring Ltd), sonicated at
4-6 pm for 30 sec and injected intradermally into the
rabbits at multiple sites on the back (approximately 10
pg pure enzyme per site). Injections were repeated at
2 and 4 weeks, using Freund's incomplete adjuvant for
the booster at 4 weeks. A week later blood was taken
from the ear vein of the animals and the serum tested
for immunoreactivity with pure and crude prolidase
preparations. A further booster was injected after 7
weeks and 10 days later blood was taken by cardiac
puncture under anaesthesia. Antisera from the rabbits
was stored at -40°C. Immunoreactivity was checked by
immunotitration of succesive dilutions of the antisera
with the purified enzyme.
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8.2.4.2. SDS-Polyacrylamide gel electrophoresis
Extracts of control fibroblasts, brain, kidney
and the purified enzyme were immunoprecipitated prior
to SDS-PAGE and Western blotting. 175 pi immuno-
precipitation buffer (0.4M Tris / HC1 pH 7.4 containing
4% Triton-X-100 and 1.6 M KCl) and 25pl antiserum or
pre-immune serum was added to 0.5 ml of sample and left
at 4°C overnight to precipitate. The mixture was then
centrifuged at 8,800 x g for 15 min (Eppendorf 5413
centrifuge), washed twice with 10 rnM phosphate buffer
pH 7.0, given a final wash with acetone and dried under
nitrogen. The precipitate was then dissolved in 50 pi
sample buffer (62.5 mM Tris / HCl buffer pH 6.8
containing 2% (w/v) SDS, 10% glycerol, 5% 2-mercapto-
ethanol and 0.002% bromophenol blue) and heated at 95°C
for 5 min. Molecular weight standards were similarly
prepared. SDS-PAGE was then performed as described in
section 8.2.3.1. with the acrylamide to bis-acrylamide
ratio changed to 30:0.312%. After electrophoresis of
the immunoprecipitates the gel was removed and prepared
for Western blotting.
8.2.4,3. Western Blotting
Western blotting was carried out in an Electro-
blot Transfer Apparatus (Bio-Rad Ltd) according to the
manufacturers instructions. Blotting was performed
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overnight at 0.1 A then for 60 min at 0.25 A as
described by Towbin et al. (1979). Following blotting,
the nitrocellulose was removed and prepared for
immunoblotting.
8.2,4.4. Immunoblotting
The nitrocellulose paper was washed in 20 mM Tris
/ HCl pH 7.5 containing 0.5 M NaCl (TBS) for 10 min. A
thin strip containing the molecular weight standards at
the edge of the nitrocellulose was cut off and stained
with amido black as described by Gershoni and Palade
(1983) as follows: The strip was immersed in 0.1%
(w/v) amido black in 45% (v/v) methanol / 10% (v/v)
acetic acid for 2-3 min, followed by rinsing in
distilled water for 30 sec. The strip was destained in
90% (v/v) methanol / 2% (v/v) acetic acid with 3x1
min washes, followed by a final rinse in distilled
water for 1-2 min and left to dry. The remainder of
the nitrocellulose sheet was immersed in 3% (w/v)
gelatin in TBS containing 0.05% (v/v) Tween-20 (TTBS)
for 60 min to block unfilled sites with protein. After
blocking, the nitrocellulose was immersed in 0.5% (v/v)
antiserum in antibody buffer (TTBS containing 2% (w/v)
gelatin) and agitated for 3 hr at room temperature.
The nitrocellulose was then rinsed in distilled water
and washed in TTBS for 20 min before transferring to
0.033% (v/v) goat anti-rabbit IgG-peroxidase (Bio-Rad
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Ltd) for 60 min with agitation. After rinsing with
distilled water, washing with TTBS for 10 min twice and
a rinse in TBS, the nitrocellulose was transferred to
freshly prepared colour reagent (60 mg chloronaphthol
dissolved in 20 ml methanol mixed with 100ml TBS
containing 60 pi ice-cold 30% hydrogen peroxide) and
developed for 5-15 min.
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8.3. RESULTS
8.3.1. Purification of prolidase
The chromatographic profiles obtained during the
purification of prolidase peak. I are shown in Fig. 50,
the hatched areas represent the fractions pooled for
the next chromatographic step. The purification
achieved and yield of prolidase at each step are shown
in Table 15. As with prolinase, to assay the fractions
after each stage of the purification it was necessary
to dilute to very low protein concentrations at which
the enzyme was unstable. Addition of bovine serum
albumin (0.25 mg/ml) stabilised prolidase to dilution.
More than 90% of protein was removed by DEAE-
Cellulose including peak II prolidase which may
comprise 30% of the enzyme activity in human kidney
(Table 12, section 7.3). The Concanavalin-A step was
included to specifically remove glycoproteins which
accounted for a quarter of the protein in the pooled
DEAE-Cellulose fractions. Gel filtration with a
calibrated Ultrogel AcA 44 column indicated a molecular
weight of 110,000 for the native enzyme. After
preparative PAGE, less than 0.005% of the original
protein remained and the enzyme had an activity of 225
pmol/min/mg protein with Phe-Pro as substrate. The
purified prolidase after the final step showed a single




50 Chromatographic profiles obtained during the
purification of prolidase from human kidney.
The hatched areas represent fractions pooled.
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single band on staining with Coomassie blue.
8.3.2. Properties of purified prolidase
The purified enzyme also showed a single band
after SDS-PAGE (Fig. 51). The molecular weight of the
subunit was calculated to be 55,000, indicating that
the native enzyme comprises two identical subunits.
Figure 51 also shows electrophoresis of samples from
the pooled enzyme peaks after DEAE-Cellulose,
Concanavalin-A Sepharose, nickel-chelate chromatography
and hydrophobic chromatography. As with crude enzyme
preparations, the purified enzyme was optimally active
at about pH 8 (Fig. 52). Of five substrates studied,
Gly-Pro had the highest specific activity of 921 pmol/
min/mg protein and Val-Pro was the weakest with about








































Fig. 52 pH profile for purified prolidase assayed
with Phe-Pro in 25 mM Barbital / HC1.
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The effect of preincubation with different levels
of manganese for Gly-Pro and Phe-Pro is shown in Fig.
53. Activity against Gly-Pro was highest when
preincubated with 2.5 mM MnCl2 for 60 min, though 1 mM
and 5 mM MnCl2 gave similar activities. Phe-Pro
activity was highest after 30 min preincubation with
2.5-5 mM MnCl2.
Fig. 53 Preincubation of purified prolidase with different
levels of MnClg (mM as shown) for a) Phe-Pro and
b) Gly-Pro.
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Substrate Kms for Phe-Pro and Gly-Pro were
determined from Lineweaver and Burk plots (Fig. 54).
After preincubation of the purified enzyme for 60 min
with 5 mM MnC^f the Km for Gly-Pro was 22 mM whereas
30 min preincubation with 1 mM MnCl2 resulted in a Km
















Fig. 53 Lineweaver and Burk plots for purified prolidase





The immunoreactivity of the antisera raised in
the two rabbits was measured by immunotitration with
the purified enzyme and the results shown in Fig. 55.
The antisera from the two rabbits showed similar
immunotitration curves.
Dilution
Fig. 55 Immunotitration of purified prolidase.
50 pi purified prolidase (1/50 dilution in 0.2 M Tris / HC1
pH 7-4 containing 2% Triton-X-100 and 0.8 M KC1) was mixed
with 50 pi antiserum at various titres as indicated. After
incubation at 'I'C overnight the mixtures were centrifuged




The results for immunoblotting following immuno-
precipitation of pure prolidase, kidney, cerebral
cortex and fibroblasts are shown in Fig. 56. The major
band in each lane was prolidase with a calculated
subunit molecular weight of 55,000. The band of
approximately 30,000 molecular weight seems to be a
contaminating protein which has copurified with
prolidase and is highly immunoreactive. However it was
not present in enough quantity to be seen in the tissue
preparations. The other three bands which can be seen
are due to rabbit immunoglobulin and were observed when
the first antibody step was omitted from the procedure.
As yet it has not been possible to immuno-
precipitate prolidase peak II obtained from skin
fibroblasts and pancreas using the DEAE batch method.
However, in preliminary studies with prolidase-
deficient fibroblasts, it appears that prolidase peak I
is present in normal quantities. To establish this
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8.4.1. Purification and properties
Prolidase peak I was successfully purified
640-fold from human kidney. As with the purification
2 +
of prolinase (section 4.3.1.), Ni chelate gel
chromatography was a highly effective preparative step
removing more than 90% of protein with little loss of
activity. Although the purification factor was much
lower than that achieved for prolidase from human
erythrocytes (Endo et al., 1982), the specific activity
against Gly-Pro in the present study was four times the
activity of the purified erythrocyte enzyme. Indeed
this is the highest specific activity obtained for any
of the purified preparations from animal tissues
previously reported (Sjostrom et al., 1973; Hui and
Lajtha, 1980; Browne and O'Cuinn, 1983; Yoshimoto et
al., 1983). The relative specific activities for the
substrates Gly-Pro, Ala-Pro and Leu-Pro (Table 16.)
were almost the same as for the purified erythrocyte
enzyme (Endo et al., 1982). This contrasts with pig
intestinal prolidase which hydrolysed Gly-Pro at less
than a third of the rate of Ala-Pro (Sjostrom et al.,
1973).
SDS polyacrylamide gel electrophoresis showed a
single band of molecular weight 55,000, indicating
prolidase peak I to be a dimer consisting of two
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identical subunits. This is the same as the result for
erythrocyte prolidase (Endo et al., 1982) and compares
with the subunit molecular weight of 56,000 reported
for bovine intestinal prolidase (Yoshimoto et al.,
1983). In contrast, the enzyme purified from guinea
pig brain was reported to be a dimer comprising two
dissimilar subunits of molecular weights 64,000 and
68,000 (Browne and O'Cuinn, 1983).
The optimal pH for purified prolidase activity
was between 7.5 and 8.0 which is similar to crude
enzyme preparations (sections 5.3.2. and 7.3.3.1.),
erythrocyte enzyme (Endo et al., 1982) and the guinea
pig brain enzyme (Browne and O'Cuinn, 1983).
Manganese levels and preincubation times required
for optimal activity of the purified prolidase against
Phe-Pro and Gly-Pro were similar to those found for
peak I prolidase in cultured skin fibroblasts (section
7.3.3.2.). Endo et al. (1982) used 16 mM MnC^ and
didn't specify any preincubation which may partly
account for the lower specific activity against Gly-Pro
with their purified preparation. Prolidase purified
from bovine intestine didn't require manganese ions for
activation and was inhibited 65% by preincubation with
1 mM MnC^ for 10 min (Yoshimoto et al., 1983).
The Km of 22 mM for Gly-Pro was of a similar
order to that of 14 mM obtained for the erythrocyte
enzyme (King and Kuchel, 1984), but was ten-fold higher
than the Km of 1.9 mM reported for rat brain prolidase
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(Middlehurst et al., 1984).
8.4.2. Immunological studies
The subunit molecular weight of 55,000 determined
after immunoblotting confirmed the result obtained with
SDS polyacrylamide gel electrophoresis.
That prolidase peak II doesn't appear to react
with the antisera may imply that peaks I and II do not
have a common subunit as proposed earlier (section
7.4.6.). However, if peak II is a dimer like peak I,
it may be possible that the second subunit is occluding
immunoreactive sites on the common subunit. If there
proves to be no common subunit, changes in the
properties of peak II prolidase in the prolidase-
deficient fibroblasts (section 7.3.) may possibly be a
result of a defect in the processing of precursor forms
of the enzyme.
The presence of prolidase peak I in cultured skin
fibroblasts from the two cases of prolidase deficiency,
implies that the primary genetic defect may be causing
a change in molecular structure resulting in a
distortion of the active site. Using antisera to the
erythrocyte enzyme, Endo et al. (unpublished
observations) have found the prolidase subunit to be
absent in their patient with prolidase deficiency.
This seems to be due to a different mutation from the
two cases studied here.
184
At the present time, only preliminary studies
have been completed using the antisera raised to
purified prolidase. It is hoped that a variety of
further studies will elucidate the relationship between




9.1. Prolinase and prolidase in human tissues
The initial work for the present study required
the development of a reliable, sensitive method for the
assay of prolinase. Most previous studies, carried out
with animal tissue extracts (Davis and Smith, 1953;
Sarid et al., 1962; Mayer and Nordwig, 1973), used
Pro-Gly as substrate and were relatively insensitive.
A number of methods, based on the reaction of a primary
amine with o-phthalaldehyde in the presence of a
sulphhydryl reagent, have been developed and used to
study peptidases (Reeder et al., 1978; Porter et al.,
1982). This reaction was considered to be ideally
suited for the assay of prolinase because of the lack
of a primary amine on proline dipeptide substrates. On
hydrolysis of the substrate the C-terminal amino acid
liberated reacts with the o-phthalaldehyde whereas
proline is inert. A modification of the method of Roth
(1971) was then successfully developed and subsequently
used to study prolinase in human tissues. The method
also proved to be suitable for the assay of proline
iminopeptidase (PIP) and enabled the study and
characterisation of this enzyme (Butterworth and
Priestman, 1984a). With the use of the new method it
was possible to determine optimal assay conditions for
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studying human prolinase in both cultured cells and
tissues.
An investigation of the physicochemical
properties of the enzyme showed it was a soluble
dipeptidase activated by manganese ions in common with
prolinase in animal tissues (Mayer and Nordwig, 1973;
Akrawi and Bailey, 1977). DEAE-Cellulose ion-exchange
and gel filtration chromatography showed prolinase to
consist of two components of activity, a property
unobserved in previous studies.
The coincidence of one component of prolinase
with a non-specific dipeptidase, used as a reference
enzyme in the chromatographic studies, raised the
possibility of proline dipeptides being hydrolysed by a
broad specificity dipeptidase. However, the rate of
hydrolysis was almost a tenth of that of other
dipeptide substrates such as Gly-Leu (section 4.3.3.).
Several authors have suggested that proline dipeptide
substrates may be hydrolysed by a non-specific
dipeptidase (Hayman and Patterson, 1971; Mayer and
Nordwig, 1971; Das and Radhakrishnan, 1973) in animal
tissue extracts, but no conclusion has yet been
established.
Unlike cultured human skin fibroblasts, human
kidney had only a single component of prolinase
activity and this was the highest of a range of tissues
studied (Table 3, section 2.3.4.), so it was decided to
purify prolinase from human kidney and study its
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properties to determine the specificity of the enzyme.
Throughout the purification it was impossible to
separate the activities against Pro-Ala and Gly-Leu and
the ratio of the activities was constant for each
successive separative procedure. The responses of the
two activities to heat and inhibition by PHMB were the
same and substrate kinetic studies indicated a single
enzyme for the hydrolysis of both prolinase and non¬
specific dipeptidase substrates in human kidney.
Having studied prolinase three methods were
developed for assaying prolidase and optimal assay
conditions for enzyme activity were determined. The
enzyme was then studied in cultured skin fibroblasts
from controls and two unrelated cases of prolidase
deficiency using a variety of imidodipeptide
substrates. The two cases showed a marked loss of
activity against Gly-Pro but only moderate reductions
in activity against other substrates (section 6.3.1.).
A study of the properties of prolidase including heat
stability, substrate kinetics and inhibition with PHMB,
showed considerable differences between controls and
the cases (section 6.3.). Incubation with high levels
of manganese inactivated the abnormal enzyme and made
it more susceptible to heat inactivation. Optimal
manganese levels for control prolidase activity were
therefore not optimal for the abnormal enzyme,
explaining the variable activities reported in the
literature (Powell et al., 1974; Sheffield et al.,
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1977; Arata et al. , 1979; Myara et al., 1982). The
relationship between cell density in culture and
fibroblast activity as noted by Myara et al., (1984c,
1985a) was not observed in the present study and
implies some difference in tissue culture technique.
Increased Km values in the prolidase-deficient
fibroblasts (Table 9, section 6.3.3.) indicated that
the disease results from production of enzyme with
altered properties rather than a marked deficiency of
normal enzyme.
The heat stability results and biphasic kinetics
for Phe-Pro pointed towards the existence of a second
component of prolidase activity previously unobserved.
A second form of prolidase was then discovered after
DEAE-Cellulose ion-exchange chromatography of cultured
skin fibroblast extracts. The previous inability to
detect it in this study and previous studies (Endo et
al., 1982; Myara et al., 1984a) was due to a variety of
possible reasons. In the present study, dialysis of
the extract prior to chromatography inactivated peak
II. In other studies Gly-Pro is the most common
substrate used but is a relatively poor substrate for
peak II, also, erythrocytes have little peak II and
prolonged incubation with high levels of manganese
inactivates peak II. Having found a second component
of prolidase, the two cases of prolidase deficiency
were shown to be deficient in peak I activity against
all the substrates tested, whereas peak II had a much
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reduced activity only against Gly-Pro. This,
therefore, provided an explanation for the presence of
moderate activities in the cases with substrates other
than Gly-Pro. Also, Gly-Pro was the only imidodi-
peptide detectable in the plasma and erythrocytes in
the patients of Freij et al. (1984). As the hydrolysis
of Gly-Pro in the disease is reduced much more than the
other substrates tested, it seems likely that this
shortfall in activity would be important in the
clinical manifestations of the disease. This may be
reflected in the most promising results for treatment
of the leg ulcerations with a topical ointment
containing both glycine and proline (Arata et al.,
1986 ) .
A DEAE-Cellulose batch method was also developed
to enable rapid separation of the two peaks for further
studies. Control peak II was then found to be more
labile than peak I, being less stable to heat and
unprotected by manganese in the presence of PHMB
(section 7.3.). The properties of peak II in
prolidase-deficient fibroblasts were found to differ
from control peak II, implying a possible structural
relationship between the two peaks.
Prolidase peak I was then purified from human
kidney and injected into rabbits to raise specific
antisera to the enzyme for further studies. It has not
yet been possible to show a structural relationship
between the two peaks of prolidase as peak II does not
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appear to react with the antisera. However,
preliminary studies indicate that prolidase peak I does
seem to be present though inactive, in the two cases of
prolidase deficiency. This is in contrast with the
recent findings of Endo et al. (unpublished results)
for a Japanese patient in whom the subunit protein is
apparently absent, representing a different genetic
defect causing prolidase deficiency.
In conclusion, the hydrolysis of the two types of
proline dipeptides in human tissues now appears more
complex than was originally thought. The results
presented in this thesis show that there are two
components of enzyme activity for both prolinase and
prolidase and that at least one form of prolinase
activity is due to a non-specific dipeptidase. The
existence of more than one form of enzyme must
therefore be borne in mind when studying possible
deficiencies of either enzyme as activity may still be
present due to the other component as found with some
substrates in prolidase deficiency.
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9.2. Suggestions for further research
Although the present study has elucidated many of
the properties of prolinase and prolidase, there is
still a wide scope for continuing research with both
enzyme activities.
As the major peak of prolinase has been shown to
be a non-specific enzyme, it is necessary to determine
the full range of its substrate specificity with
homogeneous pure enzyme. The specificity of the enzyme
may also be dependent on metal ions other than
manganese as found for pig kidney dipeptidase
(Capobianco and Vescia, 1967). The second DEAE-
Cellulose peak of prolinase present in some tissues,
also deserves further study to establish its substrate
specificity and the effect of metal ions. It is
possible that this peak is a "true" proline-specif ic
enzyme or it may also be non-specific with a different
range of specificity.
Similar investigations on the specificity of the
two components of prolidase activity may help clarify
the relationship between them and their exact roles.
The high level of peak II activity in pancreas
certainly seems to indicate a particularly important
role for the enzyme in this tissue. Pancreas would
also be a useful source for the purification of peak II
prolidase after which antibodies could be raised and
used to study the possibility of a common subunit with
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peak I. This still seems to be the most likely reason
for the change in the properties of peak II in
prolidase deficiency. The other possibility of a
processing defect which may be present, will be studied
3
using pulse-chase H -Leucine labelling experiments with
cultured skin fibroblasts.
It has been suggested that prolidase may be of
some clinical importance in chronic liver disease and
could be used as an index of collagen catabolism in
hepatic fibrosis (Myara et al., 1984d). Although
plasma prolidase in rats seems to reflect liver cell
leakage rather than active stages of fibrosis
(Zuyderhoudt et al., 1985), Myara et al. (1984d) found
an increased plasma prolidase activity in the early
stages of hepatic fibrosis. As there are no reliable
markers of hepatic fibrosis in plasma, such a marker
would be most useful in the clinical and experimental
evaluation of liver disease and should therefore be
investigated further.
The recent observation that the antihypertensive
drug Captopril (D-3-mercapto-2-methyl propanoyl-L-
proline, SQ 14,225) is an effective inhibitor of
prolidase in human kidney, liver and intestine
(Ganapathy et al., 1985) also deserves further study.
Captopril therapy is often associated with adverse side
effects including urticarial and maculopapular
eruptions. These are similar to the skin lesions seen
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in prolidase-deficient patients and may be a result of
prolidase inhibition by the drug.
These are some of the possibilities for future
research into prolinase and prolidase which should give
us a greater understanding of their physiological roles
in human cells and tissues.
194
10. REFERENCES
Adams, E. and Smith, E.L.
Peptidases of erythrocytes II: Isolation and properties
of prolidase.
J. Biol. Chem. 1952; 198: 671-682.
Akrawi, A.F. and Bailey, G.S.
Purification and specificity of prolyl-dipeptidase from
bovine kidney.
Biochim. Biophys. Acta 1976; 422: 170-178.
Akrawi, A.F. and Bailey, G.S.
The separation of prolyl-dipeptidase from other
dipeptidases of bovine kidney.
Biochem. Soc. Trans. 1977; 5: 272-274.
Alderman, M.H., Frimpter, G.W., Isaacs, M. and
Scheiner, E.
Glycylproline peptiduria in familial hyperostosis of
obscure nature.
Metabolism 1969; 18: 692-699.
Arata, J., Umemura, S., Yamamoto, Y., Hagiyama, M. and
Nohara, N.
Prolidase deficiency. Its dermatological manifestations
and some additional biochemical studies.
Arch. Dermatol. 1979; 115: 62-67.
195
Arata, J., Hatakenaka, K. and Oono, T.
Effect of topical application of glycine and proline on
recalcitrant leg ulcers of prolidase deficiency.
Arch. Dermatol. 1986; 122: 626-627.
Baksi, K. and Radhakrishnan, A.N.
Purification and properties of prolidase from monkey
small intestine.
Indian J. Biochem. Biophys. 1974; 11: 7-11.
Bergmann, M. and Fruton, J.S.
On proteolytic enzymes. XII. Regarding the specificity
of aminopeptidase and carboxypeptidase. A new type of
enzyme in the intestinal tract.
J. Biol. Chem. 1937; 117: 189-202.
Bergmeyer, H.U.
Methods of enzymatic analysis.
New York: Academic Press, 1965: 736-743.
Binkley, F., Liebach, F. and King, N.
A new method of peptidase assay and the separation of
three leucylglycinases of renal tissue.
Arch. Biochem. Biophys. 1968; 128: 397-405.
196
Brown, S., Lalley, P.A. and Minna, J.D.
Assignment of the gene for peptidase-S (Pep-S) to
chromosome 4 in man and confirmation of peptidase-D
(Pep-D) assignment to chromosome 19.
Cytogenet. Cell. Genet. 1978; 22: 167-171.
Browne, P. and O'Cuinn, G.
The purification and characterisation of a proline
dipeptidase from guinea pig brain.
J. Biol. Chem. 1983; 258: 6147-6154.
Buist, N.R.M., Strandholm, J.J. and Bellinger, J.F.
Further studies on a patient with iminopeptiduria: A
probable case of prolidase deficiency.
Metabolism 1972; 21: 1113-1123.
Butterworth, J. and Duncan, J.J.
Carboxypeptidase B activity of cultured skin
fibroblasts and relationship to Cystic Fibrosis.
Clin. Chim. Acta 1979; 97: 39-43.
Butterworth, J. and Duncan, J.J.
The hydrolysis of N-benzoyl-phenylalanine-L-valyl-L-
arginine-p-nitroanilide and its use as a substrate for
the assay of Cathepsin B.
Anal. Biochem. 1980; 106: 156-162.
197
Butterworth, J. and Guy, G.J.
Primary amniotic fluid cells, skin fibroblast and liver
a-L-fucosidase and its relation to cystic fibrosis.
Clin. Chim. Acta 1979; 92: 109-116.
Butterworth, J. and Priestman, D.A.
Fluorometric assay for prolinase.
J. Inher. Metab. Dis. 1982a; 5: 9-10.
Butterworth, J. and Priestman, D.A.
Fluorimetric assay for prolinase and partial
characterisation in cultured skin fibroblasts.
Clin. Chim. Acta 1982b; 122: 51-60.
Butterworth, J. and Priestman, D.A.
Proline iminopeptidase: chromatographic demonstration
of a single form in human cultured skin fibroblasts,
liver and kidney using a fluorimetric assay.
Clin. Chim. Acta 1984a; 137: 239-244.
Butterworth, J. and Priestman, D.A.
Substrate specificity of manganese-activated prolidase
in control and prolidase deficient fibroblasts.
J. Inher. Metab. Dis. 1984b; 7: 32-34.
Butterworth, J. and Priestman, D.A.
Prolidases of human skin fibroblasts.
Biochem. Soc. Trans. 1985a; 13: 237.
198
Butterworth, J. and Priestraan, D.A.
The presence in human cells and tissues of two
prolidases and their alteration in prolidase
deficiency.
J. Inher. Metab. Dis. 1985b; 8: 193-197.
Cahill, R., Smith, R. and Westall, R.G.
A detailed study of the urinary peptides in a patient
with osteomalacia and hyperparathyroidism.
Clin. Sci. 1970; 38: 519-532.
Campbell, B.J., Lin, Y.C., Davis, R.V. and Ballew, E.
The purification and properties of a particulate renal
dipeptidase.
Biochim. Biophys. Acta 1966; 118: 371-386.
Capabianco, G. and Vescia, A.
Further studies on the effect of metal ions on the
specificity of peptidase activity.
Ital. J. Biochem. 1967; 16: 33-42.
Charpentier, C., Dagbovie, K. and Lemonnier, L.
Prolidase deficiency with iminodipeptiduria.
Biochemical investigations and first results of
attempted therapy.
J. Inher. Metab. Dis. 1981; 4: 77-78.
199
Chrastil, J. and Wilson, J.T.
The effect of chemical and physiological factors on the
kinetics for product formation as it relates to enzyme
activity and concentration, reaction time and to
substrate absorbtion and affinity.
Int. J. Biochem. 1982; 14: 1-17.
Das, M. and Radhakrishnan, A.N.
Substrate specificity of a highly active dipeptidase
purified from monkey small intestine.
Biochem. J. 1972; 128: 463-465.
Das, M. and Radhakrishnan, A.N.
Glycyl-L-Leucine hydrolase, a versatile 'Master'
dipeptidase from monkey small intestine.
Biochem. J. 1973; 135: 609-615.
Davis, B.J.
Disc, electrophoresis. II. Method and application to
human serum proteins.
Ann. N.Y. Acad. Sci. 1964; 121: 404-427.
Davis, N.C. and Adams, E.
Specificity of iminodipeptidase: Effect of alteration
in the pyrrolidine ring of L-prolyl-glycine.
Arch. Biochem. Biophys. 1955; 57: 301-305.
200
Davis, N.C. and Smith, E.L.
Partial purification and specificity of
iminodipeptidase.
J. Biol. Chem. 1953; 200: 373-384.
Davis, N.C. and Smith, E.L.
Purification and some properties of prolidase of swine
kidney.
J. Biol. Chem. 1957; 224: 261-275.
Delange, R.J. and Smith, E.L.
In: Boyer, P.D., ed, The enzymes. New York: Academic
Press, 1971; 3: 81-118.
Der Kaloustian, V.M., Freij, B.J. and Kurvan, A.K.
Prolidase deficiency: an inborn error of metabolism
with major dermatological manifestations.
Dermatologica 1982; 164: 293-304.
Dixon, M.
Determination of enzyme inhibitor constants.
Biochem. J. 1953; 55: 170-171.
Dixon, M. and Webb, E.C.
Enzymes, 2nd edn., Longman's Green, London. 1964.
201
Endo, F. and Matsuda, I.
Screening method for prolidase deficiency.
Hum. Genet. 1981; 56: 349-351.
Endo, F., Matsuda, I., Ogata, A. and Tanaka, S.
Human prolidase and prolidase deficiency.
Paed. Res. 1982; 16: 227-231.
Felix, D. and Kunzle, H.
The role of proline in nervous transmission.
Adv. Biochem. Psychopharmacol. 1976; 15: 165-174.
Freij, B.J., Levy, H.L., Dudin, G. , Mutasim, D., Deeb,
M. and Der Kaloustian, V.M.
Clinical and biochemical characteristics of prolidase
deficiency in siblings.
Amer. J. Med. Genet. 1984; 19: 561-571.
Fruton, J.S., Smith, V.A. and Driscoll, P.E.
On the proteolytic enzymes of animal tissues. VII. A
peptidase of calf thymus.
J. Biol. Chem. 1948; 173: 457-469.
Ganapathy, V., Pashley, S.J., Roesel, R.A., Pashley,
D.H. and Leibach, F.H.
Inhibition of rat and human prolidases by
Captopril.
Biochem. Pharmacol. 1985; 34: 1287-1291.
202
Gejyo, F., Kishore, B.K. and Arakawa, M.
Prolidase and prolinase activities in the erythrocytes
of patients with chronic uremia.
Nephron 1983; 35: 58-61.
Gershoni, J.M. and Palade, G.E.
Protein blotting: Principles and applications.
Anal. Biochem. 1983; 131: 1-15.
Godson, N.G.
A simple apparatus for rapid isoelectric focusing of
multiple samples on a micro-scale.
Anal. Biochem. 1970; 35: 66-76.
Goodman, S.J., Solomons, C.C., Muschenheim, F.,
Mclntyre, C.A., Miles, B. and O'Brien, D.
A syndrome resembling lathyrism associated with
iminodipeptiduria.
Amer. J. Med. 1968; 45: 152-159.
Grassman, W., Von Schoenebeck, O. and Auerbach, G.
Enzymic cleavage of proline peptides. II.
Hoppe-Seyler's Z. Physiol. Chem. 1932; 210: 1-14.
203
Gray, R.G.F., Green, A., Ward, A.M., Anderson, I. and
Peck, D.S.
Biochemical and immunological studies on a family with
prolidase deficiency.
J. Inher. Metab. Dis. 1983; 6: 143-144.
Guy, G.J. and Butterworth, J.
Carboxypeptidase A activity of cultured skin
fibroblasts. Relationship to Cystic Fibrosis.
Clin. Chim. Acta 1978; 87: 63-69.
Hayman, S. and Patterson, E.K.
Purification and properties of a mouse ascites tumour
dipeptidase, a metalloenzyme.
J. Biol. Chem. 1971; 246: 660-669.
Hui, K.S. and Lajtha, A.
Prolidase activity in brain; comparison with other
organs.
J. Neurochem. 1978; 30: 321-327.
Hui, K.S. and Lajtha, A.
Activation and inhibition of cerebral prolidase.
J. Neurochem. 1980; 35: 489-494.
204
Imai, K., Nagatsu, T., Yajima, T., Maeda, N., Kumegawa,
M. and Kato, T.
Developmental changes in the activities of prolinase
and prolidase in rat salivary glands and the effect of
thyroxine administration.
Mol. Cell. Biochem. 1982; 42: 31-36.
Isaacs, M., Scheiner, E., Dimich, A.B., Frimpter, G.W.,
Greenberg, E. and Alderman, M.H.
Familial hyperostosis of obscure nature.
Metabolism 1971; 20: 910-926.
Isemura, M., Hanyu, T., Gejyo, F., Nakazawa, R.,
Igarashi, R., Matsuo, S., Ikeda, S. and Sato, Y.
Prolidase deficiency with iminodipeptiduria. A
familial case with and without clinical symptoms.
Clin. Chim. Acta 1979; 93: 401-407.
Isemura, M., Hanyu, T. , Ono, T., Igarashi, R., Sato,
Y., Gejyo, F., Nakazawa, R., Miyakawa, T., Takagi, T.,
Kubogi, Y. and Sasaki, S.
Studies on prolidase deficiency with a possible defect
in collagen metabolism.
Tohoku J. Exp. Med. 1981; 134: 21-28.
205
Jackson, S.H. and Heininge^, J.a.
Proline recycling during collagen metabolism as
determined by concurrent l8o2 and 3H labelling.
Biochim. Biophys. Acta 1975; 381: 359.
Jackson, S.H., Dennis, A.W. and Greenberg, M.
Iminodipeptiduria: A genetic defect in recycling
collagen; a method for determining prolidase in
erythrocytes.
Can. Med. Ass. J. 1975; 113: 759-763.
Josefsson, L. and Lindberg, T.
Intestinal dipeptidases. I. Spectrophotometric
determination and characterisation of dipeptidase
activity in pig intestinal mucosa.
Biochim. Biophys. Acta 1965; 105: 149-161.
Kaminogawa, S., Azuma, N., Hwang, I., Suzuki, Y. and
Yamauchi, K.
Isolation and characterisation of a prolidase from
Streptococcus Cremoris H.61.
Agric. Biol. Chem. 1984; 48: 3035-3040.
King, G.F. and Kuchel, P.W.
A proton n.m.r. study of iminodipeptide transport and
hydrolysis in the human erythrocyte: possible
physiological roles for the coupled system.
Biochem. J. 1984; 220: 553-560.
206
King, G.F., Middlehurst, C.R. and Kuchel, P.W.
Direct NMR evidence that prolidase is specific for the
trans isomer of imidodipeptide substrates.
Biochemistry 1986; 25: 1054-1062.
Kodama, H., Umemura, S., Shimomura, M. , Mizuharas, S.,
Arata, J., Yamamoto, Y., Yasutake, A. and Izumiya, N.
Studies on a patient with iminopeptiduria.
I. Identification of urinary iminopeptides.
Physiol. Chem. Phys. 1976; 8: 463-473.
Laemmli, U.K.
Cleavage of structural proteins during the assembly of
the head of bacteriophage T4.
Nature 1970; 227: 680-685.
Lapiere, C.M. and Nusgens, B.
Plaies cutanees torpides et trouble du metabolisme du
collagene.
Arch. Belg. Dermatol. Syphiligr. 1969; 25: 353-356.
Lewis, W.H.P. and Harris, H.
Peptidase D (prolidase) variants in man.
Ann. Hum. Genet. 1969; 32: 317-322.
207
Lin, L.N. and Brandts, J.F.
Evidence suggesting that some proteolytic enzymes may
cleave only the trans form of the peptide bond.
Biochemistry 1979; 18: 43-47.
Lineweaver, H. and Burk, D.J.
The determination of enzyme dissociation constants.
J. Amer. Chem. Soc. 1934; 56: 658.
Lombeck, I., Wendel, U., Versieck, J., van
Ballenberghe, L., Bremer, H.J., Duran, R. and Wadman,
S.
Increased manganese content and reduced arginase
activity in erythrocytes of a patient with prolidase
deficiency (iminodipeptiduria).
Eur. J. Pediatr. 1986; 144: 571-573.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall,
R.J.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem. 1951; 193: 265-275.
Marinkovic, D.V. and Marinkovic, J.N.
Isolation and properties of a-D-mannosidase from human
kidney.
Biochem. J. 1976a; 155: 217-223.
208
Marinkovic, D.V. and Marinkovic, J.N.
Purification of two hexosaminidases from human kidney.
Biochem. J. 1976b; 163: 133-140.
Marshall, W.C.
A chronic progressive osteopathy with
hyperphosphatasia.
Proc. Roy. Soc. Med. 1962; 55: 238-239.
Matsuomoto, T., Furuta, T., Nimura, Y. and Suzuki, 0.
Increased sensitivity of the fluorimetric method of
Snyder and Hendley for oxidase assays.
Biochem. Pharmacol. 1982; 31: 2207-2209.
Mayer, H. and Nordwig, A.
The cleavage of prolyl peptides by kidney peptidases.
Purification of iminodipeptidase (prolinase).
Hoppe-Seyler's Z. Physiol. Chem. 1973; 354: 371-379.
McAlpine, P.J., Mohandas, T., Ray, M., Wang, H. and
Hamerton, J.L.
Assignment of the peptidase D gene locus (PEPD) to
chromosome 19 in man.
Cytogenet. Cell. Genet. 1976; 16: 204-205.
209
Merril, C.R. and Goldman, D.
in: Two-dimensional gel electrophoresis of proteins.
(Celis, J.E. and Bravo, R., eds), London, Academic
Press, 1984: 93-109.
Middlehurst, C.R., King, G.F., Beilharz, G.R., Hunt,
G.E., Johnson, G.F.S. and Kuchel, P.W.
Studies of rat brain metabolism using proton nuclear
magnetic resonance: Spectral assignments and monitoring
of prolidase, acetylcholinesterase and glutaminase.
J. Neurochem. 1984; 43: 1561-1567.
Myara, I., Charpentier, C. and Lemonnier, A.
Optimal conditions for prolidase assay by proline
colorimetric determination: application to
iminodipeptiduria.
Clin. Chim. Acta 1982; 125: 193-205.
Myara, I., Charpentier, C. and Wolfrom, C.
In vitro responses to ascorbate and manganese in
fibroblasts from a patient with prolidase deficiency
and iminopeptiduria: cell growth, prolidase activity
and collagen metabolism.
J. Inher. Metab. Dis. 1983; 6: 21-26.
Myara, I., Charpentier, C. and Lemonnier, A.
Prolidase and prolidase deficiency.
Life Sciences 1984a; 34: 1985-1998.
210
Myara, I., Wolfrom, C., Charpentier, C., Gautier, M.
and Lemonnier, A.
Prolidase and prolinase activity in Ehler's-Danlos
fibroblasts.
IRCS Med. Sci. 1984b; 12: 636.
Myara, I., Myara, A., Mangeot, M., Fabre, M. ,
Charpentier, C. and Lemonnier, A.
Plasma prolidase activity: A possible index of collagen
catabolism in chronic liver disease.
Clin. Chem. 1984c; 30: 211-215.
Myara, I., Wolfrom, C., Charpentier, C., Gautier, M.
and Lemonnier, A.
Relationship between cell density and prolidase
activity in human skin fibroblasts: effects of
ascorbate and fructose.
Biochimie 1984d; 66: 445-449.
Myara, I., Charpentier, C., Gautier, M. and Lemonnier,
A.
Cell density affects prolidase and prolinase activity
and intracellular amino acid levels in cultured human
cells.
Clin. Chim. Acta 1985a; 150: 1-9.
211
Myara, I., Marcon, P. and Lemonnier, A.
Determination of prolinase activity in plasma.
Application to liver disease and its relation with
prolidase activity.
Clin. Biochem. 1985b; 18: 220-223.
Naughten, E.R., Proctor, S.P., Levy, H.L., Coulombe,
J.T. and Ampola, M.G.
Congenital expression of prolidase defect in prolidase
deficiency.
Pediatr. Res. 1984; 18: 259-261.
Nordwig, A. and Mayer, H.
The cleavage of prolyl peptides by kidney peptidases.
Detection of a new peptidase capable of removing
N-terminal proline.
Hoppe-Seyler's Z. Physiol. Chem. 1973; 354: 380-383.
Noren, 0., Sjostrom, H. and Josefsson, L.
Studies on a soluble dipeptidase from pig intestinal
mucosa.
I. Purification and specificity.
Biochim. Biophys. Acta 1973; 327: 445-456.
O'Cuinn, G. and Fottrell, P.F.
Purification and characterisation of an aminoacyl
proline hydrolase from guinea pig intestinal mucosa.
Biochim. Biophys. Acta 1975; 391: 388-395.
212
Ogata, A., Tanaka, S., Tomoda, T., Murama, E., Endo, F.
and Kikuchi, I.
Autosomal recessive prolidase deficiency.
Arch. Dermatol. 1981; 117: 689-695.
Pedersen, P.S., Christensen, E. and Brandt, N.J.
Prolidase deficiency.
Acta Paed. Scand. 1983; 72: 785-788.
Piggott, C.O. and Fottrell, P.F.
Purification and characterisation from guinea pig
intestinal mucosa of two peptide hydrolases which
preferentially hydrolyse dipeptides.
Biochim. Biophys. Acta 1975; 391: 403-409.
Porath, J. and Olin, B.
Immobilised metal ion affinity adsorption and
immobilised metal ion affinity chromatography of
biomaterials. Serum protein affinities for
gel-immobilised iron and nickel ions.
Biochemistry 1983; 22: 1621-1630.
Porath, J., Carlsson, J., Olssen, I. and Belfrage, G.
Metal chelate affinity chromatography, a new approach
to protein fractionation.
Nature 1975; 258: 598-599.
213
Porter, R.R. and Reid, K.B.M.
The biochemistry of complement.
Nature 1978; 275: 699.
Porter, D.H., Swaisgood, H.E. and Catigani, G.L.
A rapid fluorimetric assay for measurement of peptidase
activity.
Anal. Biochem. 1982; 123: 41-48.
Powell, G.F., Rasco, M.A. and Maniscalco, R.M.
A prolidase deficiency in man with iminopeptiduria.
Metabolism 1974; 23: 505-513.
Powell, G.F. and Maniscalco, R.M.
Bound hydroxyproline excretion following gelatin in
prolidase deficiency.
Metabolism 1976; 25: 503-508.
Powell, G.F., Kurosky, A. and Maniscalco, R.M.
Prolidase deficiency: Report of a second case with
quantitation of excessively excreted amino acids.
J. Pediatr. 1977; 91: 242-246.
Priestman, D.A. and Butterworth, J.
Prolidase deficiency: characteristics of human skin
fibroblast prolidase using colorimetric and
fluorimetric assays.
Clin. Chim. Acta 1984; 142: 263-271.
214
Priestman, D.A. and Butterworth, J.
Prolinase and non-specific dipeptidase of human kidney.
Biochem. J. 1985; 231: 689-694.
Reeder,D.J., Sniegoski, L.T. and Schaffer, R.
o-Phthalaldehyde for the fluorimetric assay of
non-protein amino compounds.
Anal. Biochem. 1978; 86: 490-497.
Reith, M.E.A. and Neidle, A.
The isolation of two dipeptide hydrolases from mouse
brain cytosol.
Biochem. Biophys. Res. Commun. 1979; 90: 794-800.
Roth, M.
Fluorescence reaction for amino acids.
Anal. Chem. 1971; 43: 880-882.
Royce, P.M. and Danks, D.M.
Normal hydroxylation of proline in collagen synthesized
by skin fibroblasts from a patient with prolidase
deficiency.
J. Inher. Metab. Dis. 1982; 5: 111-113.
215
Ryden, A.C.
Separation and characterisation of three proline
peptidases from a strain of Arthrobacter.
Acta Chem. Scand. 1971; 25: 847-858.
Sarid, S., Berger, A. and Katchalski, E.
Proline iminopeptidase. II. Purification and comparison
with iminodipeptidase (prolinase).
J. Biol. Chem. 1962; 237: 2207-2212.
Saville, P.O. and Alderman, M.H.
Deficiency rickets in New York: Dissociation between
urinary hydroxyproline and glycylproline with
treatment.
Arch. Intern. Med. 1970; 125: 341-343.
Scriver, C.R.
Glycyl-proline in the urine of humans with bone
disease.
Can. J. Physiol. Pharmacol. 1964; 42: 357-364.
Scriver, C.R., Goldbloom, R.B. and Roy, C.C.
Hypophosphataemic rickets with renal hyperglycinuria,
renal glycosuria and glycyl-prolinuria - syndrome with
evidence for renal tubular secretion of phosphorus.
Paediatrics 1964; 34: 357-371.
216
Scriver, C.R., Smith, R.J. and Phang, J.M.
Prolidase deficiency with hyperimidopeptiduria.
in: Stanbury, J.B., Wyngaarden, J.B., Fredrickson,
D.S., Goldstein, J.L. and Brown, M.S., eds. The
metabolic basis of inherited disease. New York:
McGraw-Hill, 1983: 375-377.
Seakins, J.W.T.
Peptiduria in an unusual bone disorder - isolation of
two peptides.
Arch. Dis. Child. 1963; 38: 215-219.
Sekiya, M., Ohnishi, Y. and Kimura, K.
An autopsy case of prolidase deficiency.
Virc. Arch. (Pathol. Anat.) 1985; 406: 125-131.
Sheffield, L.J., Schlesinger, P., Faull, K., Halpern,
B.J., Schier, G.M., Cotton, R.G.H., Hammond, J. and
Danks, D.M.
Iminopeptiduria, skin ulcerations and oedema in a boy
with prolidase deficiency
J. Pediatr. 1977; 91: 578-583.
Shoaf, C.R., Isselbacher, K.J. and Heizer, W.D.
Rapid colorimetric assay for intestinal peptide
hydrolases.
Anal. Biochem. 1974; 61: 72-85.
217
Sjostrom, H. and Noren, 0.
Structural properties of pig intestinal proline
dipeptidase.
Biochim. Biophys. Acta 1974; 359: 177-185.
Sjostrom, H., Noren, 0. and Josefsson, L.
Purification and specificity of pig intestinal
prolidase.
Biochim. Biophys. Acta 1973; 327: 457-470.
Smith, E.L.
Some properties of glycyl-leucine dipeptidases of
animal tissues.
J. Biol. Chem. 1948a; 176: 9-19.
Smith, E.L.
The peptidases of skeletal, heart and uterine muscle.
J. Biol. Chem. 1948b; 173: 553-569.
Smith, E.L.
Specificity of certain peptidases. VII. Prolidase.
Adv. Enzymol. 1951; 12: 219-221.
Smith, E.L.
Dipeptidases. C. Prolidase (imidodipeptidase).
Meth. Enzymol. 1955; 2: 100-105.
218
Smith, E.L.
in: Boyer, P.D., Lardy, H. and Myrback, K., eds.
The enzymes. New York: Academic Press, 1960; 4: 1-10.
Smith, I.
Preparative acrylamide disc electrophoresis.
in: Smith, I., ed. Chromatographic and electrophoretic
techniques Vol.2. London: Heineman, 1976: 379-387.
Snyder, R.A. and Brady, R.O.
The use of white cells as a source of diagnostic
material for lipid storage diseases.
Clin. Chim. Acta 1969; 25: 331-338.
Thompson, R.C., Gaull, G.E., Horwitz, S.J. and Schenk,
R.K.
Hereditary hyperphosphatasia - studies of three
siblings.
Amer. J. Med. 1969; 47: 209-219.
Towbin, H., Staehelin, T. and Gordon, J.
Electrophoretic transfer of proteins from
polyacrylamide gels to nitrocellulose sheets: Procedure
and some applications.
Proc. Nat. Acad. Sci.,USA. 1979; 76: 4350-4354.
219
Traniello, S. and Vescia, A.
Properties of a dipeptidase from swine kidney.
Arch. Biochim. Biophys. 1964; 105: 465-469.
Troll, W. and Lindsley, J.
A photometric method for the determination of proline.
J. Biol. Chem. 1955; 215: 655-660.
Umernura, S.
Studies on a patient with imidodipeptiduria. II. Lack
of prolidase in blood cells.
Physiol. Chem. Phys. 1978; 10: 279-283.
Vescia, A.
Ion-determined specificity of peptidase activity.
Biochim. Biophys. Acta 1956; 19: 174-175.
Walter, R., Simmons, W. and Yoshimoto, T.
Proline-specific endo- and exopeptidases.
Mol. Cell. Biochem. 1980; 30: 111-127.
Weber, K. and Osborn, M.
The reliability of molecular weight determinations by
dodecyl-sulphate polyacrylamide gel electrophoresis.
J. Biol. Chem. 1969; 244: 4406-4412.
220
Whittaker, V.P. and Barker, L.A.
The subcellular fractionation of brain tissue with
special reference to the preparation of synaptosomes
and their component organelles.
Methods Neurochem. 1972; 2: 1-52.
Yoshimoto, T., Matsubara, F., Kawano, E. and Tsuru, D.
Prolidase from bovine intestine: Purification and
characterisation.
J. Biochem. 1983; 94: 1889-1896.
Zivin, J.A. and Waud, D.R.
How to analyse binding, enzyme and uptake data: the
simplest case, a single phase.
Life Science 1982; 30: 1407-1422.
Zuyderhoudt, F.M.J., Brugman, A.M., Smit, J.J.H. and de
Jong, L.
Plasma prolidase in the rat: no index of liver
fibrosis.




Tissue culture was carried out by tissue culture
and cytogenetics staff of the Pathology Department of
the Royal Hospital for Sick Children, Edinburgh.
The tissue culture medium consisted of Ham's F10
containing 1.6 mM glutamine (BDH Ltd), 20% foetal calf
serum, Kanamycin sulphate BPC ('Kanasyn', Winthrop Ltd)
or Penicillin-streptomycin ('Crystamycia', Glaxo Ltd)
and 0.09% NaHCO^. The medium was prepared non-sterile
and filtered through a Millipore filter (pore size
0.22p), and then sterility tested.
Cells were cultured in babys' feeding bottles of
2
225 ml capacity and 40 cm growth surface area.
Amniotic fluid cell primary cultures were in Nunclon-
delta petri dishes of 5 cm diameter.
Skin biopsies were cut up into small pieces in
thrombin and placed on drops of chicken plasma on one
face of a baby's feed bottle. Excess liquid was
removed with a Pasteur pipette and the plasma drops
containing the skin left to clot. When clotted, 10 ml
medium was added and the bottle gassed with 5% CC>2 in
air. Outgrowths of fibroblasts spread from the pieces
of skin and these were subcultured.
Amniotic fluid cells were precipitated by
centrifugation at 300 x g for 10 min, the supernatant
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was poured off and the cells resuspended in medium
supplemented with 30% foetal calf serum. The
resuspended cells were put into petri dishes ( 5 ml in
each), placed in anaerobic jars (modified Mcintosh and
Fildes design) and gassed with 5% CC>2 in air.
Cells were subcultured by trypsinisation using
0.25% (w/v) trypsin solution (Trypsin 1:250, Difco Ltd)
in phosphate buffered saline (Dulbecco 'A', Oxoid Ltd).
After centrifugation and resuspension, the cells were
transferred to two culture vessels. Incubation of
cells was at 37°C at all times.
11.2. Preparation of cultured cells
Cultured cells were harvested at confluency by
trypsinisation in 0.25% trypsin and 0.04% (w/v) EDTA in
PBS. The cells were then transferred to a 10 ml
conical centrifuge tube and sedimented by
centrifugation at 400 x g for 5 min. Finally, the
cells were washed twice with isotonic saline and stored
at -70°C prior to enzyme studies.
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11.3. Lowry protein assay
The protein concentration of cell or tissue
extracts was determined by a modification of the method
of Lowry et al. (1951) as follows:-
Reaqents
A 10% (w/v) Na2C03 in 0.5M NaOH
B 0.5% (w/v) CuS04.5H20 in 1% sodium tartrate
C 9 ml A + 1 ml B, prepared just before use
D Folin-Ciocalteau reagent (Sigma Ltd)
diluted 1/5 with distilled water prior to
use
Protein standard was lyophilised bovine serum
albumin (Sigma Ltd), 0.25 mg/ml in distilled
water.
Procedure
0.4 ml solution C was added to 0.4 ml sample
(0.05 ml extract + 0.35 ml distilled water) and mixed
on a vortex mixer and left at room temperature. After
10 min, 0.4 ml solution D was added with thorough
mixing on a vortex mixer and left at room temperature
for 30 min. The extinction at 650 nm was read against
a blank solution without any protein.
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11.4. Isoelectrofocusing in a sucrose gradient
The method used for isoelectrofocusing was a
modification of the method of Godson (1970) which
enabled the use of small samples. The 'J-tubes' were
as specified in the original method. Solutions were






12g sucrose, 14 ml distilled
water, 0.2 ml orthophosphoric
acid (s .g . 1.7)
2% (v/v) ethanolamine in
distilled water
2.8g sucrose, 4.2 ml distilled
water, 0.06 ml 10% (v/v)
Triton-X-100, 0.75 ml 10%
ampholine
sample made up to 6 ml with
distilled water containing
0.06 ml 10% Triton-X-100 and
0.25 ml 10% ampholine
dilute H2SO4 in tap water
The anode (14 ml) was run into the short arm of
the J-tube. The sucrose gradient was made using a
gradient mixer constructed from two 5 ml syringe
barrels. Heavy gradient (4.5 ml) was added to the
mixing chamber and allowed to fill the dead volume in
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the exit tube and the tube connecting the two chambers
before running the light gradient (5 ml) into the
second chamber. The gradient was then run gently into
the long arm of the J-tube, heavy to light. 1-2 ml
cathode was then layered on top of the gradient. The
final column consists of a heavy anode solution filling
almost completely the short arm of the J-tube plus a
few cm at the bottom part of the long arm. The
ampholine/sucrose/sample gradient fills the remaining
part of the long arm, supported on the heavy anode
solution and with a light cathode solution layered on
top (see figure below).
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The anode and cathode were connected to a power
pack with platinum wires dipped into the electrolyte in
a small dish at the cathode and was used as a coolant
for the J-tubes at the anode. The electrolyte was
connected to the power pack by platinum wires. The
current was raised step-wise until a voltage of 400 V
was reached. This voltage was then maintained at 4°C
for 18 hours.
On completion, an airtight connection was
attached to the short arm and heavy sucrose (anode
solution) was gently pumped in, displacing the sucrose
gradient from the long arm. Fractions (0.25 ml) were
collected and the pH of each read at 4°C.
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11.5. Dixon and Webb substrate kinetics
The substrate kinetic studies as described by
Dixon and Webb ( 1964 , pp 84-87) were used to
investigate the hydrolysis of Pro-Ala and Gly-Leu.
If an enzyme is not absolutely specific for one
substrate only, it may act on two different substrates
present at the same time. This cannot be considered as
a simple case of two independent parallel reactions, as
there will be competition between the substrates for
the active site on the enzyme. For an enzyme acting on
two substrates A and B, as far as A is concerned, B
behaves simply as a competitive inhibitor and vice
versa. The rate of breakdown of A in the presence of B
as a competitive inhibitor is therefore given by
analogy with the equation for competitive inhibition as
given by Dixon (1953)
V
t aI. v =
a
1 + Ka (1 + [b] / Kb )/ [a]
and that of B by
1 + K. (1 + [a] / K ) / [b]
b a
where v and v, are the reaction velocities of A and B,
Si D
V and V, are the respective maximum velocities,
a b '
and are the respective Michaelis constants,
[a] and [b] are the substrate concentrations.
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If Pro-Ala is substrate A and Gly-Leu substrate B, the
experimentally determined values of Km and Vmax can be
substituted into the equations to calculate the
expected activities for each substrate.
V = 0.484 and K = 0.47
a a
V, = 24.6 and K, = 0.79
b b
[a] = [b] = 5 mM
This gives a total estimated velocity (v + v^) of 8.9
compared with the observed value of 9.2 units/ml.
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11.6. Product formation kinetic studies
The kinetics for product formation as it relates
to enzyme activity and concentration, reaction time and
to substrate adsorption and affinity were studied
according to Chrastil and Wilson (1982).
The movement of molecules in the pores of a
protein is a diffusion process which can be expressed
by the equation :
P = Pco [ 1- exp(-kEt)]n
where P is a product which diffused in time t, Pa, is a
product which diffused in t = ® , k is a rate constant
proportional to a diffusion coefficient D and n is a
sterical constant dependent on the sterical structure
of the system. This equation was found to accurately
characterise many enzyme systems, except those with
very short reaction times. The exponent n, and the
rate constant k remained constant for a wide range of
reaction times or enzyme concentrations.
A number of conclusions were reached:
a) If n and k were constant, and P^ were found to be
changed, then the number of free active centres
(competitive inhibition or activation) would be
changed.
b) If n and Pa, were constant, and k were found to be
changed, then the surface reaction rate (non¬
competitive inhibition or activation) or the specific
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activity of an enzyme (presence of inactive protein),
and/or the diffusion coefficient would be changed.
c) If Pa, and k were constant, and n were found to be
changed, then the overall sterical structure of the
system would be changed.
Estimation of the constants
Constant Po (product formation in equilibrium)
was estimated visually or by the higher order
regression analysis of the corresponding time or enzyme
concentration curves. To reach equilibrium in a
reasonable time interval, it is recommended to use
relatively high concentrations of an enzyme. Constant
n was easily obtained as a slope of the linear part of
the log t vs log P plot. Constant k was obtained as
1,
the slope of the linear part of t vs -In [ 1-(P/Poo)n ] /E.
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Fluorimetric assay for prolinase and partial
characterisation in cultured skin fibroblasts
J. Butterworth * and D. Priestman
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Summary
A sensitive assay for the estimation of prolinase has been developed, using
o-phthaldialdehyde to detect the liberated amino acid. Substrates of the form
proline-^ (X = amino acid with one amino group) can be used. Prolinase can be
estimated in cells used for diagnostic purposes with as little as 1 jug cell protein.
Partial characterisation of the enzyme indicates the presence of at least two forms of
the enzyme in skin fibroblasts which needs consideration when testing for a
prolinase deficiency.
Introduction
During collagen degradation dipeptides of the type proline-X (X = amino acid)
are hydrolysed by prolinase (EC 3.4.13.8) and of the type X-proline by prolidase
(EC 3.4.13.9). Existing methods [1-4] for prolinase, being relatively insensitive, are
unsuitable for the characterisation of prolinase in the small quantities of human
cultured cells available for diagnosis of collagen diseases. In addition, the described
conditions of assay have been derived from animal tissues, as human prolinase has
not been characterised [5-7]. Using a new simple and sensitive fluorimetric method,
conditions of assay for prolinase in cultured skin fibroblasts were developed.
Although a deficiency has been described for prolidase [1-3], no such deficiency has
been reported for prolinase. The enzymic detection of Tay-Sachs disease only
became possible with the realisation that there were two major forms of hexosa¬
minidase, and the partial characterisation of prolinase was undertaken to see if the
same held for prolinase.
* To whom correspondence should be addressed.
0009-8981/82/0000-0000/S02.75 © 1982 Elsevier Biomedical Press
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Materials and methods
Human amniotic fluid cells and skin fibroblasts were cultured as previously
described [8], except that 20% (v/v) newborn calf serum was used. Tissue samples
were obtained at autopsy 24 h after death. Red and white blood cells were prepared
from fresh venous blood from children by dextran sedimentation [9]. All the samples
were stored at — 70°C. Extracts were prepared by the addition of ice-cold distilled
water, sonication at 4-6 jam (M.S.E. Ultrasonic Disintegrator Mk. 2) for 30 s for
cells and 60s for tissues, and centrifugation at 1000 Xg for 10 min.
The following fluorimetric assay systems were developed to estimate prolinase in
cultured cells, although the same procedures were used for other samples, (a) 50 ^1
extract (0.2 mg protein/ml), 50 jul 50 mmol/l veronal-HCl buffer pH 7.4 containing
4mmol/l MnCl2 and 100 jul 30 mmol/l dipeptide and (b) 50 jul extract, 50 /xl 50
mmol/l veronal-HCl buffer pH 9.2 containing 0.1 mmol/l MnCl, and 100 jul 30
mmol/l dipeptide. Amino acids coupled to proline (Sigma Ltd.) included glycine,
alanine, valine, leucine, phenylalanine and glutamic acid (Pro-Gly, Pro-Ala, Pro-Val,
Pro-Leu, Pro-Phe, Pro-Glu). After up to 120 min incubation at 37°C, 200 gl 7.2 g/1
perchloric acid was added, kept at 5°C for 15 min, spun at 2000 X g for 10 min and
50-jul portions used to estimate the liberated amino acid. If required, assays can be
kept at this point without hydrolysis of the substrate. Substrate and extract blanks
and apiino acid standards were run simultaneously. Amino acids were estimated by
a method based on that used for tyrosine [10]. The reagent (100 ml) consisting of
3 ml o-phthaldialdehyde (12 g/1 methanol), 3 ml 2-mercaptoethanol (0.6%, v/v, in
ethanol) and 94 ml 150 mmol/l Na2C03-NaHC03 buffer, pH 9.5, was freshly
prepared, and 850 jul added to a 50-jul portion of the incubation mixture. After a
minute for development, the fluorescence was read in a Perkin-Elmer 1000 fluorime-
ter (excitation 365 nm, emission 455 nm).
For a comparison with the fluorimetric method, the spectrophotometric method
for prolinase as given by Powell et al [2] was used. The assay consisted of 50 jul cell
extract, 100 jul 200 mmol/l borate buffer, pH 8.0, and 50 jul 24 mmol/l L-prolylgly-
cine (Pro-Gly). After 30 or 60 min incubation at 37°C, 1.3 ml ethanol was added,
allowed to stand for 10 min, spun at 2000 X g for 10 min and a 1-ml sample read at
220 nm. The assay was also stopped and analysed as for the fluorimetric assay.
Using the fluorimetric assays various characteristics of prolinase of cultured skin
fibroblasts were studied. Subcellular fractionation was carried out as previously
described [11]. For heat stability, extracts in water or 10 mmol/l veronal-HCl buffer,
pH 7.4, were kept at 45-60°C for 5 min or at 52°C for up to 60 min prior to assay.
For pH stability, the pH of the extract was adjusted with 0.01 mmol/l HC1 or
NaOH for 30 min and neutralised prior to assay.
For Sephadex G150-120 (Sigma Ltd.) gel filtration, the extract was dialysed for
60 min against the elution buffer and spun at 100000 Xg for 30 min, 2 ml was
applied to a 2.5X55 cm column, eluted with 10 mmol/l veronal-HCl pH 7.4
containing 100 mmol/l NaCl at 4ml/h and 1.25 ml fractions collected. For
DEAE-cellulose ion-exchange chromatography, the extract was dialysed for 60 min
against the elution buffer and spun at 100000 X g for 30 min, 2 ml was applied to a
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1 X 25 cm column, eluted with a 0-250 mmol/1 NaCl linear gradient in 10 mmol/1
veronal-HCl buffer, pH 7.4, and 1.25-ml fractions collected. Sucrose density isoelec-
trofocusing was carried out as previously described [11], with the sample being
applied without prior dialysis.
Hydrophobic chromatography was carried out by applying a 2-ml sample, di-
alysed against elution buffer, to a 0.8 X 10 cm column of butyl-agarose (Miles Lab.
Ltd.) and eluted with a 0-300 mmol/1 NaCl linear gradient in 20 mmol/1 maleate
buffer, pH 6.5. Affinity chromatography was performed by applying a 2-ml sample,
dialysed against elution buffer, to a 0.8 X 9 cm column of concanavalin A-Sepharose
(Pharmacia Ltd.) using a 10 mmol/1 veronal-HCl buffer, pH 7.4, containing 0.1
mmol/1 MnCl2, 100 mmol/1 NaCl and 0.1% (v/v) Triton X-100 (Sigma Ltd.) and
eluted with 0-1 mol/1 a-methyl-D-glucoside (Sigma Ltd.). Chromatography using
wheat-germ lectin-Sepharose (Sigma Ltd.) was undertaken using a 0-1 mol/1
A-acetyl-D-glucosamine (Sigma Ltd.) linear gradient in 10 mmol/1 veronal-HCl
buffer, pH 7.4, containing 100 mmol/1 NaCl and 0.1% (v/v) Triton X-100.
Cathepsin B [12], a-L-fucosidase and A-acetyl-/?-D-glucosaminidase [13], /3-d-
glucuronidase [14], fumarase [15], lactic dehydrogenase [16] and protein [17] were
estimated as previously described. Non-specific dipeptidase activity was estimated
using a micromethod based upon the assay of Shoaf et al [18]. Each assay contained
25 ;ul extract, 50 jul 100 mmol/1 Tris(hydroxymethyl) aminomethane-HCl buffer, pH
8.0, and 25 jal 150 mmol/1 glycyl-L-leucine (Gly-Leu; Sigma Ltd.) or L-phenylalanyl-
L-alanine (Phe-Ala; Sigma Ltd.). Following incubation for 15 min at 37°C, 250 /u.1
L-amino acid oxidase reagent (2.7 g/1 L-amino acid oxidase, 2 mg/1 horseradish
peroxidase and 7.2 g/1 o-dianisidine) was added. After a further 10 min, 250 jtl 50%
H2S04 was added and the colour read at 530 nm.
Results and discussion
The time taken to reach the maximum fluorescence and the rate of decay of this
fluorescence depended upon the particular amino acid. Glycine and alanine showed
maximum fluorescence after 1 min and had lost 25% of this fluorescence after 8 min.
The fluorescence for valine, leucine, phenylalanine and glutamic acid was maximal
after 1^ min and remained at this level for at least 5 min. Prolylglycine was used,
despite the relatively short-lived fluorescence of the glycine conjugate, in order to
compare the present with previous studies. All the amino acids tested gave linear
calibration curves up to at least the limits of the fluorimeter with the fluorescence
units being 950, 830, 1050, 990, 1050 and 1060 for 10 nmol glycine, alanine, valine,
leucine, phenylalanine and glutamic acid, respectively. The reagent blank was less
than 20 units when prepared and increased by only a few units after many hours.
The fluorimeter was standardized against the stable fluorochrome quinine to give
250 fluorescence units at 1 mg/1.
The fluorescence depended upon the molarity of the reagent buffer, as it has to
counteract the low pH consequent to the use of perchloric acid as a protein
precipitant. The amount of assay mixture taken to estimate the liberated amino acid







Fig. 1. Effect of manganese on fibroblast prolinase assayed at pH 7.4 (X, 0-2 mmol/1) and pH 9.2 (•,
0-0 2 mmol/1).
Fig. 2. Effect on fibroblast prolinase activity of (X) heating at various temperatures for 5 min and (•)
heating at 52°C for up to 60 min.
100 mmol/1 buffer will suffice for 50 /xl assay volume, 150 mmol/1 was routinely
used to permit either 50 or 100 jul to be taken, and for 400 jal, the maximum tested,
1000 mmol/1 buffer was needed. At the level of o-phthaldialdehyde and 2-
mercaptoethanol used, no changes in concentrations were needed for up to 400 ju 1
assay volume.
The pH profile of prolinase was dependent upon the level of Mn2 + present.
Without added Mn2+ a broad optimum at pH 8.4-9.4 was found, whilst the
optimum with 1 mmol/1 Mn2+ was pH 7.4-7.8 and with 0.025 mmol/1 Mn2+ pH
9.2, this last condition giving the highest activity. The saturating concentration of
Mn2+ at pH 7.4 was 1 mmol/1 and at pH 9.2, 0.025 mmol/1, with inhibition above
those respective concentrations (Fig. 1). The assay was linear with time for at least
3 h at pH 7.4 and pH 9.2, and with protein concentrations up to that hydrolysing
20% substrate. A typical assay using about 10 jug fibroblast protein hydrolysed less
than 4% of the substrate. The time linearity was in contrast to the marked
non-linearity after 40 min observed by Powell et al [2]. As analysed by Lineweaver-
Burke plots the Km for L-prolylglycine was 6.8 mmol/1 at pH 7.4 and 2.3 mmol/1 at
pH 9.2.
Dialysis of the enzyme for 60 min against distilled water reduced prolinase
activity by 75-85%, but by only 25% against 100 mmol/1 NaCl and less than 20%
against 10 mmol/1 veronal-HCl buffer pH 7.4. The enzyme was thermolabile with a
marked transition point at about 55°C (Fig. 2) with a linear fall off at 52°C. The
presence of 100 mmol/1 NaCl or 0.2 mg bovine serum albumin during the heat
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treatment increased the thermolability. The enzyme was stable between pH 6.5-9.5,
but the activity was reduced by 70% below pH 6.0.
Prolinase was present in the final soluble fraction on subcellular fractionation,
with lactic dehydrogenase, fumarase, a-L-fucosidase and A-acetyl-/?-D-glucosamini-
dase showing their expected distribution and latency effect for the last two enzymes.
Using Pro-Gly, cultured skin fibroblasts (n = 15) had a prolinase mean specific
activity (nmol • min-1 ■ mg~' protein ± SD) of 42.4 ± 12.2 (range 26-72) at pH 7.4
and 80.1 ± 24.2 (range 47-134) at pH 9.2, whilst amniotic fluid cells (passage 2 + 3,
n= 19) had 56.9 ±30.3 (range 21-124) and 108.5 ±58.5 (range 41-237), respec¬
tively. The omission of the four epithelioid amniotic fluid cell cultures tested, which
had high prolinase values, resulted in mean values very similar to those for
fibroblasts. The fibroblast values were about three times higher than those previ¬
ously reported by Arata et al [1], who omitted manganese. Three white blood cell
samples (polymorphonuclear cells) had specific activities of 34, 55 and 82 at pH 7.4
and 51, 77 and 122 at pH 9.2, respectively, which compare with a mean value of 24
reported by Powell et al [2] for pH 8.0. Three red blood cell samples had rather low
specific activities of 7.3, 8.7 and 8.8 at pH 7.4, and 10.5, 11.8 and 12.9 at pH 9.2,
respectively, which were much higher than the value of 0.2 reported by Powell et al
[2]. This very low value was probably due to the dialysis step used in their method.
Prolinase activity was also estimated in a number of tissues obtained at autopsy
TABLE I
SPECIFIC ACTIVITY (nmolmin-lmg_l protein) OF TISSUE PROLINASE, CATHEPSIN B AND
HEXOSAMINIDASE
Tissue Prolinase
pH 7.4 pH 9.2
Cathepsin B Hexosaminidase
Kidney 451 974 8.2 49.5
Thyroid 338 554 94.2 41.9
Thymus 200 324 28.6 82.6
Pancreas 160 317 5.3 29.1
Adrenal 153 273 7.9 52.4
Pituitary 150 270 2.9 26.2
Liver 115 237 6.9 68.4
Choroid plexus 116 234 5.2 31.1
Cerebral cortex 123 231 0.8 5.8
Small bowel 107 211 3.8 69.1
Lung 101 183 2.2 14.4
Skeletal muscle 87 155 1.1 6.5
Skin 80 125 2.6 7.2
Spleen 64 117 2.4 15.9
Cartilage 54 108 4.0 23.4
Placenta 55 89 1.8 9.7
Heart 19 29 2.4 13.8
L/l
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*Veronal-HClbuffer,p7.6,+1mmol/1Mn2+ ,9 20.025mmol/1+,p8 8+1mo /1Mn +;Tris-HClbuffer,p8.0.
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(Table I). Apart from heart muscle, all tissues had moderate activity, with kidney
being particularly active.
The hydrolyses of a number of proline dipeptides, hydroxyprolylglycine (Hypro-
Gly) and two non-specific dipeptidase substrates Gly-Leu and Phe-Ala by skin
fibroblast and amniotic fluid cell cultures are given in Table II. The substrate
Pro-Gly previously used for studies on human prolinase [1-4] gave a lower specific
activity than Pro-Leu, Pro-Phe and Pro-Val, and together with the more unstable
fluorescence for glycine this makes any of these three substrates preferable to
Pro-Gly. The variable ratios of activities at pH 7.6 to pH 9.2 for the different
substrates indicate that there is a single enzyme with variable responses for each
substrate or that there is more than one form of prolinase. Pig kidney prolinase was
found [19] to hydrolyse Hypro-Gly faster thwn Pro-Gly, and was claimed to be more
specific for prolinase, but Mayer and Nordwig [20] found Hypro-Gly to be hydro-
lysed at only a third of the rate of Pro-Gly. For the cultured cells, Hypro-Gly was a
poor substrate and of little use for the estimation of prolinase. Prolyl-glutamic acid
was not hydrolysed by cultured cell prolinase in agreement with the finding for pig
kidney enzyme [21]. It is noteworthy that the non-specific dipeptidase activity was
higher than the prolinase activity, and the difference between the fibroblast and
amniotic fluid cell cultures for the two non-specific substrates deserves further study.
The main advantage of the use of o-phthaldialdehyde for the assay of prolinase is
that it does not react with proline unless modified and hence substrates of the type
proline-X (X = amino acid with one NH2 group) will not give a fluorescence,
whereas ninhydrin reacts with proline, necessitating separation of substrate and
products. Furthermore, the estimation of amino acids using ninhydrin is about ten
times less sensitive than using o-phthaldialdehyde. The method given for prolinase
by Powell et al [2], based upon the detection of proline using the ninhydrin method
of Troll and Lindsley [22], is time-consuming, used benzene, and required at least 20
VOLUME (ml)
Fig. 3. Sephadex G150-120 gel fillration of fibroblast prolinase assayed at pH 7.4 (X) and pH 9.2 (•).
2.5X55 cm column eluted with 10 mmol/1 veronal-HCl buffer, pH 7.4, containing 100 mmol/1 NaCl. Vo,








40 60 80 100
VOLUME (ml)
Fig. 4. DEAE-Cellulose column chromatography of fibroblast prolinase assayed at pH 7.4 (X) and pH
9.2 (•). 1 X25 cm column eluted with 0-250 mmol/1 NaCl in 10 mmol/l veronal-HCl buffer, pH 7.4. A,
hexosaminidase B; B, a-L-fucosidase.
times more enzyme protein in the assay than the present method. The method of
Arata et al [1] used an amino acid analyser to separate the products for the substrate,
followed by ninhydrin detection, and required at least 20 times more enzyme protein
in the assay than the present method. This technique is also not suitable for a large
number of samples as generated by kinetic and chromatographic studies. Compari¬
son was made with the method of Josefsson and Lindberg [3] as modified for
prolinase by Powell et al [2], which depends upon the fall in absorbance with
substrate hydrolysis. However, the low rate of substrate hydrolysis with cultured
cells only gave a very small drop in absorbance, which, read against the initial high
value, resulted in low sensitivity. The spectrophotometric method was not feasible in
the presence of haemoglobin [2], whereas it had no effect in the present fluorimetric
method. By taking 400 /x 1 rather than the usual 50 jal assay volume for amino acid
estimation, the amount of enzyme needed can be reduced to about 1 jag protein/as¬
say, making the present method about 200 times more sensitive than the other
methods.
Chromatographic techniques were used to characterise the enzyme from skin
fibroblasts to see if more than one form was present. For assays of prolinase by the
fluorescent method after chromatographic procedure, it was not usually necessary to
centrifuge following addition of perchloric acid, as the enzyme blank was very low.
Gel filtration of prolinase showed a large and a small peak, the latter being more
pronounced at pH 7.4 than at pH 9.2 (Fig. 3). Bovine prolinase [23] gave a single
peak of molecular mass 75000, similar to the fibroblast large peak. Ion-exchange
chromatography (Fig. 4) also gave a large (120 mmol/1 NaCl) and a small peak (145
mmol/1 NaCl), with the latter again being more pronounced at pH 7.4. The two
peaks gave the same pH profile with 0.025 mmol/1 Mn2 +, but with 1 mmol/1 Mn2 +
the first peak gave an optimum near pH 8.0, whilst that of the second peak was
nearer pH 7.4, and would explain the variable pH profiles for a total extract.
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pH
Fig. 5. Sucrose density isoelectrofocusing of fibroblast prolinase assayed at pH 7.4 (X) and pH 9.2 (•).
( ) Hexosaminidase.
Hydrophobic chromatography, using butyl-agarose only gave a single peak for pH
7.4 and pH 9.2 at 90 mmol/1 NaCl. Cathepsin B was unbound, /J-D-glucuronidase
released almost immediately on application of the gradient, whilst jV-acetyl-/?-D-glu-
cosaminidase was tightly bound. Fur sucrose density isoelectrofocusing it was
necessary to dilute the fractions tenfold to reduce the blanks produced by the
ampholine. A large peak was obtained at pi 5.75 with a smaller peak at pi 4.8
(Fig. 5). This latter peak was associated with a protein band, although it was not
removed by centrifugation and showed a relatively higher activity at pH 7.4. A pi
4.3 was reported [23] for bovine prolinase, markedly different to the present value
for the human enzyme. Prolinase did not bind to concanavalin A-Sepharose nor
wheat-germ lectin-Sepharose, although TV-acetyb/J-D-glucosaminidase did, indicating
it is not a glycoprotein. It is of interest that the fluorimetric method detected
fV-acetyl-D-glucosamine such that 50 /xl 200 mmol/1 gave a reading of 390 after
6 min development time and can be used to easily measure the gradient of the lectin
column.
The present study indicates that prolinase exists in two forms. Thus a deficiency
of prolinase may be partial, not absolute, and explain why no such deficiency has as
yet been found. In this case it will be necessary to estimate the two forms of
prolinase separately, which would require an assay at least as sensitive as the present
fluorimetric method.
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Substrate Specificity of Manganese-activated
Prolidase in Control and Prolidase-deficient Cultured
Skin Fibroblasts
J. Butterworth and D. Priestman
Department of Pathology, Royal Hospital for Sick Children and University of Edinburgh,
Edinburgh EH9 1EF, Scotland
Skin fibroblasts have a single enzyme, Mn2+-activated prolidase, that hydrolyses a range of amino acid-
proline dipeptides. Two cases of prolidase deficiency showed a marked loss of activity against glycyl-proline
irrespective of Mn2+ conditions. However, the abnormal enzyme showed only moderate reductions in
activity against phenylalanyl-, alanyl-, and leucyl-proline following preincubation with Mn2+ or addition of
Mn2 + with the substrate. Control prolidase was stable to prolonged preincubation with Mn2 +, whereas the
abnormal prolidase was progressively inactivated. The findings indicate, for at least the present two cases, that
prolidase deficiency results from an altered rather than a marked reduction in the amount of normal enzyme.
Prolidase (EC 3.4.13.9) deficiency (McKusick 26413) is
an autosomal recessive disease associated with chronic
ulcerative dermatitis, mental retardation and urinary
excretion ofiminodipeptides (Scriver, 1977). The disease
can be diagnosed by assay of prolidase in cultured skin
fibroblasts (Arata et ah, 1979; Myara et al., 1983;
Sheffield et al., 1977) as well as red and white blood cells
(Endo and Matsuda, 1981; Ogata et al., 1981; Powell et
al., 1974). All reports have utilized glycyl-proline as the
substrate and have indicated an almost complete
deficiency of the enzyme. The present study shows that
human cultured skin fibroblast Mn2 + -activated pro¬
lidase, as for other sources (Endo et al., 1982; Sjostrom et
al., 1973), can hydrolyse a range of proline dipeptides
and that in two unrelated cases of prolidase deficiency
the enzyme is altered, not absent, such that activity
against glycyl-proline is very low, but only moderately
reduced against other substrates.
MATERIALS AND METHODS
Skin fibroblast cultures were supplied from a male
Turkish patient (Case 1) by Dr E. Christensen,
Denmark, and from a male Italian patient (Case 2;
Sheffield et al., 1977) by Professor Danks, Australia. The
patients had iminodipeptiduria and a marked deficiency
of prolidase against glycyl-proline. Fibroblasts were
grown in bottles (40 cm2 surface area) using Ham's F10
(Flow Lab. Ltd.) with 20% (v/v) calf serum (Gibco-
Biocult Ltd.) in the presence of 5 % C02-95 % air. Cell
extracts were prepared (Butterworth, 1982) using
confluent cultures at passages 10-25.
DEAE-cellulose ion-exchange chromatography,
Sephadex G-150 gel filtration and sucrose density
isoelectric focusing were carried out as described
previously (Butterworth and Priestman, 1982).
Prolidase was assayed using 25 pi extract, 50 pi
50mmol/l barbital-HCl buffer pH 8.0 and 25 pi
80 mmol/1 glycyl-proline (gly-pro), phenylalanyl-proline
(phe-pro), leucyl-proline (leu-pro) or alanyl-proline
(ala-pro; Sigma Ltd.). After incubation at 37°C for
30min the liberated proline was estimated by the
method of Mayer and Nordwig (1973) using half their
volumes. Where appropriate, extracts with the buffer
were preincubated at 37 °C with orwithout MnCl2 at the
indicated concentration or an equivalent final Mn2 +
concentration was added with the substrate. Prolinase
was assayed using prolyl-alanine (Sigma Ltd.) as the
substrate (Butterworth and Priestman, 1982). Protein
was estimated (Lowry et al., 1951) using bovine serum
albumin (Sigma Ltd.) as the standard.
RESULTS
Sephadex gel filtration gave a single peak of prolidase
eluting just prior to the first prolinase peak, whilst
DEAE-cellulose ion-exchange chromatography gave a
single peak of prolidase eluting at 135 mmol/1 NaCl, just
after the second major peak of prolinase at 130 mmol/1
NaCl. As all the prolidase activity was found to be below
pH 6.0, isoelectric focusing was carried out using a pH
4-6 gradient. Control fibroblast prolidase showed a
peak against gly-pro and phe-pro at pi 4.5 (Figure 1). A
prolidase-deficient cell line (Case 1) showed a peak at pi
4.6 for both these substrates. Prolidase activity against
leu-pro and ala-pro coincided with these peaks. The
minor peak at about pi 5.0 was associated with a large
protein band and was probably artefactual. These
results indicate that cultured skin fibroblasts have a
single enzyme, prolidase, hydrolysing amino
acid-proline dipeptides.
The activity of prolidase from control and prolidase-
deficient fibroblasts was estimated against gly-pro, phe-
pro, leu-pro and ala-pro after preincubation with or
without 1.33 mmol/1 Mn2+ (1 mmol/1 in assay) for 5 min
(Table 1). Clearly, assaying without Mn2+ resulted in a
deficiency for all four substrates. However, prolidase is a
Mn2 + -activated enzyme as seen in Table 1 and when
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Figure 1 Sucrose-density isoelectric focusing of control (X)
and Case 1 (O) fibroblast prolidase assayed with gly-pro
( ) or phe-pro ( ). Control was assayed for 30min and
Case 1 for 60 min
preincubated with Mn2+ the deficiency was still marked
for gly-pro (94 %), but less so for phe-pro (55 %), leu-pro
(40%) and ala-pro (70%).
The response of prolidase to Mn2+ was analysed
further. Control prolidase activity assayed against phen-
pro was unaltered by preincubation in buffer. Addition
of Mn2+ to the enzyme immediately followed by the
substrate and addition ofMn2+ with the substrate gave
the same increase in activity ( x 3-4) compared to no
Mn2 + . Preincubation with Mn2+ gave a further
increase in activity maximal at 5 min followed by a
gradual return to the initial Mn2 + value (Figure 2). The
abnormal prolidase (Cases 1 and 2) was stable in buffer
but was progressively inhibited in the presence ofMil2 +
PREINCUBATION TIME (min)
Figure 2 Effect of preincubation of control (X) and Case 1
(O) fibroblast extract for up to 60 min with 1.33 mmol/1 Mn2 +
( ) or without Mn2+ ( ) on prolidase activity assayed
with phe-pro. Mn2+ was added to the assay with the substrate
or extract preincubated without Mn2 +
(Figure 2; Case 1 shown). Similar results were obtained
against leu-pro and ala-pro. The data (Figure 2, zero
time) illustrate another feature that addition of Mn2 +
with the substrate resulted in only a small reduction
(25%) in activity against phe-pro for both cases. A
similar reduction was noted against ala-pro, whilst no
reduction was found for leu-pro. The findings for gly-pro
were different to those for the above three substrates.
Control prolidase activity increased over a 60 min
period of preincubation with Mn2+ (1.33 mmol/1), such
that the activity was increased 4-5 fold after 5 min and
8-10 fold after 60 min compared to the no Mn2 +
activity. In contrast, the abnormal prolidase (Cases 1
and 2) increased by only 10% after 5 min and 50% after
60 min. Addition of Mn2+ with the substrate gly-pro
showed a greater reduction (75'%) in activity for the
abnormal prolidase (Cases 1 and 2) than found for the
other three substrates. The deficiency in prolidase
activity against the four substrates was in the order: gly-
pro > ala-pro ^ phe-pro > leu-pro, whilst the de¬
ficiency against all four substrates varied with the
Table 1 Prolidase activity (nmol min 'mgprotein ') against different substrates in cultured skin fibroblasts from controls (n = 10)
and cases
Cells Gly-pro
— Mn2 * +Mn2 +
Phe-pro






Mean 13.4 87.6 28.1 95.4 21.3 77.9 68.8 135.8
SD 2.8 12 2.7 11 2.3 8.4 3.7 17.6
Case
1 0.31 5.7 0.8 49.1 1.1 41.5 7.5 39.5
2 0.34 5.3 0.7 38.0 3.1 52.4 7.0 43.5
Extracts were preincubated in buffer without Mn2+ (— Mn2 + ) or with 1.33 mmol/1 Mn2 + ( + Mn2 +) for 5 min at 37 °C. No additional Mn2 + was added to the assay
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assay conditions in the order: no Mn2+ > 5min Mn2 +
preincubation > 60min Mn2+ preincubation > Mn2 +
with substrate.
DISCUSSION
The present chromatographic findings show that human
skin fibroblasts have only a single enzyme hydrolysing
amino acid-proline dipeptides, in agreement with
previous work on human erythrocyte prolidase (Endo et
al., 1982). Hence an absence of the enzyme should result
in the disappearance of activity against all the amino
acid-proline substrates, but this was not so in the present
two unrelated cases of prolidase deficiency. When
activated with Mn2+ prolidase showed a marked
deficiency against gly-pro, but not against the other
substrates tested, indicating the enzyme was altered in
specificity rather than absent. Previous studies (Arata et
al., 1979; Endo and Matsuda, 1981; Endo et al., 1982;
Ogata et al., 1981; Powell et al., 1974; Sheffield et al.,
1977) have all used gly-pro with differing levels ofMn2 +
added to the assay and have shown an almost complete
absence of the enzyme. The present study showed that a
deficiency in prolidase would be expected with gly-pro
irrespective of the conditions of assay. However, using
other substrates the detection of the disease would be
more difficult requiring a more detailed study of the
enzyme. Whether other cases have a similar gene
mutation to the present two unrelated cases resulting in
an altered ability ofMn2 + to stabilize/activate prolidase
and a changed substrate specificity or a mutation
resulting in a prolidase inactive against all the substrates
deserves investigation.
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Introduction
Prolidase (EC 3.4.13.9) deficiency (McKusick 26413) is an autosomal recessive
disease associated with chronic ulcerative dermatitis, mental retardation and imino-
dipeptiduria [1]. A single form of prolidase was found in human erythrocytes [2] and
an almost total deficiency of the enzyme against the substrate glycyl-proline has
been reported [3-9] in the disease. In a preliminary report on cultured human skin
fibroblast prolidase [10] we showed that the disease enzyme activity against other
substrates was not as reduced. Characteristics of the normal and abnormal enzyme
of skin fibroblasts are described that enable diagnosis of the disease to be made
using substrates in addition to glycyl-proline.
Materials and methods
Skin fibroblast cultures were obtained from a Turkish male patient (Case 1) [9]
and a male Italian patient (Case 2) [4], The cells were cultured and extracts prepared
as previously described [10,11].
Prolidase was assayed using glycyl-proline (gly-pro), phenylalanyl-proline (phe-
pro), alanyl-proline (ala-pro), valyl-proline (val-pro), seryl-proline (ser-pro),
methionyl-proline (met-pro) obtained from Sigma Ltd. (St. Louis, MO, USA) and
glutamyl-proline (glu-pro) obtained from BaChem Ltd. as substrates and followed
by estimating liberated proline [10]. Two other possible methods for phe-pro were
* To whom correspondence should be addressed.
0009-8981 /84/$03.00 © 1984 Elsevier Science Publishers B.V.
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evaluated. Firstly, liberated phenylalanine was estimated spectrophotometrically
using a micromethod based upon the nonspecific dipeptidase assay of Shoaf et al
[12], The assay contained 25 gl extract, 50 /x. 1 50 mmol/1 barbital-HCl buffer pH 8.0
and 25 /xl 80 mmol/I phe-pro and after 30 min incubation at 37 °C the reaction was
stopped by heating at 100 °C for 1 min. Reagent (250 gl of 25 mmol/1 barbital-HCl
buffer pH 8.0 containing 0.27 g/1 L-amino acid oxidase, Sigma Ltd. type VI; 20
mg/1 horseradish peroxidase, Sigma Ltd. type II; and 0.2 g/1 o-dianisidine ■ 2 HC1
Sigma Ltd.) was added and after 10 min at 37 °C 250 jul 50% (v/v) sulphuric acid
added. The colour was read at 530 nm and compared to a phenylalanine standard
curve. Secondly, the method of Matsumoto et al [13] for monoamine oxidase was
applied to the fluorimetric estimation of phenylalanine. After heating the assay tubes
at 100 °C for 1 min, 400 jttl reagent (25 mmol/1 barbital-HCl buffer pH 8.0
containing 0.1 g/1 L-amino acid oxidase, 10 mg/1 horseradish peroxidase, 50
mmol/1 EDTA and 0.5 gmol/1 homovanillic acid, Sigma Ltd.) was added. After
incubation at 37°C for 10 min, 500 jui 0.5 mol/1 NaOH was added and the
fluorescence read on a Perkin-Elmer 1000 fluorimeter (excitation 323 nm; emission
426 nm) and related to a phenylalanine standard curve. Addition of EDTA was
needed to prevent the precipitation of Mn2+ used to activate prolidase. Protein was
estimated [14] using bovine serum albumin (Sigma Ltd.) as standard.
The effect of Mn2+ on prolidase activity was followed by the addition of
increasing amounts of MnCl2 to the assay or by preincubating extract with 1.33
mmol/1 Mn2 + . Substrate kinetics for enzyme preincubated with 1.33 mmol/1 Mn2 +
for 5 min was calculated by Eadie-Hofstee plots using a Hewlett-Packard HP97
[15] for a number of substrates over the range 1-20 mmol/1. Substrate interaction
was also studied for phe-pro by the method of Chrastil and Wilson [16] by following
product (phenylalanine) formation with time under limiting substrate level (0.5
mmol/1) for normal and abnormal enzyme at the same protein level. Heat stability
of prolidase in the presence (1.33 mmol/1) or absence of Mn2+ was investigated by
treating extract at 30-60 °C for 5 min or at 48 °C for up to 60 min. For extracts
treated without Mn2 + an equivalent amount of Mn2+ was added with the substrate.
The effect of />-hydroxymercuribenzoate (PHMB, Sigma Ltd.) on prolidase activity
against phe-pro was studied by the addition of 0.01-0.5 mmol/1 PHMB before or
after treatment with 1.33 mmol/1 Mn2 + . Based upon these results 0.05 mmol/1
PHMB was added to normal and abnormal prolidase following preincubation with
1.33 mmol/1 Mn2+ and assayed with a number of substrates.
Results and discussion
Assays for prolidase
Myara et al [8] reported a method using Chinard's ninhydrin reagent optimised
for the assay of prolidase. With this method gly-pro was rapidly hydrolysed, such
that at 100 °C an absorbance of 1.0 was reached after 20 min necessitating the use of
a lowered temperature which reduced assay sensitivity. The present method was
based on the ninhydrin method of Mayer and Nordwig [17] and at 100 °C the
absorbance was only. 0.09 after 20 min enabling 100 °C to be used. The development
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of the proline colour and hydrolysis of gly-pro to give the substrate blank were
critically dependent upon the temperature. Using heating blocks in which there was
a difference of only a degree between blocks gave unreliable readings. This problem
was overcome by ensuring a uniform temperature in a boiling waterbath by
continuous stirring. All the other substrates were more stable and gave a lower blank
than gly-pro. Glycine was found to increase the proline standard reading and its
inclusion in the method, as recommended by Mayer and Nordwig [17], eliminated
any tendency for the glycine liberated by the enzyme from gly-pro to increase the
reading.
The L-amino acid oxidase colorimetric method gave 3.8 times the colour for a
given phenylalanine standard (10 nmol = absorbance 0.285) compared to an equiva¬
lent proline standard in the Mayer and Nordwig [17] method and a slightly better
enzyme reading to blank ratio. The method was linear up to at least an absorbance
of 1.0 equivalent to 35 nmol phenylalanine. The L-amino acid oxidase fluorimetric
method gave a reading of 900 fluorescent units for 10 nmol phenylalanine with the
fluorimeter standardised to 200 U with 1 mg/1 quinine and an enzyme reading to
blank ratio twice as high as the proline method. Hence, both L-amino acid oxidase
methods gave larger readings for a given enzyme level than the proline method and
were suited for the rapid analysis of a large number of samples as generated by
kinetic and chromatographic studies.
An optimum of pH 8.0 was obtained for normal and abnormal fibroblast
prolidase using barbital-HCl buffer. The three enzyme assays were linear with time
for at least 60 min and with protein up to at least 40 jug/assay. A range of 5-15 ju.g
protein/assay was used for the L-amino acid oxidase methods and 15-40 jag
protein/assay for the proline method. The three methods gave similar prolidase
activities for a number of fibroblast cultures.
Effects of manganese
Control prolidase was activated by the addition of Mn2+ with the substrate (2.5
mmol/1 Mn2+ optimal gly-pro; 1 mmol/1 Mn2+ optimal other substrates), except
for glu-pro which did not require Mn2+ . Preincubation of the enzyme with Mn2+ at
37°C further increased control prolidase activity, with the same levels of Mn2 +
being optimal (Fig. 1). Preincubation for 60 min for gly-pro and 5 min for the other
substrates (phe-pro and leu-pro shown) were required for optimal activation. The
increase in activity with preincubation at 37 °C did not occur at 48 °C. The
abnormal enzyme was activated by the addition of Mn2+ with the substrate, but the
optimal Mn2+ for Case 1 prolidase activity against phe-pro was about 0.05 mmol/1
Mn2+ and Case 2 showed about 90% of maximum activity at this level (Fig. 2).
Abnormal prolidase against phe-pro was always reduced by preincubation irrespec¬
tive of the level of Mn2 + . However, both cases still required 60 min preincubation
for gly-pro, but maximum prolidase activity only required 0.05 mmol/1 Mn2+.
Previous studies have used different conditions for Mn2+ ranging from no Mn2+ [5],
10 mmol/1 [4] or 16 mmol/1 [6] with no preincubation to 1 mmol/1 preincubated for
2 h [3,7] or 24 h [8] or 10 mmol/1 for 1 h at 37 °C [3,6]. Based upon the present data
these variable Mn2+ conditions would partly explain the very variable prolidase
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levels reported [3-9]. In addition, Mn2+ conditions optimised for control prolidase
are not necessarily those needed by the abnormal enzyme.
Substrate specificity
Skin fibroblast prolidase activated by preincubation for 5 min at 37°C with 1.33
mmol/1 Mn2+ showed a tight range of values for all the eight substrates (20
80-
Mn2*(mmol/l) Incubation Time(min)
Fig. 1. Effect of preincubation with 1.33 mmol/1 Mn2 + at 37°C on control prolidase activity against
gly-pro (...), phe-pro (-) and leu-pro (- - -).
Fig. 2. Effect of preincubation with different Mn2+ levels for 5 min at 37°C on control (•), Case 1 (X)




SER ALA MET PHE GLY LEU
Substrate
Fig. 3. Activity of control (•), Case 1 (X) and Case 2( ▲) skin fibroblast prolidase ( ; mean activity)
following preincubation with 1.33 mmol/1 Mn2+ for 5 min at 37 °C against 20 mmol/1 substrate (x-pro;
x = amino acid shown).
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mmol/1) used (Fig. 3). The highest specific activity was against ser-pro, whilst the
lowest was against glu-pro, the only substrate not requiring Mn2+. Activity against
gly-pro, when fully activated by 60 min preincubation with 2.5 mmol/1 Mn2+,
would be increased about 2.5 times to a mean specific activity of 220 nmol • min"1 •
mg"1 protein. The reported mean specific activity (nmol • min^1 • mg-1 protein) of
skin fibroblast prolidase ranged from 7.2 [5], 20 [4], 50 [8] to 154 [9], all less than the
present level, and, in part, reflects the variable Mn2+ conditions used. Abnormal
prolidase activity against gly-pro has consistently been reported [3-10] to be absent
or very low and in the present study activity in the two cases was reduced to 3-6%
depending upon the Mn2+ conditions. The reduction in activity against the other
substrates was not as marked ranging from 27 to 80% (Fig. 3). The enzyme
deficiency against substrates with a polar amino acid (gly, ser, glu) was greater than
against those with a non-polar amino acid (ala, val, phe, leu, met).
Substrate kinetics
The response of normal and abnormal prolidase (Case 2), following preincubation
with 1.33 mmol/1 Mn2+ for 5 min at 37 °C, to a number of substrates was analysed
by Eadie-Hofstee plots [15] and the results for corrected Km and Vmax given in
Table I. The estimate of data variation [SD(E)rad; 15] for all substrates was less than
0.07 indicating the results to be acceptable. The normal enzyme exhibited biphasic
kinetics against phe-pro, whilst the abnormal enzyme showed only a single line. The
abnormal enzyme had a lowered affinity for all the substrates with the smallest
change being for glu-pro and the largest for ser-pro, phe-pro and leu-pro. The
maximum activity of the abnormal enzyme, calculated from the Eadie-Hofstee plots
was increased for met-pro, unchanged for phe-pro and leu-pro, somewhat reduced
for ser-pro and val-pro and most reduced for ala-pro, glu-pro and gly-pro. Owing to
the altered Km values the deficiency in abnormal prolidase activity would be more
marked the lower the substrate level used. The substrate (gly-pro) level used in
previous work has varied from 1 [4], 3.7 [3,7], 7 [5], 10 [6] to 47 mmol/1 [8] which
TABLE I
Substrate kinetics of control and Case 2 prolidase
Substrate Km Vmax
Control Case Control Case
Ser-pro 3.8 36.2 279 142
Ala-pro 2.3 8.1 221 62
Met-pro 4.5 14.4 147 210
Phe-pro 2.8, 6.8 24.9 136 147
Gly-pro 2.8 13.7 150 20
Leu-pro 1.3 10.4 80 72
Val-pro 0.5 3.3 68 40
Glu-pro 4.4 6.1 33 6
1-20 mmol/1 substrate analysed by Eadie-Hofstee plots [15]
268
would differentially affect the level of control and abnormal prolidase. As with
Mn2 + conditions, the level of substrate optimised for the assay of control prolidase
would not be optimal for the measurement of the abnormal enzyme.
Analysis of product formation using phe-pro as substrate by the method of
Chrastil and Wilson [16] indicated the abnormal enzyme had an unchanged n
(sterical structure constant) value of o.ver 0.9 and poo (maximum product formation)
value of 0.35 mmol/1, but the k (rate constant related to diffusion coefficient) was
reduced to 0.0023 as compared to 0.0086 1 • g~1 • s-1 of the normal enzyme. The data
indicated no major alteration in enzyme structure or absorption affinity for the
substrate, but faulty activation or presence of inactive enzyme.
Heat stability
Both normal and abnormal prolidase activity against phe-pro were thermolabile
above 45°C with only about 10% residual activity at 55°C after 5 min (Fig. 4A).
The addition of Mn2 + increased the heat stability of normal, but decreased that of
the abnormal enzyme. Following the loss of activity at 48 °C with time showed (Fig.
4B) that 70-90% of control enzyme activity (example shown typical of six tested)
was lost after 60 min without Mn2+, but that with 1.33 mmol/1 Mn2+ only about
25% was lost. The two cases (Case 2 shown) showed a similar pattern of loss without
Mn2+ as control enzyme, but in the presence of 1.33 mmol/1 Mn2+ the abnormal
enzyme was initially even more labile. These results indicate that normal prolidase
consists of two forms, one labile and one stable in the presence of Mn2+ and that for
the abnormal enzyme the stable form is largely absent.
Effect ofp-hydroxymercuribenzoate (PHMB)
The effect of PF1MB on prolidase activity was tested, as PHMB binds to swine
intestinal prolidase [18] and sulphydryl reagents inhibit swine kidney prolidase [19].
The normal and abnormal prolidase activity against phe-pro was strongly inhibited
by treatment with PHMB prior to incubation with Mn2 + . However, preincubation
with 1.33 mmol/1 Mn2+ protected the normal enzyme, but not the abnormal enzyme
0-1 1 1 1 ni 1 1 1
30 AO 50 60 u 20 AO 60
Temperature (°C) Incubation Time (min)
Fig. 4. Heat stability of control (-) cand Case 2 ( ) prolidase activity against phe-pro without (X) or
with (•) 1.33 mmol/1 Mn2 + . A. Effect of 5 min at 30-60 °C. B. Effect of preincubation at 48 °C for up
to 60 min.
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against PHMB inhibition (Fig. 5). Addition of PHMB and Mn2+ simultaneously
gave an intermediate result for control prolidase with 0.05 mmol/1 PHMB plus 1.33
mmol/1 Mn2+ inhibiting 30% compared to < 5% when PHMB was added after the
Mn2 + . The abnormal enzyme (Cases 1 and 2) was inhibited > 95% under both these
conditions. A level of 0.05 mmol/1 PHMB was, therefore, chosen to analyse the
effect of PHMB on the normal and abnormal enzyme for a number of substrates
(Table II). The addition of Mn2+ prior to PHMB protected normal prolidase activity
for all the substrates, except for a small reduction with gly-pro and a moderate
reduction with met-pro. However, the abnormal enzyme was markedly inhibited by
PHMB for all the substrates, except for a moderate reduction of the small residual
activity against gly-pro. Inhibition of swine kidney prolidase activity by iodoaceta-
mide has previously been noted [19] to be prevented by Mn2+. Since PHMB and
iodoacetamide react with SH groups, it seems likely that Mn2+ activates prolidase by
binding to SH groups.
TABLE II
Relative activity (%) of prolidase against different substrates following PHMB treatment
Substrate Controls Cases
1 2 3 1 2
Ser-pro 100 97 100 14 14
Ala-pro 92 98 100 0 4
Met-pro 45 53 56 4 3
Phe-pro 113 108 100 6 3
Gly-pro 76 81 80 58 58
Leu-pro 117 93 75 2 4
Val-pro 131 126 120 4 3
Prolidase activated by preincubation with 1.33 mmol/1 Mn2+ for 5 min at 37 °C and PHMB added with
the substrate to give a concentration of 0.05 mmol/1.
PHMB (mmol/l)
Fig. 5. Effect of PHMB on control (-) and abnormal ( ) prolidase activity against phe-pro. ■ = PHMB
added before Mn2+; O = PHMB added with Mn2 + ; # = PHMB added after Mn2+; a = PHMB added
before or after Mn2+.
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Diagnostic properties of abnormal prolidase
The present data showed that the following properties can distinguish control and
abnormal prolidase: (1) Mn2+: control activated but abnormal inactivated by
preincubation with high level of Mn2 + ; (2) substrates: abnormal enzyme reduced
specific activities and increased Km values compared to control; (3) heat stability:
control more stable, but abnormal enzyme more labile to heat treatment in presence
of Mn2+ and (4) PHMB: inhibition of control prevented, but abnormal enzyme not
protected by Mn2+. Any one of these properties could be used to detect the
abnormal prolidase in cultured skin fibroblasts. The results could be explained by
either a change in the properties of a single form of prolidase or the presence of two
forms of prolidase at least one of which is altered. Although only a single form of
prolidase was found in erythrocytes using gly-pro as substrate [2], the present results
indicate that a second form of the enzyme would not be able to hydrolyse gly-pro
efficiently and would require the use of another substrate for detection. Which of the
possibilities is correct will be resolved by the use of chromatographic procedures and
detection of prolidase with a number of substrates.
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Prolidases of human skin fibroblasts
JOHN BUTTERWORTH and DAVID A.
PRIESTMAN
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Prolidase deficiency (McKusick 26413) is an autosomal
recessive disease of humans associated with chronic
ulcerative dermatitis, mental retardation and iminodipepti-
duria (Scriver, 1977). In the disease, cultured skin
fibroblasts have been shown (Sheffield et al., 1977; Arata et
al., 1979; Myara et al., 1983) to have little or no prolidase
(EC 3.4.13.9) activity against glycyl-L-proline. However, we
have found (Butterworth & Priestman, 1984; Priestman &
Butterworth, 1984) that the activity against other substrates
was only reduced 30-80%, with the reduction being the
largest for TV-terminal polar amino acids.
Control prolidase was activated by the addition of Mn2+
with the substrate and even more so after preincubation
with Mn2+. However, the abnormal enzyme required a
much lower level of Mn2+ when added with the substrate
and was inactivated by preincubation with the usual level of
Mn2+. The affinity of the abnormal enzyme for a number of
substrates was reduced with, for example, the Km for leucyl-
L-proline being increased from 1.3 to 10.4mM. Heat stability
(48°C) of normal prolidase activity was increased, but
abnormal prolidase activity decreased in the presence of
Mn2+. Inhibition of normal prolidase by /?-hydroxymecuri-
benzoate (0.05mM) was largely prevented by preincubation
of the enzyme with Mn2+, whereas the abnormal enzyme
was almost totally inactivated whether or not Mn2+ was
present. These results indicate that either a single form of
prolidase is altered kinetically or that there are two forms of
prolidase, at least one of which is altered in the disease.
To decide between these two alternatives, the separation
of fibroblast prolidase into different forms was attempted
by using ion-exchange chromatography. Fibroblasts were
cultured and cell extracts prepared as before (Butterworth,
1982; Butterworth & Priestman, 1982). DEAE-cellulose
ion-exchange chromatography was carried out as before
(Butterworth & Priestman, 1982), except the sample was
applied without prior dialysis and prolidase assayed with a
number of substrates (Butterworth & Priestman, 1984). Two
peaks of prolidase activity were obtained eluting at 135 and
220mM-NaCl (Fig. 1). Peak 1 was very active against glycyl-
L-proline compared with phenylalanyl-L-proline, whereas
peak 2 was relatively less active against glycyl-L-proline.
The activity against phenylalanyl-L-proline was split about
60% peak 1 and 40% peak 2. Both peaks were also active
against leucyl-L-proline, alanyl-L-proline, valyl-L-proline
and methionyl-L-proline. A previous inability to detect the
second peak in fibroblasts (Butterworth & Priestman, 1984)
was due to dialysis of the extract before chromatography, as
it was found that peak 2 activity was lost by dialysis.
Although a sulfhydryl reagent was not needed for peak 2
activity, the inclusion of 0.1 mM-dithiothreitol during
dialysis prevented its loss. We found that human
erythrocytes contained about 10% peak 2 activity against
phenylalanyl-L-proline, and the previous failure (Endo et
al., 1982) to demonstrate this peak 2 activity was probably
due to the low level measurable with glycyl-L-proline and
the preparative procedure used. The fibroblast prolidase
activity of two unrelated cases with prolidase-deficiency
showed almost a total lack of peak 1 activity against all the





Fig. 1. Cultured skinfibroblast prolidase separated by DEAE-
cellulose chromatography
Prolidase was assayed with glycyl-L-proline (x x) and
phenylalanyl-L-proline (# #).
against glycyl-L-proline, but not the other substrates tested.
The abnormal prolidase second peak showed a reduced
affinity for phenylalanyl-L-proline and decreased heat
stability (48°C), as compared with that of the control. Hence
there are two forms of prolidase in cultured skin fibroblasts,
both showing changes in the disease indicating them to be
inter-related.
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Molecular differences between the human and pig erythrocyte nucleoside transporters
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The entry of nucleosides into mammalian cells occurs largely
by nucleoside-specific facilitated diffusion mechanisms
which can be selectively inhibited by nanomolar concen¬
trations of NBMPR (Young & Jarvis, 1983). Inhibition of
nucleoside transport by NBMPR is associated with revers¬
ible high-affinity binding of inhibitor to the carrier
mechanism (apparent 0.1-lnM). This binding is
normally reversible. However, exposure of site-bound
[3H]NBMPR to high-intensity u.v. light results in the
specific covalent radiolabelling of the transporter (Wu et al.,
1983; Young et al., 1983; Shi et al., 1984). We report here a
comparison of radiolabelled nucleoside transporters from
human and pig erythrocytes.
Human and pig erythrocyte membranes were photo-
affinity labelled with [3H]NBMPR under equilibrium
binding conditions in the absence and in the presence of
excess non-radioactive NBTGR as described previously
(Wu et al., 1983). The radiolabelled membranes were then
subjected to SDS/polyacrylamide-gel electrophoresis by the
method of Thompson & Maddy (1982). Gel-associated
radioactivity was determined by slicing gels into 2mm
fractions and measuring the 3H content of these slices by
liquid scintillation counting (Wu et al., 1983).
Fig. 1 compares the SDS/polyacrylamide-gel 3H profiles
of radiolabelled human and pig erythrocyte membranes run
on the same slab gel. Membranes from human species gave
a major peak of radiolabelling in the band 4.5 region of the
gel (Mt 45 000-66 000) [nomenclature of Steck (1974)]. How¬
ever, the two radiolabelled transporters migrated with
significantly different apparent Mr values, the pig protein
having the higher apparent MT. Covalent labelling of these
polypeptides was abolished when photolysis was performed
in the presence of NBTGR (data not shown). The minor
high and low Mr peaks in Fig. 1 represent aggregates of the
transporters and degradation products, respectively. Both
the human and pig erythrocyte membrane preparations
exhibited non-specific labelling in the lipid region of the gel.
The human and pig erythrocyte nucleoside transporters
were also found to behave differently during DEAE-
cellulose ion-exchange chromatography of n-octyl glucoside
membrane extracts. For these experiments, human and pig
erythrocyte membranes were depleted of extrinsic mem¬
brane proteins and photoaffinity labelled with [3H]-
NBMPR as before except that photoactivation was
performed in the absence of unbound 3H-labelled ligand
(non-equilibrium binding conditions) to minimize the
possibility of non-specific labelling (e.g. of membrane lipid)
(Wu et al., 1983). Under these photolysis conditions, more
than 80% of the covalently bound radioactivity represented
specific radiolabelling of carrier protein. Samples were
solubilized with 46mM-n-octyl glucoside in 50mM-Tris/HCl,
2mM-dithiothreitol (pH7.4 at 4°C) and the 130000# super¬
natant applied to DEAE-cellulose columns equilibrated
with the same buffer. Proteins bound to the columns were
eluted with buffer containing lM-NaCl.
For human erythrocyte membrane extracts, the majority
of applied radioactivity (75%) was recovered in the column
Abbreviationsused: NBMPR,nitrobenzylthioinosine; NBTGR,
nitrobenzylthioguanosine; SDS, sodium dodecyl sulphate.
Migration (cm)
Fig. 1. Comparison ofthe photoaffinity labelling ofhuman and
pig erythrocyte membranes with [3 7/]NBMPR
Human (^) and pig erythrocyte 'ghosts' (#) were
equilibrated with 75nM-[3H]NBMPR, supplemented with
dithiothreitol (final concentration 50mM), and exposed to
high-intensity u.v. light from a 450W mercury arc lamp (Wu
et al., 1983) for 45s. Unreacted [3H]NBMPR was removed
by washing and the washed membrane pellets (100/rg of
protein) electrophoresed in a 12% SDS/polyacrylamide-gel
as described in the text. Mr standards are from the same slab
gel. The positions of the stacking gel-running gel interface
and the tracking dye are indicated by A and B, respectively.
void-volume fractions containing only 9% of the applied
protein. The 1 M-NaCl fractions contained large amounts of
protein (mostly band 3), but little radioactivity. There was
therefore an 8-fold purification of radiolabelled transporter
during ion-exchange chromatography, a value similar to
that obtained by Jarvis & Young (1981) using an assay
based on reversible [3H]NBMPR-binding activity. In
contrast, void-volume fractions from pig erythrocyte
membrane extracts contained only traces of radioactivity.
The majority of applied 3H and protein eluted in the lM-
NaCl fractions.
We conclude from these experiments that there are
significant molecular differences between the human and
pig erythrocyte nucleoside transporters. Isolation tech¬
niques devised for the partial purification of the human
erythrocyte transporter (Jarvis & Young, 1981) are not
appropriate for the pig system.
This work was funded by a project grant from the Cancer
Research Campaign, U.K. S. M. J. acknowledges support from
the Medical Research Council, Canada, and the Alberta Heritage
Foundation for Medical Research.
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Presence in Human Cells and Tissues of Two
Prolidases and their Alteration in Prolidase Deficiency
J. Butterworth and D. A. Priestman
Department of Pathology, Royal Hospital for Sick Children and University of Edinburgh,
Edinburgh EH9 1LF, UK
Two forms of prolidase can be separated for all the human cells and tissues examined by DEAE-cellulose
column chromatography or batch methods. Serum had a very low prolidase activity eluting as a single peak
prior to tissue peak I prolidase. Analysis of the two peaks can readily be carried out using white blood cells,
cultured skin fibroblasts and amniotic fluid cells. Dialysis inactivated peak II prolidase although the loss can
be prevented by the presence of dithiothreitol. The two peaks differed in their response to Mn2+, substrate
specificity, heat stability and inhibition by p-hydroxymercuribenzoate. In two unrelated cases of prolidase
deficiency, fibroblast peak I was markedly reduced, although still detectable, whereas peak II was active
against all the substrates, except for a 90 % reduction against glycyl-l-proline. The properties of peak II were
altered in the disease. The results imply that the two forms of prolidase are structurally related.
Prolidase (EC 3.4.13.9) deficiency (McKusick 26413) is
an autosomal recessive disease associated with chronic
ulcerative dermatitis, mental retardation and urinary
excretion of iminodipeptides (Myara et ai, 1984).
Although activity against the substrate glycyl-l-proline
has often been found to be almost totally deficient in the
disease (Butterworth and Priestman, 1984; Myara et al,
1984), activity against other substrates was not so
deficient (Butterworth and Priestman, 1984; Priestman
and Butterworth, 1984). Properties of residual prolidase
in the disease have been shown to be different to control
enzyme from cultured skin fibroblasts (Priestman and
Butterworth, 1984). The present study shows by ion-
exchange chromatography that different tissues have
different proportions of two enzymes capable of
hydrolysing amino acid-proline substrates and that
both enzymes are altered in the disease.
MATERIALS AND METHODS
Skin fibroblasts were obtained from a male Turkish
patient (Case 1) (Pedersen et al., 1983) and a male
Italian patient (Case 2) (Sheffield et al., 1977) with
prolidase deficiency. Fibroblasts and amniotic fluid cells
were cultured as previously described (Butterworth,
1982; Butterworth and Priestman, 1984). Red and white
blood cells were obtained from venous blood from
children by dextran sedimentation (Snyder and Brady,
1969) and washed three times with 155 mmol L_1
sodium chloride. Tissues were obtained at autopsy
within 48 h of death from children aged less than 1 year
old. All cells and tissues were stored at — 70°C until
required. Cell and tissue extracts were prepared in
lOmmolL-1 veronal-HCl buffer pH 7.4 with
50mmol L-1 sodium chloride and centrifuged at
100 000 g for 60 min (Butterworth and Priestman, 1982),
or without sodium chloride and centrifuged at 8800 g for
5 min (Eppendorf 5413 Centrifuge).
The separation of cell and tissue prolidase into two
components was achieved by applying 1 ml (10% w/v)
tissue extract, 1 ml red blood cell extract or serum (50mg
proteinml"1) or 1ml fibroblast extract (5mg protein
ml-1) in lOmmolL"1 veronal-HCl buffer pH7.4
containing 50mmolL_1 sodium chloride to a
0.8 x 5 cm DEAE-cellulose column, eluting with a
50-300mmol L_1 sodium chloride gradient and
collecting 1.5 ml fractions. A DEAE-cellulose batch
method was developed for the separation and estimation
of the two prolidase activities. A mixture of 0.25 ml 50 %
(v/v) DEAE-cellulose slurry in 10 mmol L_1
veronal-HCl buffer pH7.4, 0.125 ml sodium chloride
and 0.125 ml 2% (w/v) extract in 10mmol L_1
veronal-HCl buffer pH 7.4 was mixed for 15 min at
10°C, centrifuged at 1000 g for 10 min and the amount of
unbound prolidase estimated against phenylalanyl-l-
proline. The addition of 480mmolL"1 sodium chloride
released peak I prolidase and 1000 mmol 1_1 sodium
chloride released both peaks and their sequential use
allowed the separation of both peaks.
Prolidase activity was measured using a variety of
substrates (glycyl-l-proline, Gly-Pro; phenylalanyl-l-
proline, Phe-Pro; alanyl-l-proline, Ala-Pro; valyl-l-
proline, Val-Pro and leucyl-l-proline, Leu-Pro; Sigma
Ltd) by estimating liberated proline or phenylalanine
(Mayer and Nordwig, 1973; Butterworth and Priestman,
1984; Priestman and Butterworth, 1984) and related to
protein using bovine serum albumin as standard (Lowry
et al., 1951). The properties of the two peaks were




Using DEAE-cellulose column chromatography two
peaks of prolidase were eluted at 135 and 210 mmol L~1
sodium chloride with a > 70 % recovery (Figure 1).
Dialysis of a sample against buffer inactivated peak II
but the inclusion of 0.1 mmol L~1 dithiothreitol during
dialysis prevented this loss. This would explain previous
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Figure 1 DEAE-cellulose column chromatography of control, Case 1 and Case 2 fibroblast prolidase activity against Phe-Pro.
Peaks I and II are named in order of elution. Samples were preincubated at 37°C for 5min with ImmolL"1 Mn2 +
failures to detect peak II activity (Butterworth and
Priestman, 1984; Myara et al, 1984). All the control cells
and tissues examined had the two peaks of prolidase,
whilst serum with a very low activity (1 nmol min-1 (mg
protein-1)) showed a single peak eluting prior to the
position of peak I at about 85mmolL-1 NaCl. A
marked reduction in peak I activity, but an unchanged
peak II activity, was found in fibroblasts from the two
cases of prolidase-deficiency (Figure 1). The first of the
two peaks, therefore, corresponds to the prolidase
purified from red blood cells by Endo et al. (1982).
The DEAE-cellulose batch method gave a recovery of
> 95 % of total activity. The reproducibility of the batch
method, as checked by estimating the two peaks ten
times for one frontal cortex extract, was excellent with
the coefficient of variation for peak I being 2 % and for
peak II 3%. Hence estimation of the two peaks should
be more reliable, besides being quicker and easier, with
the batch than the column method. Following
separation the two peaks could be mixed together to
give the expected activity indicating no interference with
each other in the assay. The specific activities against
Phe-Pro and the percentage of peak I determined by the
batch method for the different cells and tissues are given
in Table 1. A 2 % (w/v) extract was needed for the tissues,
except for kidney and pancreas (1% w/v), and about
1 mg protein for the cells. An assay time of 20 min was
required for all the enzyme sources, except for red blood
cells (30 min). The percentages of peak I in control cells
and tissues determined by the DEAE-cellulose column
method were similar to the values given for the batch
method. The high level of peak II prolidase in the
pancreas indicates a particularly important role for this
enzyme in the pancreas. The percentage of residual peak
I activity in the two cases was higher for the batch than
the column method. The greater loss of enzyme in the
Table 1 Cell and tissue prolidase activity against Phe-Pro*
and percent peak I estimated by the DEAE-cellulose batch
method
Sample Specific activity % Peak I
Fibroblasts:
Controls, n — 10 100 + 8f 53 + 4
Case 1 42 16
Case 2 57 11
Amniotic fluid cells,
n = 10 108 + 15 55 + 3
Red blood cells 5.7, 6.1, 6.7 68, 73
White blood cells 54, 58, 64, 66 42, 42, 44, 50
Kidney 190, 213, 236, 291 60, 68, 73
Liver 56, 63 77, 77
Spleen 57, 71 68, 74
Pancreas 235, 287 24, 34
Cerebral frontal cortex
n = 10 108 + 16 40 + 4
Heart 64, 77 53, 61
Skeletal muscle 55 50
*nmol min"1 (mg protein)"1; enzyme preincubated 5min with ImmolL"1
Mn2 +
t Mean + SD
Control
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ible 2 Activity, relative % and residual percent of prolidase peaks of control and Case 1 prolidase-deficient fibroblasts separated by the DEAE-
llulose batch method
Control Case 1
Peak I Peak II Peak I Peak II
bstrate Activity* Relative %t Activity Relative % Activity Relative % Residual °/0% Activity Relative % Residual %
le-Pro 4.5 100 3.2 100 0.40 100 9 3.6 100 113
il-Pro 3.1 69 2.6 81 0.11 28 4 2.5 69 96
u-Pro 3.3 73 3.0 94 0.26 65 8 3.4 95 113
a-Pro 9.4 211 4.3 135 0.16 40 2 4.3 119 100
y-Pro 16.4 365 3.4 106 0.46 115 3 0.34 9 10
mol min "1 ml"1; peak I preincubated with 1 mmol L~1 Mn2 + 30 min, except Gly-Pro 60 min; peak II no preincubation, 1 mmol L ~1 Mn2 + with substrate, except Gly-Pro 60min
incubation
elative %: activity against substrate relative to Phe-Pro
esidual %: case peak activity relative to control peak activity
column method possibly resulted in an underestimate of
abnormal peak I. The specific activity and percentage of
the two peaks for cultured skin fibroblasts and amniotic
fluid cells were similar indicating that a prolidase
abnormality detected in skin fibroblasts should also be
present in amniotic fluid cells.
Properties
Scaling up the DEAE-cellular batch method allowed
the rapid preparation of the two peaks with excellent
recovery permitting analysis of both prolidase peaks
from control and prolidase-deficient fibroblasts.
Substrates (Table 2)
Control peak I prolidase hydrolysed Ala-Pro, and
particularly Gly-Pro, at a faster rate than peak II. As
shown for Case 1, peak I residual activity against all five
substrates was low compared with the control. Peak II
relative and residual activities were similar to those of
the control except that both of these parameters were
reduced to about 10 % forGly-Pro The previous finding
(Priestman and Butterworth, 1984) that the enzyme in
prolidase-deficient fibroblast extracts showed changes
in the rate of hydrolysis of a number of substrates can be
explained by the changed rate at which both peaks of
abnormal prolidase hydrolyse the various substrates.
Indeed the much reduced ability of abnormal peak II to
hydrolyse Gly-Pro as compared with the other
substrates explains why only activity against Gly-Pro
showed a marked deficiency in an abnormal fibroblast
extract (Priestman and Butterworth, 1984). Reports
(Gray etai, 1983 ;Pedersen etal., 1983; Butterworth and
Priestman, 1984; Naughton et al., 1984; Priestman and
Butterworth, 1984) showing residual activity against
Gly-Pro in prolidase deficiency can be attributed to the
use of assay conditions capable of detecting peak II
activity.
Mn2+ Response (Figure 2)
Control peak I activity towards Phe-Pro was optimal
following 10-20 min preincubation at 37°C with Mn2 + ,
but was reduced by preincubation without Mn2+'
(Figure 2(A), (B)). In contrast, control peak II was
inactivated by preincubation with Mn2+ (Figure 2(A))
Figure 2 Effect ofMn2+ on control (•) and abnormal (A) peak I ( ) and peak II ( ) fibroblast prolidase activity. (A) Phe-
Pro: preincubated with 1 mmolL"1 Mn2+ for up to 60 min. (B)Phe-Pro: peak I preincubated 20min with Mn2+; peak II Mn2 +
added with substrate. (C) Gly-Pro: preincubated 60min with Mn2 +
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Table 3 Km values of control and abnormal fibroblast prolidase
Preincubation Mn1 +
Substrate Source (min) (mmolL-1) Km
Gly-Pro Control extract 5 5 2.5
Control extract 60 5 9.0
Control peak I 60 5 17
Control peak II 60 5 7
Case 2 peak II 60 5 33
Phe-Pro Control peak I 30 1 0.5
Control peak II 0 18
Case 1 peak II 0 1 16
Case 2 peak II 0 1 36
Enzyme was preincubated with Mn2+ or Mn2+ added with substrate (0-20mmol L ')
and optimal activity was obtained by the addition of
0.5-1 mmol L_1 Mn2+ with the substrate (Figure 2(B)).
The two abnormal peaks had the same responses, except
that peak II was even more unstable in the presence of
Mn2 + . Full activity against Gly-Pro for both control
peaks required preincubation with 5mmolL"1 Mn2 +
for 60 min (Figure 2(C)). The small amount of peak I in
the cases also needed 5mmolL_1 Mn2+, but peak II
only required 0.1 mmol L~1 Mn2+ (Figure 2(C)). Hence
the failure of prolidase-deficient fibroblast activity
against Phe-Pro to be increased by Mn2 + preincubation
(Butterworth and Priestman, 1984; Priestman and
Butterworth, 1984) can be explained by the loss of
Mn2 +-activated peak I in the disease.
Substrate Km (Table 5)
The response of normal and abnormal prolidase to a
number of substrates was analysed by Eadie-Hofstee
plots and the Km values are given in Table 3. The
estimate of data variation (SD(E)Rad; Zivin and Waud,
1982) for both substrateswas less than 0.07, indicating the
results to be acceptable. There was insufficient abnormal
peak I for the reliable estimation of Km values. The
results indicate that peak II prolidase of the cases had
decreased affinities for both Gly-Pro and Phe-Pro.
Decreased affinities for eight substrates have previously
been reported (Priestman and Butterworth, 1984) for
abnormal fibroblast prolidase. The present results for
Gly-Pro and Phe-Pro would indicate that this finding
was due to the loss of peak I and the increase in the Km
values for peak II in the disease.
Heat stability (Figure 3)
At 48°C loss of control peak I activity against Phe-Pro
was completely prevented by the presence of
1 mmol L ~1 Mnu, whereas control peak II activity was
only partially protected. However, abnormal peak II





















Figure 3 Effect of heat (48°C) on control, Case 1 and Case 2 fibroblast prolidase peak I ( )and peak II ( ) in the presence (O)
or absence (x ) of lmmolL"1 Mn2+ and assayed with Phe-Pro
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present, whilst in Case 2 the activity was more stable in
the absence of Mn2 + and more labile in the presence of
Mn2+ than control peak II. Similar, but smaller,
changes were observed at 37°C. Loss of Mn2 + stabilized
peak I and decreased stability of peak II explains the
reduced heat stability of prolidase-deficient fibroblast
activity (Priestman and Butterworth, 1984).
Para-hydroxymercuribenzoate (PHMB) inhibition
Control peak I preincubated with 1 mmol L "1 Mn2 + for
30min lost about 20 % of activity against Phe-Pro when
treated with 0.05 mmol L_1 PHMB. Control peak II
activity towards Phe-Pro, which does not require
Mn2+ preincubation, was inhibited 90% by
0.05mmol L"1 PHMB, whilst the activity against Gly-
Pro, which does require Mn2+ preincubation, was only
inhibited 50% following preincubation with
1 mmol L"1 Mn2+ for 60 min. However, irrespective of
conditions of treatment peak II activity of both cases
against Phe-Pro and Gly-Pro was completely abolished
by 0.05mmol L_1 PHMB. Protection of human
fibroblast peak I prolidase activity by Mn2+ against
PHMB inhibition suggests that Mn2+ binds to
prolidase via sulfhydryl groups, as found for swine
kidney prolidase (Davis and Smith, 1953). The inability
of Mn2+ to protect peak II activity and the need to add
Mn2+ with the substrate indicates that at least part of
the Mn2+ effect on peak II activity involves interaction
with the substrate. The loss of peak I explains the failure
of Mn2+ to protect prolidase-deficient fibroblast
activity against PHMB (Priestman and Butterworth,
1984).
Implications
The finding of a second form of prolidase can explain the
presence of a moderate prolidase activity in prolidase
deficiency cells (Butterworth and Priestman, 1984;
Priestman and Butterworth, 1984). The differences in the
properties of the two prolidases and their changes in the
disease mean that particular attention has to be paid to
their estimation. This can most easily be achieved by the
use of the DEAE-cellulose batch method followed by
appropriate assay conditions. Alteration of both
prolidases in prolidase-deficiency indicates a structural
relationship. As prolidase (peak I) is known (Endo et al.,
1982) to consist of two subunits, the most likely
explanation is a common subunit, which is changed in
the disease such as to alter substrate hydrolysis, but
further work on the purified enzymes will be needed to
answer this point.
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Intracellular Activity of HPRTC Town : Purine
Uptake and Growth of Cultured Cells in Selective Media
L. M. STEYN1 and E. H. HARLEY2
Department of Chemical Pathology, University of Cape Town Medical School,
Observatory, 7925, South Africa
The low activity of the human variant H PRTCape Town is associated with substrate inhibition by hypoxanthine
and guanine in vitro. The intracellular activity of this variant was investigated by studying the relative uptake
of radiolabeled purine nucleotide precursors and the growth in selective media of EBvirus-transformed
lymphoblasts prepared from the proband (TK). These cells incorporated less than 10% of the
[14C]hypoxanthine and [14C]guanine of the control cells; while their purine de novo synthesis was
accelerated 8-fold. In selective media the HPRTCapeTown cells grew in a similar manner to HPRT-ve cells.
These results indicate that if substrate inhibition is responsible for the low intracellular activity of
HPRTCapeTown> the concentration of either hypoxanthine or guanine in the vicinity of the active site of the
enzyme must be greater than the Ai(app) for these substrates, 118 and 28 pmol L~1 respectively. Evidence is
presented that the intracellular concentration of guanine, but not hypoxanthine, is well in excess of the Ai(app)
in cultured lymphoblasts.
Hypoxanthine-guanine phosphoribosyltransferase (EC
2.4.2.8) (HPRT) catalyses the salvage of the purine bases
hypoxanthine and guanine to form the product
nucleotides IMP and GMP with 5-phosphorylribose-l-
pyrophosphate, PP-ribose-P, acting as the phosphori-
bosyl donor. In man, hereditary deficiency of this
enzyme activity is associated with purine over¬
production and gout. The Lesch-Nyhan syndrome,
with its characteristic neurological features of choreo-
athetosis, mental retardation and compulsive self-
mutilation, is found in patients with the lowest
intracellular enzyme activities (Page et al, 1981).
Several low activity variants of human HPRT have
been described and changes in various kinetic para¬
meters and physical properties of these variants have
been characterized. These include altered Michaelis
constants for both purine base and phosphoribosyl
pyrophosphate substrates (McDonald and Kelley,
1971; Benke et al., 1973; Henderson et al., 1976;
Gutensohn and Jahn, 1979), increased intracellular
enzyme lability (Balis et al., 1974), increased suscepti¬
bility to product inhibition (Sperling et al., 1974;
Gutensohn and Jahn, 1979), a reduction in immuno¬
logically detectable HPRT protein (Upchurch et al.,
1975; Ghangas and Milman, 1975), and altered
electrophoretic mobility (Bakay and Nyhan, 1972;
Steyn and Harley, 1981; Wilson et al., 1982). The
molecular defect in HPRTLondon has been defined as an
amino acid substitution (Ser -<■ Leu) at position 109
(Wilson et al., 1983).
We have recently studied the low activity variant,
HPRTCape-rown, which is associated with purine over¬
production and gout in the proband, TK (Cassidy et al.,
1 Present address: Department of Medical Microbiology, University
of Cape Town Medical School, Observatory, 7925, South Africa.
2 Author to whom correspondence should be addressed.
1980). Kinetic studies on the isolated enzyme have
shown that the decreased activity is not caused by a
change in the Kmax or Km of the enzyme for any of its
substrates, but is associated with substrate inhibition by
the purine bases, hypoxanthine and guanine (Steyn and
Harley, 1984). The acquisition of substrate inhibition
represents a most unusual association with a low
enzyme activity in an inherited metabolic disorder. In
HPRTCapeTown it is not certain whether this property is the
consequence of a mutation affecting the primary amino
acid sequence of the enzyme, a mutation resulting in
altered post-translational modification, or even the
absence or alteration of a factor influencing normal
HPRT kinetics.
In order to help resolve these questions the
intracellular activity of HPRTCapeTown was investigated
in transformed lymphocytes by assessing the uptake of
radioactive purines by these cells and by determining
whether there were any secondary biochemical changes
that could be attributed to disruption of the purine
metabolic pathways. The incorporation of radioactive
purine bases into these cells by the salvage pathway was
found to be less than 10% of that of the control cell lines.
In contrast the flux through the de novo purine synthetic
pathway was eight times higher than in the normal cells
and was similar to that found in HPRT-ve cells,
obtained from a patient with the Lesch-Nyhan
syndrome. Furthermore, the HPRTCapeTown cells be¬
haved like the HPRT-ve cells when they were cultured in
various selective media.
MATERIALS
The following radioactive substrates were obtained from
The Radiochemical Centre, Amersham, UK: [8-
14C]hypoxanthine (SSmCimmoU1); [8-l4C]guanine
sulphate (51 mCimmol-1); [G-3H ]hypoxanthine
(1.2Cimmol x); [8-3H]guanine sulphate
(7Cimmol-1); [14C]formic acid, sodium salt
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Prolinase and non-specific dipeptidase of human kidney
David A. PRIESTMAN and John BUTTERWORTH
Department of Pathology, Royal Hospital for Sick Children and University of Edinburgh, Edinburgh EH9 1LF, Scotland, U.K.
Human kidney prolinase, assayed with Pro-Ala, and non-specific dipeptidase, assayed with Gly-Leu, were
purified by using DEAE-cellulose, gel-filtration, metal-ion-chelate, hydrophobic and adsorption chromato¬
graphy and chromatofocusing. Both enzymes gave single peaks of activity that were congruent and the ratio
of their activities was constant throughout the purification. Gel filtration indicated an Mr of 100000 and
chromatofocusing a pi of 5.4. Ni2+-chelate chromatography demonstrated the presence of exposed histidine
residues on the enzyme and was an effective separative procedure. Polyacrylamide-gel electrophoresis of the
final preparation showed the two enzyme activities to be coincident. Both enzyme activities decayed at the
same rate at 53 °C and were inhibited to the same extent by p-hydroxymercuribenzoate. Of six non-specific
dipeptidase substrates tested Gly-Leu gave the highest activity, and of six prolinase substrates Pro-Leu had
the highest activity. Gly-Leu was hydrolysed at double the rate of Pro-Leu. Pro-Ala was a competitive
inhibitor of activity towards Gly-Leu, and Gly-Leu was a competitive inhibitor of activity towards Pro-Ala.
Mixed-substrate studies strongly suggested that Gly-Leu and Pro-Ala were hydrolysed at a common active
site. The data are consistent with prolinase and non-specific dipeptidase activity in human kidney being due
to a single enzyme.
INTRODUCTION
Prolinase (EC 3.4.13.8) has been purified from a
number of animal tissues (Sarid et al., 1962; Mayer &
Nordwig, 1973; Akrawi & Bailey, 1976; Reith & Neidle,
1979), and in all cases the final preparations had
activity against non-specific-dipeptidase (EC 3.4.13.11)
substrates, which was attributed to a contaminating
enzyme. However, it has been proposed that the two
activities may be due to a single enzyme (Hayman &
Patterson, 1971). As kidney has been widely used in
studies on dipeptidases from animals (Sarid et al., 1962;
Mayer& Nordwig, 1973; Akrawi & Bailey, 1976) and had
the highest prolinase activity of the human organs tested
(Butterworth & Priestman, 1982), prolinase was purified
from human kidney. Increasing lability of dipeptidases
with purification appears to preclude purification to
homogeneity (Hayman & Patterson, 1971; Mayer &
Nordwig, 1973). To ascertain whether human kidney
prolinase and non-specific dipeptidase were the same
enzyme, we studied properties of the enzyme, including
substrate kinetics (Dixon &Webb, 1964, pp. 84-87), after




DEAE-cellulosewas obtained fromWhatman, Ultrogel
AcA-44 was from LKB, butyl-agarose from Miles
Laboratories, spheroidal hydroxyapatite was from BDH
Chemicals, 4-methylumbelliferyl 2-acetamido-2-deoxy-
/?-D-glucopyranoside and 4-methylumbelliferyl a-D-
mannopyranoside were from Koch-Light Laboratories,
and all other chemicals were from Sigma Chemical Co.
Enzyme assays
Prolinase was assayed in 25 mM-barbital/HCl buffer,
pH 9.2, containing 12.5 /<M-MnCl2 and 10 mM-prolyl-L-
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alanine (Pro-Ala), prolyl-L-glycine (Pro-Gly), prolyl-L-
leucine (Pro-Leu), prolyl-L-phenylalanine (Pro-Phe),
prolyl-L-valine (Pro-Val) or hydroxyprolylglycine
(Hyp-Gly), and the liberated amino acid was determined
fluorimetricallybyusingo-phthaldialdehyde (Butterworth
& Priestman, 1982). Non-specific dipeptidase was
assayed in 25mM-barbital/HCl buffer, pH 8.0, containing
10 mM-glycyl-L-leucine (Gly-Leu), L-alanyl-L-leucine
(Ala-Leu), L-valyl-L-leucine (Val-Leu), L-seryl-L-leucine
(Ser-Leu), L-phenylalanylglycine (Phe-Gly) or L-leucyl-
glycylglycine (Leu-Gly-Gly), and the liberated L-leucine
or L-phenylalanine was determined spectrophotometric-
ally by the L-amino acid oxidase/peroxidase-coupled
oxidation of o-dianisidine (Butterworth & Priestman,
1982). Prolidase (EC 3.4.13.9) was assayed against
glycyl-L-proline (Gly-Pro) by determination of liberated
proline and against L-phenylalanyl-L-proline (Phe-Pro)
by determination of liberated L-phenylalanine (Priestman
& Butterworth, 1984). Proline iminopeptidase (EC
3.4.11.5) activity was determined by determination of
liberated proline from prolylglycylglycine (Pro-Gly-Gly)
(Butterworth & Priestman, 1984).
Column fractions were diluted appropriately before
enzyme assay with bovine serum albumin (0.25 mg/ml)
in 10 mM-barbital/HCl buffer, pH 7.4, containing
50 mM-NaCl. Protein was determined by the method of
Lowry et al. (1951), with bovine serum albumin as
standard. One unit of enzyme activity was defined as the
formation of 1 /tmol of product/min at 37 °C.
Extract preparation
Human kidney was obtained at autopsy 24 h after
death and stored at —70 °C. A 20% (w/v) extract was
prepared by homogenizing in 10 mM-barbital/HCl
buffer, pH 7.4, containing 50 mM-NaCl (buffer A). The
homogenate was sonicated at 8-12 /im (MSE mark II
ultrasonic disintegrator) and centrifuged at 100000# for
60 min.
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Chromatographic procedures
All procedures were carried out at 4 °C unless
otherwise stated.
DEAE-cellulose. Kidney extract (50 ml) was applied to
a 3.5 cm x 45 cm DEAE-cellulose column equilibrated
with buffer A. After a washing with 200 ml of buffer A,
the column was eluted with 500 ml of a 50-300 mM-NaCl
linear gradient, and 10 ml fractions were collected.
Gel filtration. The DEAE-cellulose peak (95 ml) was
concentrated 10-fold by using a PM10 ultrafiltration
membrane system (Diaflo), applied to a 2.5 cm x 75 cm
Ultrogel AcA-44 column, eluted with buffer A at 20 ml/h
and 10 ml fractions were collected.
Metal-ion-chelate chromatography. Iminodiacetic acid
was coupled to epoxy-activated Sepharose 6B (Porath et
al., 1975) and converted into a metal-ion-chelate gel by
the passage of 5 ml of 50 mM-NiCl2 or 50 mM-MnCl2 in
water through 2.5 ml of gel in a 1 cm x 3.5 cm column.
The Ni2+-chelate gel was equilibrated with buffer A, and
40 ml of Ultrogel prolinase peak was applied to the
column. Afterwashing with 20 ml of 10 mM-barbital/HCl
buffer, pH 7.4, containing 10 mM-NaCl (buffer B), the
column was eluted with 60 ml of a 0-100 mM-imidazole
linear gradient (in buffer B), and 2 ml fractions were
collected.
Hydrophobic chromatography. The prolinase peak
(16 ml) from the metal-ion-chelate chromatography was
applied to a 1.4 cm x 25 cm butyl-agarose column
equilibrated with buffer B. The column was washed with
75 ml ofbufferB, eluted with 100 ml ofa 10-300 mM-NaCl
linear gradient, and 4 ml fractions were collected.
Hydroxyapatite chromatography. The prolinase peak
(30 ml) from the hydrophobic chromatography was
applied to a 1.3 cm x 6.5 cm hydroxyapatite column
equilibrated with buffer A. The column was washed with
50 ml of buffer A, eluted with 100 ml of a 0-150 mM-
sodium phosphate linear gradient in buffer A, and 5 ml
fractions were collected.
Chromatofocusing. The prolinase peak (15 ml) from
the hydroxyapatite chromatography was concentrated
10-fold by ultrafiltration, diluted (1 + 1) with 25 mM-
imidazole/HCl buffer, pH 7.4, and applied to a
1.3 cm x 5 cm PBE 94 column equilibrated with this
buffer. Elution was carried out with 60 ml of Polybuffer
74 titrated with HC1 to pH 4.0, and 2 ml fractions were
collected.
Mr determination
A 1% (w/v) kidney extract (10 ml) in buffer A was
applied to a 2.5 cm x 75 cm Ultrogel AcA-44 column,
eluted with buffer A at 20 ml/h, and 10 ml fractions were
collected. The elution volumes of prolinase, A-acetyl-
/?-D-glucosaminidase (Butterworth et al., 1976) and
a-D-mannosidase (Butterworth, 1980) were determined.
A mixture (10 ml) containing 1 ml of the enzyme peak
from hydrophobic chromatography and five protein
standards was applied to the same column, and 3 ml
fractions were collected. The elution volumes of the
protein standards were determined after detection at
280 nm.
Polyacrylamide-gel electrophoresis
Discontinuous electrophoresis (4.5% stacking, 7.5%
separating gel, 0.75 mm thick) was performed with a
Bio-Rad Protean slab electrophoresis cell (Davis, 1964).
Concentrated samples (10 /zl) of the original kidney
extract and the hydroxyapatite peak were applied and
electrophoresed at 14 mA for 4.5 h. The gel lanes were cut
into 0.25 cm strips and bisected, one half for prolinase
assay and the other half for non-specific-dipeptidase
assay. For prolinase each gel strip was put into 100//I
of 50 mM-barbital/HCl buffer, pH 9.2, containing
0.025 mM-MnCl2, incubated for 60 min after the addition
of 100 /zl of 10 mM-Pro-Phe, and liberated phenylalanine
was determined (Butterworth & Priestman, 1982). For
non-specific dipeptidase each gel strip was put into 100 /i\
of 50 mM-barbital/HCl buffer, pH 8.0, incubated for
60 min after the addition of 100 /zl of 25 mM-Gly-Leu,
and liberated leucine was determined (Butterworth &
Priestman, 1982). Protein bands were detected by using
the silver staining method of Merril & Goldman (1984).
Enzyme characteristics
Studies were performed on the dipeptidase peak eluted
after hydrophobic chromatography and after chromato¬
focusing following equilibration with buffer A by
ultrafiltration.
Heat-lability. Enzyme samples were incubated at 53 °C
for up to 30 min before the assay of prolinase (Pro-Ala)
and non-specific dipeptidase (Gly-Leu).
/>-Hydroxymercuribenzoate treatment. Enzyme samples
were treated with 1-50 /iM-p-hydroxymercuribenzoate
for 5 min at 37 °C before the assay of prolinase (Pro-Ala)
and non-specific dipeptidase (Gly-Leu).
Substrate specificity. The enzyme preparation after
chromatofocusing was tested against a number of
potential substrates (see above under 'Enzyme assays').
Substrate kinetics. The type of inhibition and Kx values
were determined (Dixon & Webb, 1964, pp. 327-329) by
studying the hydrolysis of Pro-Ala (2 or 5 mM) at pH 9.2
in the presence of Gly-Leu (0.5-10 and 1-25 mM
respectively) and of Gly-Leu (0.5 or 2 mM) at pH 8.0 in
the presence ofPro-Ala (0.1-2 and 1-10 mM respectively).
As a test of the activities being due to a single enzyme
(Dixon & Webb, 1964, pp. 84-87), Pro-Ala (5 mM)
hydrolysis at pH 9.2 with or without Gly-Leu (5 mM) and
Gly-Leu (5 mM) hydrolysis at pH 9.2 with or without
Pro-Ala (5 mM) were monitored, and the Kj value for
Pro-Ala at pH 9.2 was determined.
RESULTS
The purification ofprolinase and non-specific dipeptid¬
ase is summarized in Table 1. To assay the two enzyme
activities in the original kidney extract, it was necessary
to dilute to a low protein concentration (<0.01 mg/ml),
at which the enzyme was unstable. Addition of bovine
serum albumin (0.25 mg/ml) stabilized the enzyme to
dilution. During the purification procedure the protein
concentration of the active fractions up to and including
the hydroxyapatitecolumn chromatographywas sufficient
to maintain stability, but addition of bovine serum
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Table 1. Purification of human kidney prolinase and non-specific dipeptidase




Protein Activity activity Yield Activity activity Yield
(mg) (units) (units/mg) (%) (units) (units/m^) (%)
Crude extract 948 631 0.657 100 4888 5.16 100
100000 g supernatant 354 573 1.62 91 4444 12.6 91
DEAE-cellulose fraction 56.2 319 5.68 50 2333 41.5 48
Ultrogel AcA-44 fraction 15.6 283 18.1 45 2151 138 44
Ni2+-chelated-Sepharose fraction 3.7 148 40.0 23 1194 323 24
Butyl-agarose fraction 1.27 127 100 20 1050 827 21
Hydroxyapatite fraction 0.27 87 319 14 700 2564 14
Chromatofocusing fraction — 17 — 2.6 116 — 2.
albumin was required for dilution of the column fractions
before assay. A preparation retained after hydrophobic
chromatography was stable for 9 months at 4 °C in the
presence of bovine serum albumin. Co-elution of both of
the enzyme activities as a single peak was observed for
all the separative procedures, either performed singly
with a crude kidney extract or during the sequential
purification. The ratio of the two activities was similar
after each of the separative procedures.
During the sequential purification procedure the two
enzyme activities were co-eluted with the highest activity
at HOmM-NaCl for the DEAE-cellulose column,
30 mM-imidazole for the Ni2+-chelate column,
100 mM-NaCl for the butyl-agarose column and 30 mM-
phosphate for the hydroxyapatite column. AMn2+-chelate
gel did not retain either enzyme activity. The relative
elution volumes (ft/ V0) ofN-acetyl-/?-D-glucosaminidase
and a-D-mannosidase lay on the gel-filtration Mr
calibration curve and give Mr values of 110000 and
180000 respectively. The position of the enzyme, as
detected by its prolinase and non-specific dipeptidase
activity, indicated an MT of 100000 (Fig. 1). Elution from
the chromatofocusing column indicated a pi of 5.3 for the
enzyme. Silver staining of the polyacrylamide gel after
electrophoresis of the pooled enzyme activity from the
hydroxyapatite column revealed the presence of two
major and three minor protein bands (Fig. 2a). Band I
(Fig. 2a) was the marker Bromophenol Blue and band II
was a staining artifact. The gel showed a coincident band
of prolinase and non-specific dipeptidase activity (Fig.
2b). A crude kidney extract gave the same position for the
two enzyme activities.
As recovery of enzyme activity was poor from the
chromatofocusing column and involved exposure to
acidic pFI, properties of the enzyme were studied after the
hydrophobic-chromatography as well as the chromato¬
focusing procedures. However, the results were the same
for both enzyme preparations. Heat treatment of the
enzyme at 53 °C resulted in a similar rate of loss ofactivity
against Gly-Leu and Pro-Ala, with a 50% loss of activity
after about 12min (Fig. 3). The thiol-blocking reagent
p-hydroxymercuribenzoate was markedly inhibitory of
enzyme activity against both substrates with 50%
inhibition at about 14 pM (Fig. 4).
The activity of the final enzyme preparation against a
range of potential substrates (10 mM) is given in Table 2.
5.5 r
4.0 -
i i l i i i i i
1.0 1.5 2.0 2.5 3.0
v./v0
Fig. 1. Calibration of Ultrogel column for Mt determination
The relationship between the relative elution volumes (Ve,
elution volume; V0, void volume) and the logarithms of the
Mr values ofcertain proteins is shown for Ultrogel AcA-44.
For experimental details see the Materials and methods
section. Key: (1) a-D-mannosidase; (2) alcohol dehydro¬
genase; (3) /V-acetyl-/i-D-glucosaminidase; (4) haemo¬
globin; (5) ovalbumin; (6) chymotrypsinogen A;
(7) cytochrome c; (8) prolinase and non-specific
dipeptidase.
Of the non-specific dipeptidase substrates the highest
activitywas againstGly-Leu; Phe-Glywas not hydrolysed.
Three of the prolinase substrates (Pro-Leu, Pro-Phe and
Pro-Val) gave activities that were higher than the activity
towards Pro-Ala, the substrate used to monitor the
enzyme purification. The enzyme had no activity towards
Pro-Gly-Gly, the substrate for proline iminopeptidase,
and towards Gly-Pro and Phe-Pro, substrates for
prolidase. Analysis of substrate interactions by Dixon
(1953) plots showed that Gly-Leu was a competitive
inhibitor of enzyme activity towards Pro-Ala with a
of 1.1 mM at pH 9.2 (Fig. 5), and Pro-Ala was a
competitive inhibitor ofenzyme activity towards Gly-Leu
with a Ki of 0.22 mM at pH 8.0 (Fig. 6) and 2.2 mM at pH
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Fig. 2. Polyacrylamide-gel electrophoresis of human kidney
dipeptidase
The gel was prepared, run and stained or the enzyme
activities were determined for the hydroxyapatite peak as
described in the Materials and methods section, (a)
Silver-staining for protein in the separating gel (10 cm). O,
Origin; +, anode end of gel. Band I was the tracking dye
Bromophenol Blue and Band II was a staining artifact, (b)
Dipeptidase relative activity in gel slices (0.25 cm) against
Gly-Leu and Pro-Phe.
[p-Hydroxymercuribenzoate] (mm)
Fig. 4. Inhibition of human kidney dipeptidase by p-hydroxy-
mercuribenzoate
The enzyme peak after chromatofocusing was equilibrated
with 10 mM-barbital/HCl buffer, pH 7.4, containing
50 mM-NaCl, treated with 1-50 /zM-p-hydroxymercuri-
benzoate and remaining prolinase (#) and non-specific
dipeptidase (O) were determined as described in the
Materials and methods section.
Table 2. Hydrolysis of dipeptides and tripeptides by the purified
human kidney enzyme
Time (min)
Fig. 3. Heat treatment of human kidney dipeptidase
The enzyme peak after chromatofocusing was equilibrated
with 10 mM-barbital/HCl buffer, pH 7.4, containing
50 mM-NaCl, heated at 53 °C for up to 30 min and
remaining prolinase (#) and non-specific dipeptidase (O)
activities were determined as described in the Materials and
methods section.
The activity of the enzyme preparation after chromato¬
focusing was determined against potential substrates




















9.2. The Km for the enzyme against Pro-Ala was 0.47 mM
at pH 9.2, and the Km against Gly-Leu was 0.79 mM at
pH 8.0 and pH 9.2. The expected hydrolysis of equimolar
concentrations of two substrates by (a) one or (b) two
enzymes in an extract can be calculated by using




Fig. §. Determination of A) for Gly-Leu inhibition of prolinase
activity against Pro-Ala
The hydrolysis of (a) 2 mM- and (b) 5 mM-Pro-Ala in the
presence of a series of concentrations of Gly-Leu was
determined. The A) was determined by the method of
Dixon (1953).
[Pro-Ala] (mM)
Fig. 6. Determination of K, for Pro-Ala inhibition of non-specific
dipeptidase activity against Gly-Leu
The hydrolysis of (a) 0.5 mM- and (b) 2 mM-Gly-Leu in the
presence of a series of concentrations of Pro-Ala was
determined. The A; was determined by the method of
Dixon (1953).
the two substrates (Dixon & Webb, 1964, pp. 84-87).
Whether the activity against both substrates is due to one
or two enzymes can be assessed by comparison of the two
calculated rates of hydrolysis with the observed rate.
The present data gave a calculated total activity of 8.9
693
units/ml for one enzyme and 16.6 units/ml for two
enzymes working on equimolar concentrations (5 mM) of
the two substrates. As the observed total activity was 9.2
units/ml, it seems highly probable that the preparation
contained a single enzyme hydrolysing both substrates.
DISCUSSION
Non-specific dipeptidases purified from pig and
guinea-pig intestinal mucosa (Noren et al., 1973; Piggott
& Fottrell, 1975) and mouse ascites tumour (Hayman &
Patterson, 1971) hydrolysed prolinase substrates. Con¬
versely, prolinases purified from pig kidney (Sarid et al.,
1962; Mayer & Nordwig, 1973), bovine kidney (Akrawi
& Bailey, 1976) and mouse brain (Reith & Neidle, 1979)
hydrolysed non-specific dipeptidase substrates. Also, the
major peak of human skin-fibroblast prolinase coincided
with a peak ofnon-specific dipeptidase on DEAE-cellulose
chromatography (Butterworth & Priestman, 1984).
Generally, the two activities had been considered to be
due to at least two enzymes, and whether there is an
enzyme capable of hydrolysing both prolinase and
non-specific-dipeptidase substrates is undecided, particu¬
larly for human tissues.
Prolinase and non-specific dipeptidase from human
kidney were soluble, in agreement with results for human
skin fibroblasts (Butterworth & Priestman, 1982) and pig
kidney (Mayer & Nordwig, 1973). The elution position
of the human kidney enzyme on DEAE-cellulose
chromatography corresponded to that of the major peak
of human skin-fibroblast prolinase (Butterworth &
Priestman, 1982, 1984). The accuracy of the Mr
calibration curve was demonstrated by obtaining the
expected Mr values for a-D-mannosidase and A-acetyl-
/?-D-glucosaminidase (Marinkovic & Marinkovic, 1976a,
b). The determined Mr value of 100000 for the human
kidney dipeptidase was similar to the value reported for
bovine kidney prolinase (Akrawi & Bailey, 1976), but was
lower than the value of 300000 estimated for pig kidney
prolinase (Mayer & Nordwig, 1973).
Metal-ion-chelate chromatography separates proteins
on the basis of their affinity for heavy-metal ions (Porath
et al., 1975; Porath & Olin, 1983). Histidine and cysteine
form complexes with Zn2+, Co2+, Hg2+ and Ni2+, and
proteins containing these amino acids on their surface can
potentially bind to metal-ion-chelated Sepharose (Porath
et al., 1975). Although Mn2+ activates prolinase
(Butterworth & Priestman, 1982) and a number of other
enzymes (Dixon & Webb, 1964, pp. 672-785), the weak
capacity of gel-immobilized Mn2+ for protein binding
(Porath et al., 1975) could explain why the Mn2+-chelate
gel did not adsorb prolinase. Affinity elution of human
kidney dipeptidase from a Ni2+-chelate gel by imidazole
strongly suggests the presence of histidine residues on the
surface of the enzyme (Porath & Olin, 1983). The results
obtained with human kidney dipeptidase demonstrate the
usefulness of the inclusion of a metal-ion-chelate-
chromatography step in enzyme purification.
The binding of human skin-fibroblast prolinase to
butyl-agarose (Butterworth & Priestman, 1982) and of
pig intestinal non-specific dipeptidase to hydroxyapatite
(Noren et al., 1973) was the same as that of the human
kidney enzyme. Although bovine (Akrawi & Bailey, 1976)
and pig (Mayer & Nordwig, 1973) kidney prolinase gave
a pi of 4.3 on isoelectric focusing, the pi value of 5.3 for
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the human kidney preparation was within the range
5.05-5.3 obtained by chromatofocusing of preparations
of human skin fibroblasts, liver and kidney (Butterworth
& Priestman, 1984). The marked loss of human kidney
enzyme activity on chromatofocusing was probably due
to exposure to acidic pH, which is known to inactivate
the enzyme (Butterworth & Priestman, 1982). The
presence of multiple bands of activity, probably due to
separation into subunits and re-aggregation, on polyacryl-
amide-gel electrophoresis of purified pig kidney prolinase
(Mayer & Nordwig, 1973) was not a feature of the human
kidney enzyme.
The inhibition ofhuman kidney dipeptidase activity by
p-hydroxymercuribenzoate indicates the presence of a
thiol group at the active site, as previously suggested for
monkey intestinal (Das & Radhakrishnan, 1972) and pig
kidney enzyme (Sarid et al., 1962). Although Gly-Leu was
the best of the substrates tested for human kidney
dipeptidase, the hydrolysis of non-specific-dipeptidase
substrates varies widely, depending on conditions of
assay and source of enzyme (Hayman & Patterson, 1971;
Mayer & Nordwig, 1973; Noren et al., 1973). The ability
of the human kidney enzyme to hydrolyse prolinase
substrates was similar to that of human skin-fibroblast
prolinase (Butterworth & Priestman, 1982). In contrast
with the human enzyme, pig kidney (Mayer & Nordwig,
1973) and guinea-pig intestinal-mucosal (Piggott &
Fottrell, 1975) prolinase had very little activity towards
Pro-Leu and Pro-Phe. The failure of the human kidney
enzyme to hydrolyse Pro-Gly-Gly, the substrate for
proline iminopeptidase and Gly-Pro and Phe-Pro,
substrates for prolidase, agrees with the previous findings
for pig and bovine kidney prolinase (Sarid et al., 1962;
Mayer & Nordwig, 1973; Akrawi & Bailey, 1976).
Throughout the purification procedures the human
kidney prolinase and non-specific dipeptidase activities
could not be separated. The enzyme peaks were
congruent and the ratio of their activities was constant
after each of the separative procedures. In addition, the
responses of the two activities to p-hydroxymercuriben-
zoate and to heat treatment were the same. These data,
together with the competitive inhibition of prolinase and
non-specific dipeptidase activity by Gly-Leu and Pro-Ala
respectively and the analysis of substrate interaction
(Dixon & Webb, 1964, pp. 84-87), provide firm evidence
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for the existence of an enzyme hydrolysing both prolinase
and non-specific dipeptidase substrates in human kidney.
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